Gene	"Gene synonym"	Ensembl	"Gene description"	Uniprot	Chromosome	Position	"Protein class"	"Biological process"	"Molecular function"	"Disease involvement"	Evidence	"HPA evidence"	"UniProt evidence"	"NeXtProt evidence"	"RNA tissue specificity"	"RNA tissue distribution"	"RNA tissue specificity score"	"RNA tissue specific nTPM"	"RNA single cell type specificity"	"RNA single cell type distribution"	"RNA single cell type specificity score"	"RNA single cell type specific nTPM"	"RNA cancer specificity"	"RNA cancer distribution"	"RNA cancer specificity score"	"RNA cancer specific FPKM"	"RNA brain regional specificity"	"RNA brain regional distribution"	"RNA brain regional specificity score"	"RNA brain regional specific nTPM"	"RNA blood cell specificity"	"RNA blood cell distribution"	"RNA blood cell specificity score"	"RNA blood cell specific nTPM"	"RNA blood lineage specificity"	"RNA blood lineage distribution"	"RNA blood lineage specificity score"	"RNA blood lineage specific nTPM"	"RNA cell line specificity"	"RNA cell line distribution"	"RNA cell line specificity score"	"RNA cell line specific nTPM"	"RNA mouse brain regional specificity"	"RNA mouse brain regional distribution"	"RNA mouse brain regional specificity score"	"RNA mouse brain regional specific nTPM"	"RNA pig brain regional specificity"	"RNA pig brain regional distribution"	"RNA pig brain regional specificity score"	"RNA pig brain regional specific nTPM"	Antibody	"Reliability (IH)"	"Reliability (Mouse Brain)"	"Reliability (IF)"	"Subcellular location"	"Secretome location"	"CCD Protein"	"CCD Transcript"	"Blood concentration - Conc. blood IM [pg/L]"	"Blood concentration - Conc. blood MS [pg/L]"	"Blood expression cluster"	"Tissue expression cluster"	"Cell line expression cluster"	"Single cell expression cluster"	"Subcellular main location"	"Subcellular additional location"	"Antibody RRID"	"Pathology prognostics - Breast cancer"	"Pathology prognostics - Cervical cancer"	"Pathology prognostics - Colorectal cancer"	"Pathology prognostics - Endometrial cancer"	"Pathology prognostics - Glioma"	"Pathology prognostics - Head and neck cancer"	"Pathology prognostics - Liver cancer"	"Pathology prognostics - Lung cancer"	"Pathology prognostics - Melanoma"	"Pathology prognostics - Ovarian cancer"	"Pathology prognostics - Pancreatic cancer"	"Pathology prognostics - Prostate cancer"	"Pathology prognostics - Renal cancer"	"Pathology prognostics - Stomach cancer"	"Pathology prognostics - Testis cancer"	"Pathology prognostics - Thyroid cancer"	"Pathology prognostics - Urothelial cancer"	"Tissue RNA - adipose tissue [nTPM]"	"Tissue RNA - adrenal gland [nTPM]"	"Tissue RNA - amygdala [nTPM]"	"Tissue RNA - appendix [nTPM]"	"Tissue RNA - basal ganglia [nTPM]"	"Tissue RNA - bone marrow [nTPM]"	"Tissue RNA - breast [nTPM]"	"Tissue RNA - cerebellum [nTPM]"	"Tissue RNA - cerebral cortex [nTPM]"	"Tissue RNA - cervix [nTPM]"	"Tissue RNA - choroid plexus [nTPM]"	"Tissue RNA - colon [nTPM]"	"Tissue RNA - duodenum [nTPM]"	"Tissue RNA - endometrium 1 [nTPM]"	"Tissue RNA - epididymis [nTPM]"	"Tissue RNA - esophagus [nTPM]"	"Tissue RNA - fallopian tube [nTPM]"	"Tissue RNA - gallbladder [nTPM]"	"Tissue RNA - heart muscle [nTPM]"	"Tissue RNA - hippocampal formation [nTPM]"	"Tissue RNA - hypothalamus [nTPM]"	"Tissue RNA - kidney [nTPM]"	"Tissue RNA - liver [nTPM]"	"Tissue RNA - lung [nTPM]"	"Tissue RNA - lymph node [nTPM]"	"Tissue RNA - medulla oblongata [nTPM]"	"Tissue RNA - midbrain [nTPM]"	"Tissue RNA - ovary [nTPM]"	"Tissue RNA - pancreas [nTPM]"	"Tissue RNA - parathyroid gland [nTPM]"	"Tissue RNA - pituitary gland [nTPM]"	"Tissue RNA - placenta [nTPM]"	"Tissue RNA - pons [nTPM]"	"Tissue RNA - prostate [nTPM]"	"Tissue RNA - rectum [nTPM]"	"Tissue RNA - retina [nTPM]"	"Tissue RNA - salivary gland [nTPM]"	"Tissue RNA - seminal vesicle [nTPM]"	"Tissue RNA - skeletal muscle [nTPM]"	"Tissue RNA - skin 1 [nTPM]"	"Tissue RNA - small intestine [nTPM]"	"Tissue RNA - smooth muscle [nTPM]"	"Tissue RNA - spinal cord [nTPM]"	"Tissue RNA - spleen [nTPM]"	"Tissue RNA - stomach 1 [nTPM]"	"Tissue RNA - testis [nTPM]"	"Tissue RNA - thalamus [nTPM]"	"Tissue RNA - thymus [nTPM]"	"Tissue RNA - thyroid gland [nTPM]"	"Tissue RNA - tongue [nTPM]"	"Tissue RNA - tonsil [nTPM]"	"Tissue RNA - urinary bladder [nTPM]"	"Tissue RNA - vagina [nTPM]"	"Tissue RNA - white matter [nTPM]"	"Cell RNA - A-431 [nTPM]"	"Cell RNA - A549 [nTPM]"	"Cell RNA - AF22 [nTPM]"	"Cell RNA - AN3-CA [nTPM]"	"Cell RNA - ASC diff [nTPM]"	"Cell RNA - ASC TERT1 [nTPM]"	"Cell RNA - BEWO [nTPM]"	"Cell RNA - BJ [nTPM]"	"Cell RNA - BJ hTERT+ [nTPM]"	"Cell RNA - BJ hTERT+ SV40 Large T+ [nTPM]"	"Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [nTPM]"	"Cell RNA - CACO-2 [nTPM]"	"Cell RNA - CAPAN-2 [nTPM]"	"Cell RNA - Daudi [nTPM]"	"Cell RNA - EFO-21 [nTPM]"	"Cell RNA - fHDF/TERT166 [nTPM]"	"Cell RNA - GAMG [nTPM]"	"Cell RNA - HaCaT [nTPM]"	"Cell RNA - HAP1 [nTPM]"	"Cell RNA - HBEC3-KT [nTPM]"	"Cell RNA - HBF TERT88 [nTPM]"	"Cell RNA - HDLM-2 [nTPM]"	"Cell RNA - HEK 293 [nTPM]"	"Cell RNA - HEL [nTPM]"	"Cell RNA - HeLa [nTPM]"	"Cell RNA - Hep G2 [nTPM]"	"Cell RNA - HHSteC [nTPM]"	"Cell RNA - HL-60 [nTPM]"	"Cell RNA - HMC-1 [nTPM]"	"Cell RNA - HSkMC [nTPM]"	"Cell RNA - hTCEpi [nTPM]"	"Cell RNA - hTEC/SVTERT24-B [nTPM]"	"Cell RNA - hTERT-HME1 [nTPM]"	"Cell RNA - hTERT-RPE1 [nTPM]"	"Cell RNA - HUVEC TERT2 [nTPM]"	"Cell RNA - JURKAT [nTPM]"	"Cell RNA - K-562 [nTPM]"	"Cell RNA - Karpas-707 [nTPM]"	"Cell RNA - LHCN-M2 [nTPM]"	"Cell RNA - MCF7 [nTPM]"	"Cell RNA - MOLT-4 [nTPM]"	"Cell RNA - NB-4 [nTPM]"	"Cell RNA - NTERA-2 [nTPM]"	"Cell RNA - OE19 [nTPM]"	"Cell RNA - PC-3 [nTPM]"	"Cell RNA - REH [nTPM]"	"Cell RNA - RH-30 [nTPM]"	"Cell RNA - RPMI-8226 [nTPM]"	"Cell RNA - RPTEC TERT1 [nTPM]"	"Cell RNA - RT4 [nTPM]"	"Cell RNA - SCLC-21H [nTPM]"	"Cell RNA - SH-SY5Y [nTPM]"	"Cell RNA - SiHa [nTPM]"	"Cell RNA - SK-BR-3 [nTPM]"	"Cell RNA - SK-MEL-30 [nTPM]"	"Cell RNA - SuSa [nTPM]"	"Cell RNA - T-47d [nTPM]"	"Cell RNA - THP-1 [nTPM]"	"Cell RNA - TIME [nTPM]"	"Cell RNA - U-138 MG [nTPM]"	"Cell RNA - U-2 OS [nTPM]"	"Cell RNA - U-2197 [nTPM]"	"Cell RNA - U-251 MG [nTPM]"	"Cell RNA - U-266/70 [nTPM]"	"Cell RNA - U-266/84 [nTPM]"	"Cell RNA - U-698 [nTPM]"	"Cell RNA - U-87 MG [nTPM]"	"Cell RNA - U-937 [nTPM]"	"Cell RNA - WM-115 [nTPM]"	"Blood RNA - basophil [nTPM]"	"Blood RNA - classical monocyte [nTPM]"	"Blood RNA - eosinophil [nTPM]"	"Blood RNA - gdT-cell [nTPM]"	"Blood RNA - intermediate monocyte [nTPM]"	"Blood RNA - MAIT T-cell [nTPM]"	"Blood RNA - memory B-cell [nTPM]"	"Blood RNA - memory CD4 T-cell [nTPM]"	"Blood RNA - memory CD8 T-cell [nTPM]"	"Blood RNA - myeloid DC [nTPM]"	"Blood RNA - naive B-cell [nTPM]"	"Blood RNA - naive CD4 T-cell [nTPM]"	"Blood RNA - naive CD8 T-cell [nTPM]"	"Blood RNA - neutrophil [nTPM]"	"Blood RNA - NK-cell [nTPM]"	"Blood RNA - non-classical monocyte [nTPM]"	"Blood RNA - plasmacytoid DC [nTPM]"	"Blood RNA - T-reg [nTPM]"	"Blood RNA - total PBMC [nTPM]"	"Brain RNA - amygdala [nTPM]"	"Brain RNA - basal ganglia [nTPM]"	"Brain RNA - cerebellum [nTPM]"	"Brain RNA - cerebral cortex [nTPM]"	"Brain RNA - hippocampal formation [nTPM]"	"Brain RNA - hypothalamus [nTPM]"	"Brain RNA - medulla oblongata [nTPM]"	"Brain RNA - midbrain [nTPM]"	"Brain RNA - pons [nTPM]"	"Brain RNA - spinal cord [nTPM]"	"Brain RNA - thalamus [nTPM]"	"Brain RNA - white matter [nTPM]"	"Single Cell Type RNA - Adipocytes [nTPM]"	"Single Cell Type RNA - Alveolar cells type 1 [nTPM]"	"Single Cell Type RNA - Alveolar cells type 2 [nTPM]"	"Single Cell Type RNA - Astrocytes [nTPM]"	"Single Cell Type RNA - B-cells [nTPM]"	"Single Cell Type RNA - Basal keratinocytes [nTPM]"	"Single Cell Type RNA - Basal prostatic cells [nTPM]"	"Single Cell Type RNA - Basal respiratory cells [nTPM]"	"Single Cell Type RNA - Basal squamous epithelial cells [nTPM]"	"Single Cell Type RNA - Bipolar cells [nTPM]"	"Single Cell Type RNA - Breast glandular cells [nTPM]"	"Single Cell Type RNA - Breast myoepithelial cells [nTPM]"	"Single Cell Type RNA - Cardiomyocytes [nTPM]"	"Single Cell Type RNA - Cholangiocytes [nTPM]"	"Single Cell Type RNA - Club cells [nTPM]"	"Single Cell Type RNA - Collecting duct cells [nTPM]"	"Single Cell Type RNA - Cone photoreceptor cells [nTPM]"	"Single Cell Type RNA - Cytotrophoblasts [nTPM]"	"Single Cell Type RNA - dendritic cells [nTPM]"	"Single Cell Type RNA - Distal enterocytes [nTPM]"	"Single Cell Type RNA - Distal tubular cells [nTPM]"	"Single Cell Type RNA - Ductal cells [nTPM]"	"Single Cell Type RNA - Early spermatids [nTPM]"	"Single Cell Type RNA - Endometrial ciliated cells [nTPM]"	"Single Cell Type RNA - Endometrial stromal cells [nTPM]"	"Single Cell Type RNA - Endothelial cells [nTPM]"	"Single Cell Type RNA - Enteroendocrine cells [nTPM]"	"Single Cell Type RNA - Erythroid cells [nTPM]"	"Single Cell Type RNA - Excitatory neurons [nTPM]"	"Single Cell Type RNA - Exocrine glandular cells [nTPM]"	"Single Cell Type RNA - Extravillous trophoblasts [nTPM]"	"Single Cell Type RNA - Fibroblasts [nTPM]"	"Single Cell Type RNA - Gastric mucus-secreting cells [nTPM]"	"Single Cell Type RNA - Glandular and luminal cells [nTPM]"	"Single Cell Type RNA - granulocytes [nTPM]"	"Single Cell Type RNA - Granulosa cells [nTPM]"	"Single Cell Type RNA - Hepatic stellate cells [nTPM]"	"Single Cell Type RNA - Hepatocytes [nTPM]"	"Single Cell Type RNA - Hofbauer cells [nTPM]"	"Single Cell Type RNA - Horizontal cells [nTPM]"	"Single Cell Type RNA - Inhibitory neurons [nTPM]"	"Single Cell Type RNA - Intestinal goblet cells [nTPM]"	"Single Cell Type RNA - Ionocytes [nTPM]"	"Single Cell Type RNA - Kupffer cells [nTPM]"	"Single Cell Type RNA - Langerhans cells [nTPM]"	"Single Cell Type RNA - Late spermatids [nTPM]"	"Single Cell Type RNA - Leydig cells [nTPM]"	"Single Cell Type RNA - Macrophages [nTPM]"	"Single Cell Type RNA - Melanocytes [nTPM]"	"Single Cell Type RNA - Microglial cells [nTPM]"	"Single Cell Type RNA - monocytes [nTPM]"	"Single Cell Type RNA - Muller glia cells [nTPM]"	"Single Cell Type RNA - NK-cells [nTPM]"	"Single Cell Type RNA - Oligodendrocyte precursor cells [nTPM]"	"Single Cell Type RNA - Oligodendrocytes [nTPM]"	"Single Cell Type RNA - Pancreatic endocrine cells [nTPM]"	"Single Cell Type RNA - Paneth cells [nTPM]"	"Single Cell Type RNA - Peritubular cells [nTPM]"	"Single Cell Type RNA - Plasma cells [nTPM]"	"Single Cell Type RNA - Prostatic glandular cells [nTPM]"	"Single Cell Type RNA - Proximal enterocytes [nTPM]"	"Single Cell Type RNA - Proximal tubular cells [nTPM]"	"Single Cell Type RNA - Respiratory ciliated cells [nTPM]"	"Single Cell Type RNA - Rod photoreceptor cells [nTPM]"	"Single Cell Type RNA - Sertoli cells [nTPM]"	"Single Cell Type RNA - Skeletal myocytes [nTPM]"	"Single Cell Type RNA - Smooth muscle cells [nTPM]"	"Single Cell Type RNA - Spermatocytes [nTPM]"	"Single Cell Type RNA - Spermatogonia [nTPM]"	"Single Cell Type RNA - Squamous epithelial cells [nTPM]"	"Single Cell Type RNA - Suprabasal keratinocytes [nTPM]"	"Single Cell Type RNA - Syncytiotrophoblasts [nTPM]"	"Single Cell Type RNA - T-cells [nTPM]"	"Single Cell Type RNA - Theca cells [nTPM]"	"Single Cell Type RNA - Undifferentiated cells [nTPM]"	"Single Cell Type RNA - Urothelial cells [nTPM]"
A2M	"CPAMD5, FWP007, S863-7"	ENSG00000175899	Alpha-2-macroglobulin	P01023	12	9067664-9116229	"Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins"		"Protease inhibitor, Serine protease inhibitor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lung: 1678.3"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 1319.0;Endothelial cells: 797.7;Hepatic stellate cells: 526.1;Hepatocytes: 910.1;Horizontal cells: 681.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"gdT-cell: 1.5"	"Lineage enhanced"	"Detected in single"		"T-cells: 1.5"	"Group enriched"	"Detected in some"	5	"AF22: 772.0;ASC diff: 223.5;Hep G2: 649.8;SK-MEL-30: 230.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002265, CAB017621"	Supported				"Secreted to blood"	NA	NA	1630000000000	170000000000	"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"			"CAB017621: AB_1118894, HPA002265: AB_1078142"	"unprognostic (1.73e-2)"	"unprognostic (1.05e-3)"	"unprognostic (1.72e-1)"	"unprognostic (2.29e-2)"	"unprognostic (7.36e-2)"	"unprognostic (3.91e-2)"	"unprognostic (7.95e-2)"	"unprognostic (3.65e-2)"	"unprognostic (2.38e-1)"	"unprognostic (7.19e-2)"	"unprognostic (4.71e-2)"	"unprognostic (2.06e-2)"	"unprognostic (1.28e-2)"	"unprognostic (8.04e-3)"	"unprognostic (2.32e-2)"	"unprognostic (8.58e-2)"	"unprognostic (9.03e-3)"	451.5	182.3	157.5	149.8	158.5	5.6	295.3	169.3	223.5	227.2	163.3	257.0	141.2	306.2	244.1	218.3	228.4	452.4	312.8	149.8	175.0	311.4	1250.0	1678.3	98.2	192.9	167.6	101.7	91.5	153.7	135.3	445.2	193.0	293.8	316.3	129.9	131.8	226.7	147.8	71.5	182.7	520.0	196.2	240.6	171.6	58.9	190.7	53.9	202.7	285.6	59.2	847.0	160.2	192.7	0.3	0.0	772.0	0.0	223.5	16.2	2.0	93.1	25.5	0.1	0.0	0.1	0.0	0.1	0.4	0.1	0.0	0.3	0.1	0.0	0.0	0.2	0.1	0.4	10.1	649.8	0.0	0.8	0.8	36.9	0.0	0.0	0.0	0.0	1.4	0.0	0.2	0.2	0.0	0.0	0.2	2.0	3.3	0.0	0.1	1.8	0.9	0.8	0.0	0.3	0.3	0.7	1.8	0.0	230.1	3.2	0.0	0.3	0.3	0.1	6.7	1.5	0.5	0.7	0.3	0.7	0.2	0.5	15.4	0.0	0.1	0.0	1.5	0.0	0.8	0.0	0.1	0.4	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.5	0.0	0.1	157.5	158.5	169.3	223.5	149.8	175.0	192.9	167.6	193.0	196.2	190.7	192.7	1319.0	12.8	85.6	5.2	9.0	19.5	2.3	0.0	12.0	5.5	10.8	95.5	106.1	22.8	6.8	1.8	8.4	2.5	8.1	0.0	0.0	0.2	18.8	8.3	54.7	797.7	0.0	45.9	3.2	5.5	2.9	241.3	9.2	14.7	27.8	2.5	526.1	910.1	233.0	681.4	2.9	0.0	0.0	123.1	41.4	36.8	77.3	130.7	23.2	355.1	37.8	6.1	1.0	5.5	4.7	0.2	0.0	141.4	11.2	4.7	0.0	0.3	4.4	21.2	335.2	22.1	328.0	2.7	8.8	8.2	14.1	4.1	13.0	73.3	0.0	3.6
ADAMTS18	ADAMTS21	ENSG00000140873	"ADAM metallopeptidase with thrombospondin type 1 motif 18"	Q8TE60	16	77247813-77435034	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted secreted proteins"		"Hydrolase, Metalloprotease, Protease"	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 11.0;placenta: 20.6"	"Cell type enhanced"	"Detected in some"		"Adipocytes: 36.8;Granulosa cells: 15.0;Muller glia cells: 13.7;Oligodendrocytes: 16.9;Rod photoreceptor cells: 7.6"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"GAMG: 11.6;HUVEC TERT2: 8.0;SuSa: 10.6;TIME: 2.5;U-87 MG: 4.8"	"Region enriched"	"Detected in single"	5	"cerebellum: 3.3"	"Low region specificity"	"Detected in all"			HPA044326	Uncertain		Approved	"Midbody,Mitotic spindle"	"Secreted to extracellular matrix"	Yes	NA				"Cluster 57: Non-specific - Angiogenesis"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Midbody, Mitotic spindle"		"HPA044326: AB_10961006"	"unprognostic (1.10e-2)"	"unprognostic (2.78e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.50e-1)"	"unprognostic (8.13e-2)"	"unprognostic (2.05e-2)"	"unprognostic (1.09e-1)"	"unprognostic (6.27e-2)"	"unprognostic (2.46e-2)"	"unprognostic (2.98e-1)"	"unprognostic (4.11e-2)"	"unprognostic (2.20e-2)"	"unprognostic (8.17e-4)"	"unprognostic (1.77e-5)"	"unprognostic (2.17e-1)"	"unprognostic (3.41e-1)"	"unprognostic (2.47e-4)"	3.1	0.1	1.3	0.3	3.0	0.0	2.9	11.0	2.5	1.2	0.5	0.0	0.1	0.8	0.0	0.1	0.2	0.6	0.0	1.8	2.7	0.2	0.0	0.1	0.1	4.3	2.4	0.1	0.3	0.0	0.8	20.6	3.7	0.4	0.0	2.0	1.3	0.1	0.6	0.1	0.0	0.6	1.7	0.0	0.0	0.2	2.4	0.9	0.0	0.0	0.0	0.9	0.1	5.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.2	0.0	11.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	10.6	0.0	0.5	2.5	0.1	0.0	0.0	0.0	0.0	0.0	0.2	4.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	3.0	11.0	2.5	1.8	2.7	4.3	2.4	3.7	1.7	2.4	5.9	36.8	0.0	0.0	4.6	0.1	0.1	0.1	0.0	0.0	1.8	1.5	4.3	0.6	0.0	0.0	1.8	2.1	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.1	5.0	0.0	0.0	0.6	0.0	0.1	1.2	0.0	0.3	0.0	15.0	0.0	0.0	0.1	0.0	2.4	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	13.7	0.0	0.0	16.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.6	0.0	0.0	1.1	0.2	0.6	0.0	0.1	0.3	0.0	0.1	0.0	0.0
ADAMTS9	KIAA1312	ENSG00000163638	"ADAM metallopeptidase with thrombospondin type 1 motif 9"	Q9P2N4	3	64515654-64688000	"Cancer-related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"ER-Golgi transport, Protein transport, Transport"	"Hydrolase, Metalloprotease, Protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 41.2"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 166.3;Astrocytes: 84.2;Basal prostatic cells: 87.2;Endometrial stromal cells: 179.1;Endothelial cells: 221.0;Prostatic glandular cells: 115.7;Smooth muscle cells: 94.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HUVEC TERT2: 23.6;RPTEC TERT1: 27.1;SH-SY5Y: 128.3;SuSa: 40.5;WM-115: 28.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA028567, HPA028577, HPA028601"	Approved		Approved	"Endoplasmic reticulum,Vesicles"	"Secreted to extracellular matrix"	No	NA				"Cluster 82: Adipose tissue - ECM organization"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 48: Smooth muscle cells - ECM organization"	Vesicles	"Endoplasmic reticulum"	"HPA028567: AB_10599275, HPA028577: AB_10600330, HPA028601: AB_2672694"	"unprognostic (2.21e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.41e-1)"	"unprognostic (4.83e-2)"	"unprognostic (3.08e-1)"	"unprognostic (1.37e-2)"	"unprognostic (7.80e-3)"	"unprognostic (5.85e-2)"	"unprognostic (2.77e-1)"	"unprognostic (2.64e-1)"	"unprognostic (1.11e-1)"	"unprognostic (7.67e-2)"	"unprognostic (3.16e-3)"	"unprognostic (1.46e-2)"	"unprognostic (3.01e-1)"	"unprognostic (1.98e-3)"	"unprognostic (5.00e-3)"	41.2	4.8	4.0	12.2	5.0	0.1	19.0	5.5	5.3	16.2	7.9	8.1	1.2	13.2	1.1	5.3	10.2	7.8	15.6	4.4	5.6	9.5	2.7	13.6	1.9	10.8	8.1	7.3	9.8	6.3	2.2	31.7	8.5	7.9	2.7	1.4	3.2	3.7	7.4	2.6	3.7	12.1	8.0	4.1	4.7	0.8	8.1	1.0	7.3	7.3	1.1	22.5	9.0	6.4	0.0	1.2	13.9	0.0	0.6	0.1	1.3	0.2	0.0	0.0	0.0	1.9	0.0	0.0	2.3	0.3	0.4	0.0	1.5	0.0	0.0	0.0	0.7	0.0	0.0	0.0	1.9	0.0	8.8	2.6	0.0	0.0	0.5	0.0	23.6	0.0	0.5	0.0	0.3	0.1	0.0	0.0	7.5	1.1	0.0	0.0	2.4	0.1	27.1	0.3	0.1	128.3	0.0	0.0	0.0	40.5	0.0	0.7	5.4	0.8	0.4	0.0	0.8	0.0	0.0	0.0	0.5	0.0	28.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	5.0	5.5	5.3	4.4	5.6	10.8	8.1	8.5	8.0	8.1	6.4	166.3	3.2	4.8	84.2	0.0	17.5	87.2	0.0	4.6	0.0	6.9	15.9	6.6	2.8	2.6	38.6	2.1	1.0	0.2	1.1	0.0	69.7	0.9	13.2	179.1	221.0	1.2	0.0	4.2	3.3	0.6	31.4	1.5	33.8	0.0	8.4	27.1	0.3	7.5	0.0	14.3	1.1	0.0	0.3	20.1	0.4	2.5	2.7	26.6	21.5	0.0	0.2	0.0	26.7	0.6	45.5	1.0	2.2	0.0	115.7	0.0	10.8	0.1	0.1	0.0	20.7	94.8	0.3	0.7	1.3	13.5	1.6	3.2	12.1	0.9	36.7
ADPRH	ARH1	ENSG00000144843	"ADP-ribosylarginine hydrolase"	P54922	3	119579268-119589945	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Macrophages: 14.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 23.9;HEL: 17.1;HMC-1: 18.5;Karpas-707: 25.3;U-266/70: 24.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB001701, HPA036961"	Approved		Approved	"Nucleoplasm,Nuclear membrane"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 4: Macrophages - Innate immune response"	"Nuclear membrane"	Nucleoplasm	"CAB001701: , HPA036961: AB_2675405"	"prognostic favorable (2.42e-4)"	"unprognostic (2.29e-1)"	"unprognostic (4.77e-1)"	"unprognostic (2.39e-2)"	"unprognostic (3.38e-2)"	"unprognostic (2.65e-1)"	"unprognostic (3.06e-2)"	"unprognostic (2.63e-1)"	"unprognostic (4.24e-2)"	"unprognostic (3.31e-3)"	"unprognostic (1.88e-1)"	"unprognostic (1.71e-1)"	"unprognostic (6.04e-2)"	"unprognostic (2.60e-3)"	"unprognostic (8.87e-2)"	"unprognostic (2.03e-1)"	"unprognostic (4.35e-2)"	10.6	6.2	3.0	7.3	3.3	3.4	7.9	3.3	4.2	6.9	9.2	5.5	2.3	6.0	4.9	4.0	4.2	6.9	8.5	2.9	3.5	4.9	3.1	13.5	11.0	4.6	3.4	1.9	6.7	8.0	2.0	11.3	4.4	6.1	4.1	6.6	5.1	9.3	11.8	2.6	5.4	9.2	4.2	11.9	3.9	2.4	4.6	5.9	5.8	9.9	13.0	6.5	3.4	4.9	2.4	3.0	0.7	0.0	2.4	2.7	0.0	2.1	0.4	1.8	2.3	0.9	2.0	0.6	0.9	3.2	0.1	0.2	2.0	0.0	1.7	23.9	0.2	17.1	0.4	0.0	3.9	0.1	18.5	4.0	0.1	0.9	0.1	0.8	7.3	0.0	1.6	25.3	11.0	0.7	0.0	4.1	6.9	0.2	5.8	0.0	8.2	1.1	1.0	0.9	0.5	0.1	0.0	0.1	6.4	1.0	4.4	10.6	6.0	0.0	1.1	4.6	0.4	24.5	5.8	0.1	3.0	0.0	4.6	13.9	18.7	19.1	0.8	17.2	0.8	11.0	1.9	1.7	11.2	6.8	0.2	0.7	0.6	5.3	13.9	9.8	14.3	7.5	3.0	3.3	3.3	4.2	2.9	3.5	4.6	3.4	4.4	4.2	4.6	4.9	12.6	9.6	8.6	0.3	5.0	0.8	0.7	0.4	0.0	0.5	1.5	1.9	4.7	2.8	2.7	3.7	4.2	5.8	5.0	0.3	1.9	3.6	0.7	0.2	0.9	9.9	0.0	2.7	0.1	3.2	3.8	2.1	2.6	0.5	10.8	2.5	7.1	1.6	9.4	0.0	0.2	0.2	2.0	12.2	11.1	0.5	0.3	14.8	1.8	4.7	10.2	0.8	4.1	0.0	0.6	2.1	0.5	3.0	3.9	0.7	0.0	1.3	2.1	4.3	0.0	3.6	3.9	0.4	0.6	0.1	0.9	11.8	1.2	0.7	0.2	0.2
ANGPT2	Ang2	ENSG00000091879	"Angiopoietin 2"	O15123	8	6499632-6563409	"Cancer-related genes, Plasma proteins, Predicted secreted proteins, RAS pathway related proteins"	"Angiogenesis, Differentiation"	"Developmental protein"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 81.7;Endothelial cells: 182.2;Smooth muscle cells: 79.8"	"Cancer enhanced"	"Detected in all"		"renal cancer: 12.1"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"basophil: 1.7"	"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in some"	8	"HMC-1: 17.9;HSkMC: 39.9;HUVEC TERT2: 62.6;WM-115: 22.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB011437, CAB017626"	Approved				"Secreted to blood"	NA	NA	3780000	110000	"Cluster 10: Basophils - Unknown function"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 48: Smooth muscle cells - ECM organization"			"CAB011437: , CAB017626: AB_1118956"	"unprognostic (1.28e-1)"	"prognostic unfavorable (7.99e-5)"	"unprognostic (1.93e-2)"	"unprognostic (1.23e-1)"	"unprognostic (4.85e-1)"	"unprognostic (4.86e-2)"	"prognostic unfavorable (6.36e-5)"	"unprognostic (1.66e-3)"	"prognostic unfavorable (4.48e-4)"	"unprognostic (2.94e-3)"	"unprognostic (6.19e-3)"	"unprognostic (1.38e-1)"	"prognostic unfavorable (1.52e-7)"	"prognostic unfavorable (3.87e-4)"	"unprognostic (1.12e-1)"	"unprognostic (1.46e-2)"	"unprognostic (6.44e-2)"	15.7	0.5	5.6	3.8	5.0	0.4	9.9	6.3	9.0	6.2	2.6	2.9	1.2	4.3	1.1	2.2	4.2	4.9	7.3	4.9	6.3	5.4	2.7	4.6	6.8	12.3	5.8	2.5	0.8	2.3	0.8	11.3	12.3	3.3	1.8	1.6	2.5	2.7	4.0	3.1	2.5	6.8	7.7	0.5	1.8	0.9	7.6	6.4	8.2	2.0	2.8	10.6	3.2	7.5	0.1	0.2	0.3	0.1	0.4	0.3	0.3	0.0	0.0	0.0	0.0	0.3	0.2	0.2	0.0	0.0	0.6	0.2	0.0	0.0	0.0	0.1	0.1	4.7	0.4	0.1	0.9	0.0	17.9	39.9	0.0	0.0	0.0	0.1	62.6	0.1	0.1	0.4	0.0	0.1	0.0	0.2	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.5	0.8	0.0	0.0	0.1	0.3	0.1	0.1	1.3	0.2	0.1	0.0	0.0	0.0	0.1	0.1	0.3	0.1	22.7	1.7	0.2	0.2	0.2	0.1	0.2	0.2	0.2	0.2	0.0	0.4	0.2	0.3	0.2	0.2	0.1	0.3	0.1	0.1	5.6	5.0	6.3	9.0	4.9	6.3	12.3	5.8	12.3	7.7	7.6	7.5	81.7	9.6	0.0	5.2	7.8	8.2	2.7	2.5	1.8	9.3	1.5	1.4	2.8	2.8	1.6	0.0	29.2	1.8	3.6	0.6	0.0	1.3	3.2	4.2	5.4	182.2	13.8	1.3	17.0	0.5	1.5	6.3	1.5	5.9	4.5	2.0	30.4	0.9	0.6	38.7	16.1	1.7	0.0	2.5	10.9	5.0	43.5	2.7	16.0	26.2	2.4	2.9	7.2	24.6	11.3	1.3	1.2	3.8	0.9	9.9	2.6	1.0	1.4	12.5	0.0	8.1	79.8	1.6	1.6	0.3	8.0	30.6	5.5	2.9	1.3	4.7
ASAP1	"CENTB4, DDEF1, KIAA1249, PAP, ZG14P"	ENSG00000153317	"ArfGAP with SH3 domain, ankyrin repeat and PH domain 1"	Q9ULH1	8	130052104-130443674	"Predicted intracellular proteins"	"Cilium biogenesis/degradation"	"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 345.8;Late spermatids: 460.2;Oligodendrocyte precursor cells: 622.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 11.6"	"Group enriched"	"Detected in many"	5	"dendritic cells: 3.7;granulocytes: 11.6;monocytes: 6.7"	"Cell line enhanced"	"Detected in all"		"TIME: 167.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011136, CAB037292, HPA048565"	Approved		Approved	"Plasma membrane,Centrosome,Cytosol"		NA	NA		31000	"Cluster 14: Monocytes - Unknown function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Plasma membrane, Centrosome, Cytosol"		"CAB037292: AB_476723, HPA011136: AB_2668438, HPA048565: AB_2680445"	"unprognostic (1.20e-2)"	"unprognostic (1.15e-2)"	"unprognostic (7.68e-2)"	"prognostic unfavorable (5.81e-5)"	"unprognostic (1.77e-1)"	"unprognostic (3.33e-2)"	"prognostic unfavorable (5.63e-8)"	"prognostic unfavorable (3.56e-5)"	"unprognostic (3.34e-1)"	"unprognostic (5.27e-2)"	"unprognostic (8.56e-3)"	"unprognostic (1.10e-1)"	"prognostic unfavorable (1.50e-7)"	"unprognostic (3.79e-2)"	"unprognostic (1.19e-1)"	"unprognostic (7.38e-2)"	"unprognostic (1.22e-3)"	35.1	22.2	13.5	12.2	15.1	47.8	24.0	7.6	22.0	17.6	3.9	13.4	5.5	19.0	12.2	10.7	17.2	14.6	24.7	14.7	10.5	11.9	9.3	30.1	18.0	14.2	20.9	18.2	7.8	18.1	10.5	27.8	16.5	12.7	8.9	8.6	8.5	11.4	13.4	17.3	12.2	17.9	9.4	30.0	10.6	28.5	29.1	16.3	16.4	10.4	19.0	15.9	15.6	17.1	48.9	31.5	41.1	27.4	46.7	61.9	37.1	44.2	83.8	57.2	62.3	17.5	18.2	14.4	31.8	67.7	38.6	13.2	24.7	41.4	86.3	20.6	15.9	22.6	20.7	23.6	119.9	10.4	6.7	61.7	15.3	33.6	50.3	66.9	60.2	7.7	13.0	45.7	54.0	15.1	13.3	9.8	13.1	24.1	30.5	13.6	9.6	7.0	18.1	25.2	14.6	44.4	32.4	20.5	26.5	42.5	17.0	22.4	167.5	45.9	28.9	20.6	69.8	42.2	12.0	9.7	34.6	14.6	50.3	0.0	2.2	1.5	0.5	2.1	0.3	1.3	1.0	0.9	3.7	1.0	1.3	0.8	11.6	0.6	6.7	0.4	0.8	1.1	13.5	15.1	7.6	22.0	14.7	10.5	14.2	20.9	16.5	9.4	29.1	17.1	97.2	3.2	6.3	206.6	22.7	47.7	21.9	12.0	29.6	25.0	12.4	14.7	33.7	27.1	11.5	3.7	16.7	42.2	14.6	3.6	3.9	10.5	159.7	14.3	34.2	109.1	13.1	98.9	345.8	8.7	37.6	43.7	4.6	27.7	9.5	30.1	103.9	8.2	64.0	62.2	225.8	4.3	8.2	56.1	168.8	460.2	39.1	73.1	44.4	181.8	71.4	9.5	15.5	622.3	245.9	12.5	4.7	54.9	13.7	37.9	5.8	4.3	4.2	7.8	78.9	28.5	90.1	61.4	95.5	25.2	44.9	46.7	23.1	58.9	4.8	22.0
BMP6	"VGR, VGR1"	ENSG00000153162	"Bone morphogenetic protein 6"	P22004	6	7726099-7881728	"Predicted secreted proteins"	"Chondrogenesis, Differentiation, Osteogenesis"	"Cytokine, Developmental protein, Growth factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Adipocytes: 23.0;Hepatic stellate cells: 16.8;Inhibitory neurons: 22.8;Microglial cells: 74.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"basophil: 1.1"	"Lineage enriched"	"Detected in single"	11	"granulocytes: 1.1"	"Cell line enhanced"	"Detected in many"		"EFO-21: 37.0;HUVEC TERT2: 149.6;Karpas-707: 81.6;SiHa: 70.0;TIME: 74.3;U-266/84: 41.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB002773, HPA062683"	Approved		Approved	Mitochondria	"Secreted to blood"	No	No	4970000	46000	"Cluster 46: Basophils - DNA binding"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Mitochondria		"CAB002773: , HPA062683: AB_2684832"	"prognostic favorable (6.45e-4)"	"unprognostic (2.99e-1)"	"unprognostic (4.20e-1)"	"unprognostic (6.71e-2)"	"unprognostic (2.44e-1)"	"unprognostic (7.27e-2)"	"unprognostic (4.66e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.26e-1)"	"unprognostic (6.94e-2)"	"unprognostic (2.80e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.82e-2)"	"unprognostic (8.29e-2)"	"unprognostic (2.95e-1)"	"unprognostic (2.29e-3)"	16.5	3.1	5.1	2.2	5.9	0.4	12.7	3.9	6.2	3.2	7.8	3.7	3.0	3.5	0.6	2.0	2.4	2.1	5.1	3.9	3.7	17.8	1.9	9.1	1.5	4.9	4.5	8.2	0.6	0.6	4.6	18.1	4.7	2.8	2.7	0.1	2.3	2.6	3.1	3.5	3.0	2.3	4.8	4.6	4.7	2.2	5.7	0.9	1.5	1.3	2.4	3.3	3.0	4.1	0.9	2.4	0.3	0.0	0.4	0.3	0.0	2.0	0.1	0.0	0.0	0.0	0.0	0.0	37.0	1.1	1.6	0.5	1.1	0.2	0.0	0.0	5.7	15.9	21.8	1.4	0.8	1.1	16.7	0.0	0.0	0.7	2.4	9.6	149.6	0.0	0.0	81.6	0.0	0.3	0.0	0.0	0.8	0.5	12.0	0.6	0.0	15.3	0.5	0.0	12.3	0.0	70.0	0.0	0.0	9.3	0.0	0.0	74.3	0.0	4.7	0.5	2.6	11.3	41.3	0.1	2.3	0.0	1.4	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.5	5.1	5.9	3.9	6.2	3.9	3.7	4.9	4.5	4.7	4.8	5.7	4.1	23.0	0.0	0.5	1.6	1.1	0.3	0.0	0.0	0.0	0.0	0.1	0.1	3.5	0.0	1.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.1	0.8	0.2	8.9	0.0	0.0	7.8	0.0	0.1	2.0	0.0	2.0	0.0	1.5	16.8	0.6	0.3	0.0	22.8	0.0	0.0	0.8	2.1	4.2	0.0	1.5	1.8	74.0	0.7	0.0	0.0	0.0	0.3	0.1	0.0	0.0	6.8	0.3	0.0	0.0	0.3	0.0	0.0	4.7	0.4	0.1	1.3	0.1	0.1	0.3	0.4	0.4	0.0	0.0
BST2	"CD317, tetherin"	ENSG00000130303	"Bone marrow stromal cell antigen 2"	Q10589	19	17402939-17405630	"CD markers, Plasma proteins, Predicted membrane proteins, Transporters"	"Antiviral defense, B-cell activation, Host-virus interaction, Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"ovary: 694.2"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 1193.2;Hepatic stellate cells: 455.8;Theca cells: 490.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+ RasG12V: 615.0;Karpas-707: 603.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA017060, HPA073472"	Enhanced		Supported	"Golgi apparatus,Vesicles"		NA	NA		260000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 72: Non-specific - Transcription"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Golgi apparatus, Vesicles"		"HPA017060: AB_1845467, HPA073472: "	"prognostic favorable (6.69e-4)"	"unprognostic (1.75e-1)"	"unprognostic (8.42e-3)"	"unprognostic (8.93e-3)"	"unprognostic (4.87e-2)"	"unprognostic (2.25e-1)"	"unprognostic (2.26e-1)"	"unprognostic (1.07e-1)"	"unprognostic (3.25e-1)"	"unprognostic (6.46e-2)"	"unprognostic (6.56e-3)"	"unprognostic (1.64e-1)"	"prognostic unfavorable (3.56e-9)"	"unprognostic (1.05e-1)"	"prognostic unfavorable (4.22e-4)"	"unprognostic (1.08e-1)"	"unprognostic (2.46e-2)"	226.0	509.8	86.7	95.6	87.6	103.7	152.9	84.0	125.7	93.4	81.7	94.1	47.4	58.7	59.5	40.3	248.0	109.4	111.2	85.1	84.5	160.1	227.8	141.4	128.0	101.5	85.9	694.2	26.3	13.8	56.8	203.0	88.4	88.6	33.3	2.0	77.7	105.2	46.1	24.8	109.1	76.0	97.0	238.5	84.1	35.4	91.1	123.5	54.0	50.8	65.8	82.9	88.6	90.8	327.0	0.5	0.9	145.6	0.0	1.0	49.6	1.3	24.9	459.5	615.0	150.5	286.1	252.2	338.2	197.6	14.6	1.3	212.9	23.9	14.3	279.1	1.8	3.6	525.7	149.8	256.7	120.1	304.7	1.3	0.0	153.0	0.1	4.4	119.0	6.0	146.3	603.4	0.0	89.5	57.7	208.6	158.0	0.1	407.9	105.5	0.8	530.7	110.1	1.5	0.6	1.4	325.5	12.3	410.5	12.3	243.1	166.3	1.5	1.9	11.4	0.5	3.3	308.3	439.3	168.0	1.3	470.8	2.2	229.7	345.3	125.3	171.4	385.5	163.0	115.2	143.2	160.0	283.8	146.5	114.8	132.6	113.3	353.2	359.3	421.7	143.3	367.9	86.7	87.6	84.0	125.7	85.1	84.5	101.5	85.9	88.4	97.0	91.1	90.8	1193.2	57.7	13.6	4.9	90.7	33.1	19.6	255.7	48.9	0.2	86.2	168.5	7.0	50.1	68.5	49.7	0.0	7.8	184.2	1.5	37.2	18.7	10.7	27.8	11.2	420.2	1.2	74.0	0.0	1.2	61.5	152.4	14.8	50.1	227.8	260.9	455.8	211.1	388.9	0.0	0.0	2.8	28.5	189.4	187.6	12.0	346.7	220.4	74.7	32.8	214.5	1.3	211.2	0.5	0.3	3.3	4.8	419.4	192.8	10.3	3.7	1.3	27.4	2.1	164.3	30.7	146.3	1.3	1.2	15.5	26.1	13.1	135.8	490.6	5.0	28.6
CASKIN2	"ANKS5B, FLJ21609, KIAA1139"	ENSG00000177303	"CASK interacting protein 2"	Q8WXE0	17	75500261-75515537	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 75.5;Endothelial cells: 42.2;Hepatic stellate cells: 56.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA071906, HPA075184"	Enhanced		Supported	"Plasma membrane"		NA	NA				"Cluster 82: Adipose tissue - ECM organization"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Plasma membrane"		"HPA071906: AB_2732191, HPA075184: AB_2732281"	"unprognostic (1.60e-1)"	"unprognostic (4.54e-2)"	"unprognostic (9.12e-3)"	"unprognostic (5.27e-3)"	"unprognostic (9.32e-2)"	"unprognostic (5.78e-2)"	"unprognostic (2.87e-2)"	"unprognostic (4.10e-2)"	"unprognostic (7.67e-2)"	"unprognostic (1.33e-1)"	"prognostic favorable (2.47e-5)"	"unprognostic (1.82e-2)"	"prognostic favorable (4.83e-8)"	"unprognostic (1.43e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.39e-1)"	"unprognostic (4.95e-2)"	33.8	22.7	19.4	4.9	22.6	0.4	30.0	19.7	18.6	15.1	4.6	16.5	9.0	21.0	2.7	10.8	21.7	11.2	28.2	16.7	17.2	26.9	11.3	42.3	2.9	22.6	21.7	12.0	10.8	9.4	13.6	11.8	18.7	14.9	2.9	4.8	11.5	8.7	15.3	12.7	11.4	10.4	18.1	30.8	15.0	5.6	20.0	2.9	22.6	9.9	1.5	16.0	14.3	23.1	13.3	17.2	10.2	14.4	6.6	4.1	11.2	6.6	8.7	15.8	10.2	19.0	5.6	0.5	7.4	7.7	10.5	12.0	8.2	7.7	3.9	4.7	10.8	9.4	17.2	7.5	7.7	0.5	12.6	3.5	10.4	8.2	5.9	5.3	16.2	13.3	6.9	1.6	5.0	31.1	24.3	0.7	7.5	10.3	17.5	12.8	21.8	2.1	10.2	13.4	10.4	10.2	13.9	18.7	11.0	8.7	13.7	4.0	13.9	16.1	14.6	7.9	8.7	1.2	5.9	1.5	5.6	0.3	11.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.4	22.6	19.7	18.6	16.7	17.2	22.6	21.7	18.7	18.1	20.0	23.1	75.5	3.2	2.2	11.1	1.3	8.0	2.5	3.5	6.8	6.5	5.8	5.0	11.4	2.8	1.8	9.2	10.4	2.2	0.6	11.7	3.9	5.1	0.5	2.8	4.4	42.2	7.7	8.0	1.3	5.3	1.9	6.0	8.2	5.7	0.0	14.9	56.7	6.8	2.7	3.3	1.7	4.3	8.2	4.1	3.1	2.3	8.1	1.2	1.8	7.5	2.0	28.2	0.0	15.1	8.3	6.0	6.0	11.3	1.6	2.5	8.4	3.1	1.4	6.8	0.0	5.5	6.4	2.7	4.4	4.5	7.0	2.2	0.5	5.7	4.6	2.2
CAVIN2	"cavin-2, PS-p68, SDPR, SDR"	ENSG00000168497	"Caveolae associated protein 2"	O95810	2	191834310-191847088	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"Adipocytes: 1296.7;Alveolar cells type 1: 413.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	12	"basophil: 49.0;neutrophil: 24.3"	"Lineage enriched"	"Detected in many"	16	"granulocytes: 49.0"	"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 162.3;HEL: 119.8;HUVEC TERT2: 362.3;LHCN-M2: 561.1;TIME: 148.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA039325, HPA062122"	Enhanced		Enhanced	"Plasma membrane,Cytosol"		Yes	No		88000000	"Cluster 34: Basophils - Unknown function"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Plasma membrane"	Cytosol	"HPA039325: AB_10805473, HPA062122: AB_2684688"	"unprognostic (6.85e-3)"	"unprognostic (1.37e-1)"	"unprognostic (1.24e-1)"	"unprognostic (4.47e-2)"	"unprognostic (2.83e-1)"	"unprognostic (1.46e-1)"	"unprognostic (3.19e-2)"	"unprognostic (6.14e-2)"	"unprognostic (8.50e-2)"	"unprognostic (1.38e-1)"	"unprognostic (4.83e-2)"	"unprognostic (2.90e-1)"	"prognostic favorable (8.45e-5)"	"prognostic unfavorable (3.69e-4)"	"unprognostic (1.03e-1)"	"unprognostic (1.33e-1)"	"unprognostic (4.39e-3)"	164.9	25.1	17.9	13.0	20.1	6.5	60.9	16.9	20.2	56.8	13.1	69.4	11.5	38.9	13.2	48.2	53.9	51.8	96.7	15.1	16.5	25.9	31.2	93.9	15.3	19.5	17.3	53.0	22.5	12.9	7.1	34.0	19.5	30.2	24.9	1.1	7.1	30.0	32.3	6.9	21.1	58.1	15.9	111.9	15.0	4.3	22.3	4.1	78.3	59.9	5.6	42.7	19.5	17.0	0.0	20.2	6.8	0.1	1.0	3.4	0.1	4.1	3.5	0.8	1.5	0.0	0.0	0.1	24.8	162.3	0.0	3.4	0.0	31.8	2.3	0.1	0.0	119.8	1.4	45.6	43.6	0.0	0.0	8.4	20.5	3.4	9.6	2.2	362.3	0.0	43.9	0.0	561.1	0.0	0.0	0.1	0.1	0.0	1.0	0.0	32.3	0.2	41.7	0.0	0.0	0.1	0.0	0.0	0.0	9.1	0.0	0.1	148.9	0.0	12.4	7.4	0.0	0.0	0.0	0.1	0.0	1.0	0.0	49.0	2.4	1.2	0.2	0.8	0.3	0.1	0.0	0.0	2.3	0.3	0.2	0.0	24.3	1.3	1.5	3.1	0.5	121.3	17.9	20.1	16.9	20.2	15.1	16.5	19.5	17.3	19.5	15.9	22.3	17.0	1296.7	413.5	76.2	0.0	1.9	0.0	0.0	0.0	0.0	0.0	1.7	15.6	0.0	0.0	81.7	0.0	0.0	0.2	2.6	0.0	5.9	1.6	0.0	0.4	5.4	164.5	0.0	0.0	0.0	0.2	0.2	15.0	0.0	0.6	185.4	0.1	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	25.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.7	29.2	0.0	0.0	0.0	11.8	0.0	0.0	0.0	0.0	0.1	1.5	16.4	0.0	0.0
CCDC3	DKFZp761F241	ENSG00000151468	"Coiled-coil domain containing 3"	Q9BQI4	10	12896625-13099652	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skin 1: 132.2"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 50.1;Excitatory neurons: 100.2;Inhibitory neurons: 41.3;Peritubular cells: 60.5;Smooth muscle cells: 119.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"GAMG: 10.4;HAP1: 19.1;HDLM-2: 32.4;hTERT-RPE1: 14.8;U-2 OS: 20.0"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"spinal cord: 20.8"	HPA062425			Approved	Nucleoplasm,Cytosol	"Secreted to blood"	NA	NA				"Cluster 31: Skin - Epidermis development"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 48: Smooth muscle cells - ECM organization"	Nucleoplasm	Cytosol	"HPA062425: AB_2684759"	"unprognostic (2.26e-1)"	"unprognostic (6.65e-3)"	"unprognostic (1.70e-1)"	"unprognostic (4.30e-3)"	"unprognostic (1.72e-1)"	"unprognostic (5.08e-2)"	"unprognostic (3.11e-2)"	"unprognostic (2.99e-2)"	"unprognostic (5.56e-3)"	"unprognostic (5.41e-2)"	"unprognostic (4.25e-3)"	"unprognostic (2.22e-2)"	"prognostic unfavorable (1.38e-5)"	"unprognostic (1.54e-2)"	"unprognostic (1.49e-1)"	"unprognostic (2.29e-1)"	"unprognostic (3.88e-2)"	91.8	11.0	32.9	5.9	35.2	0.1	37.2	17.9	40.2	48.1	17.8	10.1	6.6	25.0	41.3	60.4	56.7	70.7	21.9	37.1	20.1	19.0	20.6	21.0	12.4	18.6	19.1	86.2	6.5	4.9	10.2	22.2	19.6	35.2	7.4	1.6	7.1	22.0	30.7	132.2	14.3	24.2	19.8	24.7	13.1	11.6	21.7	42.0	20.0	13.3	4.2	23.2	27.4	30.5	0.0	0.2	1.7	9.4	0.0	0.0	0.1	0.0	0.0	0.7	0.0	2.5	0.0	0.0	0.7	0.0	10.4	1.9	19.1	3.6	0.6	32.4	8.1	0.0	0.2	0.0	0.7	0.0	0.0	2.3	2.3	0.4	0.0	14.8	0.9	0.8	0.0	0.2	1.0	0.2	0.0	5.4	1.5	0.0	0.1	0.0	4.1	0.3	0.0	0.0	3.6	1.6	7.0	1.0	0.0	4.4	0.0	0.0	0.0	0.0	20.0	1.2	0.3	0.0	0.0	0.0	0.1	0.0	6.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	32.9	35.2	17.9	40.2	37.1	20.1	18.6	19.1	19.6	19.8	21.7	30.5	12.4	0.0	0.0	10.1	0.1	50.1	6.4	26.3	13.6	1.2	0.9	4.7	7.9	1.5	2.1	0.0	0.0	0.3	1.3	0.1	1.9	0.0	0.2	0.1	0.7	27.2	0.0	0.0	100.2	0.0	0.2	16.0	0.5	0.4	0.0	16.4	8.2	0.2	0.3	0.0	41.3	0.1	0.0	0.0	6.4	1.5	22.4	0.6	14.2	3.7	0.0	0.3	0.0	22.6	23.2	0.1	2.5	60.5	0.0	3.0	0.3	0.4	1.1	2.1	32.9	7.9	119.4	0.0	5.7	2.1	37.2	0.3	1.0	6.0	0.3	1.3
CEP112	"CCDC46, MGC33887"	ENSG00000154240	"Centrosomal protein 112"	Q8N8E3	17	65635537-66192133	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 49.0"	"Group enriched"	"Detected in many"	8	"Early spermatids: 1061.4;Late spermatids: 1606.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"LHCN-M2: 32.0;RH-30: 75.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA069724			Approved	"Nucleoplasm,Midbody ring,Centrosome,Cytosol"		Yes	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 77: Retina - Visual perception"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 34: Spermatids - Unknown function"	"Nucleoplasm, Centrosome"	"Midbody ring, Cytosol"	"HPA069724: "	"unprognostic (9.35e-2)"	"unprognostic (3.08e-2)"	"unprognostic (2.93e-1)"	"unprognostic (6.21e-2)"	"unprognostic (1.06e-2)"	"unprognostic (4.11e-3)"	"unprognostic (1.43e-2)"	"unprognostic (7.99e-2)"	"unprognostic (4.48e-3)"	"unprognostic (3.37e-2)"	"unprognostic (1.39e-3)"	"unprognostic (3.50e-2)"	"unprognostic (4.46e-3)"	"unprognostic (1.02e-2)"	"unprognostic (1.26e-1)"	"unprognostic (3.52e-2)"	"unprognostic (2.71e-1)"	11.3	3.9	5.0	2.7	5.4	1.7	9.5	7.1	5.8	8.3	11.9	7.8	2.0	8.5	8.2	4.3	8.3	7.0	8.0	7.4	5.1	5.6	3.2	7.4	2.5	5.8	5.7	8.2	4.6	8.7	8.3	7.2	4.2	7.2	3.1	25.4	3.0	7.9	8.8	3.3	2.9	8.0	3.4	8.8	4.2	49.0	5.5	2.8	7.1	14.0	1.7	5.4	5.9	3.4	5.0	10.5	13.3	3.8	6.9	14.0	0.4	4.5	7.7	5.5	5.0	1.5	2.0	1.6	4.3	9.8	15.5	0.6	2.9	2.9	7.8	2.6	4.8	0.3	4.7	1.9	2.9	0.6	0.2	8.4	4.8	5.2	1.6	11.0	16.8	2.7	0.3	5.0	32.0	0.7	5.3	0.4	1.3	1.1	4.4	1.5	75.9	0.4	6.0	0.3	3.5	7.4	4.7	0.5	3.6	11.4	3.8	0.4	7.9	14.3	8.2	3.9	6.7	2.3	2.1	0.2	4.4	0.2	5.3	1.3	0.4	0.4	0.3	0.2	0.6	0.3	0.8	0.3	0.2	0.8	0.5	0.3	1.3	0.8	0.2	1.4	0.5	0.1	5.0	5.4	7.1	5.8	7.4	5.1	5.8	5.7	4.2	3.4	5.5	3.4	39.7	9.6	35.8	83.6	1.1	2.5	2.9	2.2	2.2	36.7	2.7	5.5	28.3	4.3	15.3	1.8	20.9	0.7	0.8	1.5	1.9	7.4	1061.4	15.3	15.8	25.4	1.8	0.4	117.4	4.7	1.5	12.4	1.5	3.3	2.5	11.2	19.2	0.2	1.8	1.7	103.8	0.3	0.0	0.8	11.3	1606.0	24.8	2.3	14.2	99.3	0.0	14.7	1.0	29.7	6.6	4.4	0.5	19.9	0.4	1.5	0.0	4.3	23.7	154.3	13.1	43.7	12.5	40.6	16.5	2.4	1.6	0.1	2.5	3.1	1.5	1.3
CHSY3	"CHSY-2, CSS3"	ENSG00000198108	"Chondroitin sulfate synthase 3"	Q70JA7	5	129904465-130186634	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 6.0"	"Group enriched"	"Detected in some"	4	"Excitatory neurons: 509.1;Inhibitory neurons: 349.5"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"amygdala: 2.0;basal ganglia: 2.6;cerebral cortex: 2.9;hippocampal formation: 2.5;white matter: 1.1"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 13.1;ASC TERT1: 11.5;HSkMC: 7.6;TIME: 7.4;U-138 MG: 14.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA044612	Uncertain				"Intracellular and membrane"	NA	NA				"Cluster 82: Adipose tissue - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"HPA044612: AB_10795883"	"unprognostic (3.43e-2)"	"unprognostic (6.28e-3)"	"unprognostic (1.76e-2)"	"unprognostic (5.83e-2)"	"unprognostic (5.88e-2)"	"unprognostic (8.17e-2)"	"unprognostic (3.37e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.22e-1)"	"unprognostic (9.58e-2)"	"unprognostic (3.80e-2)"	"unprognostic (1.08e-6)"	"unprognostic (5.22e-3)"	"unprognostic (9.93e-2)"	"unprognostic (4.61e-3)"	"unprognostic (1.74e-2)"	6.0	0.5	2.0	1.0	2.6	0.0	2.8	0.0	2.9	4.5	0.0	0.7	0.5	1.5	0.1	0.6	1.1	2.8	1.3	2.5	0.2	0.2	1.7	1.8	0.5	0.0	0.4	0.3	0.3	0.4	0.3	2.2	0.0	0.5	0.5	1.0	0.5	0.6	1.0	1.3	0.5	2.0	0.2	0.7	0.5	0.7	0.4	0.2	1.2	0.5	0.4	1.7	1.9	1.1	0.0	0.1	1.2	0.0	13.1	11.5	1.0	3.0	0.1	0.4	0.4	0.0	0.1	0.0	0.3	4.6	0.0	0.0	0.0	0.1	0.0	0.0	1.6	1.9	5.6	0.5	1.2	0.0	0.0	7.6	0.0	0.1	1.2	0.6	3.2	0.0	0.0	1.9	5.2	0.0	0.0	0.0	0.7	0.0	1.2	0.4	5.7	0.0	0.2	0.0	4.6	0.0	0.0	0.0	0.3	1.1	0.2	0.5	7.4	14.2	3.0	0.2	2.0	0.0	0.0	0.0	0.3	0.0	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	2.6	0.0	2.9	2.5	0.2	0.0	0.4	0.0	0.2	0.4	1.1	2.0	9.6	1.1	20.2	0.0	0.5	0.0	0.0	1.2	0.0	0.1	0.3	0.9	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.9	0.5	14.8	2.4	0.0	0.0	509.1	0.0	0.1	2.9	0.0	0.3	0.0	4.1	3.6	1.8	1.9	0.0	349.5	0.0	0.0	1.3	0.7	0.1	1.2	0.1	3.6	87.1	0.0	1.3	0.0	76.9	19.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.7	0.1	6.6	0.9	6.3	1.6	0.7	0.3	0.3	0.4	0.2	0.6	0.0	0.1
CLDN5	"AWAL, BEC1, CPETRL1, TMVCF"	ENSG00000184113	"Claudin 5"	O00501	22	19523024-19527545	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 439.7;breast: 420.9;lung: 398.7"	"Group enriched"	"Detected in many"	10	"Adipocytes: 2644.3;Endothelial cells: 775.2;Hepatic stellate cells: 701.4"	"Cancer enriched"	"Detected in all"	4	"glioma: 32.0"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"basophil: 18.8"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 18.8"	"Group enriched"	"Detected in some"	10	"HUVEC TERT2: 85.4;SCLC-21H: 53.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB002607	Approved					NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"			"CAB002607: "	"unprognostic (1.26e-1)"	"unprognostic (2.05e-3)"	"unprognostic (1.77e-2)"	"unprognostic (2.07e-1)"	"unprognostic (3.05e-3)"	"unprognostic (6.00e-2)"	"unprognostic (4.98e-2)"	"unprognostic (3.24e-3)"	"unprognostic (1.33e-1)"	"unprognostic (8.95e-2)"	"unprognostic (2.29e-3)"	"unprognostic (1.15e-1)"	"unprognostic (7.31e-2)"	"unprognostic (2.01e-2)"	"unprognostic (2.47e-2)"	"unprognostic (2.22e-1)"	"unprognostic (2.96e-2)"	439.7	16.2	124.1	6.1	101.0	0.3	420.9	111.7	127.4	70.2	205.2	75.9	9.2	86.1	3.0	54.4	83.1	6.5	138.3	93.8	103.3	45.5	16.9	398.7	9.6	124.5	114.0	36.4	20.7	1.5	16.9	12.5	127.8	50.2	3.6	2.0	36.0	3.5	101.6	95.9	71.0	6.4	109.2	44.8	41.4	10.5	160.7	1.8	122.5	14.9	2.2	103.7	75.9	107.4	0.1	0.1	0.2	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.7	0.0	0.1	0.3	0.1	0.1	0.2	1.1	0.0	0.0	0.0	0.0	85.4	0.1	0.7	0.2	0.1	0.0	0.1	0.5	0.2	0.0	0.2	0.9	0.7	0.1	0.0	0.0	53.0	0.3	0.0	0.0	0.0	0.0	0.4	0.2	7.1	0.1	1.1	0.3	0.0	0.1	0.0	0.2	0.0	0.0	0.2	18.8	0.4	0.0	0.1	0.0	0.0	0.0	0.1	0.2	0.3	0.2	4.6	0.2	5.8	0.0	0.1	0.1	0.0	26.9	124.1	101.0	111.7	127.4	93.8	103.3	124.5	114.0	127.8	109.2	160.7	107.4	2644.3	3.2	7.7	0.7	2.4	32.4	1.1	0.1	3.4	1.8	5.9	7.6	14.8	2.8	0.6	7.3	0.0	0.3	4.2	0.0	0.0	0.7	5.0	8.1	0.7	775.2	2.4	8.0	0.0	0.8	0.1	12.5	0.0	1.0	1.3	0.3	701.4	2.7	0.8	0.0	0.1	0.2	4.1	17.0	33.3	5.5	5.3	46.2	14.2	129.3	0.7	2.4	1.0	0.5	0.3	0.0	0.0	0.7	2.8	4.0	0.0	0.0	0.3	7.3	0.0	61.7	12.1	1.1	1.9	1.2	30.5	0.0	4.6	25.0	0.0	6.7
COL25A1		ENSG00000188517	"Collagen type XXV alpha 1 chain"	Q9BXS0	4	108808725-109302752	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"		Heparin-binding	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 30.0;retina: 24.7;testis: 19.1"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 107.1;Inhibitory neurons: 275.3;Late spermatids: 39.2;Rod photoreceptor cells: 71.5"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	8	"HeLa: 47.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA029107			Approved	"Endoplasmic reticulum,Vesicles,Cytosol"		NA	NA				"Cluster 58: Brain - Synaptic function"	"Cluster 20: HeLa - Mitochondria"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Vesicles, Cytosol"	"Endoplasmic reticulum"	"HPA029107: AB_10600802"	"unprognostic (1.77e-1)"	"unprognostic (2.12e-1)"	"unprognostic (1.18e-1)"	"unprognostic (8.87e-5)"	"unprognostic (2.43e-2)"	"unprognostic (3.20e-1)"	"unprognostic (7.62e-3)"	"unprognostic (6.86e-2)"	"unprognostic (2.83e-1)"	"unprognostic (3.53e-1)"	"unprognostic (1.50e-2)"	"unprognostic (1.17e-1)"	"unprognostic (5.30e-3)"	"unprognostic (2.82e-3)"	"unprognostic (9.75e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.96e-1)"	6.1	0.5	13.4	0.1	10.3	0.0	2.8	0.0	30.0	1.1	0.3	0.4	2.9	0.6	1.6	0.4	0.9	2.2	0.5	17.8	13.7	1.9	2.2	0.2	0.1	6.5	9.4	1.0	0.2	1.3	7.0	0.3	1.0	0.5	0.3	24.7	4.9	0.5	1.0	0.7	2.5	0.8	6.9	0.8	0.3	19.1	8.9	0.5	2.8	0.3	0.1	0.7	1.0	1.7	0.0	0.0	5.3	0.0	0.0	0.1	0.2	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.2	0.6	0.0	0.0	2.7	0.0	0.1	0.0	3.2	5.9	47.6	0.0	0.0	0.0	0.0	3.3	0.0	0.2	0.0	0.2	0.0	0.1	1.2	0.2	5.6	0.0	0.8	0.0	1.6	0.0	0.1	0.0	2.6	0.0	0.0	0.0	1.1	0.0	0.0	0.2	1.4	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	2.8	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.4	10.3	0.0	30.0	17.8	13.7	6.5	9.4	1.0	6.9	8.9	1.7	8.2	0.0	0.0	12.4	0.1	0.0	0.1	0.0	2.2	2.1	0.4	0.6	1.0	0.0	0.6	1.8	4.2	0.0	0.0	0.0	0.0	0.0	107.1	6.5	2.0	1.6	0.0	0.0	20.5	0.0	0.0	0.7	0.0	18.9	0.0	0.5	0.7	0.0	0.0	1.7	275.3	0.0	0.0	0.0	0.4	39.2	0.6	0.2	0.0	10.3	0.0	2.8	0.0	16.6	8.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	71.5	0.0	4.7	24.6	7.8	1.6	0.0	0.1	0.0	0.1	0.3	0.0	0.0
COX4I2	"COX4-2, COX4B, COX4L2, COXIV-2, dJ857M17.2"	ENSG00000131055	"Cytochrome c oxidase subunit 4I2"	Q96KJ9	20	31637912-31645006	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"		Oxidoreductase	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 49.1;placenta: 115.4"	"Group enriched"	"Detected in some"	5	"Sertoli cells: 414.2;Smooth muscle cells: 191.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	4	"SH-SY5Y: 1.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 28: Placenta - Pregnancy"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 48: Smooth muscle cells - ECM organization"				"unprognostic (2.64e-1)"	"unprognostic (2.09e-2)"	"unprognostic (2.76e-3)"	"unprognostic (2.18e-2)"	"unprognostic (4.51e-2)"	"prognostic favorable (6.04e-5)"	"unprognostic (5.60e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.51e-1)"	"unprognostic (7.45e-2)"	"unprognostic (1.04e-2)"	"unprognostic (5.35e-2)"	"prognostic unfavorable (9.78e-4)"	"unprognostic (1.11e-1)"	"unprognostic (3.30e-3)"	"unprognostic (1.43e-1)"	"unprognostic (5.59e-2)"	19.1	1.1	6.7	1.7	6.7	0.0	15.9	6.5	9.1	4.8	6.1	4.7	1.9	7.5	3.9	5.4	4.9	10.6	39.7	6.5	6.7	10.9	1.1	49.1	4.7	6.8	7.0	2.9	2.3	9.3	2.2	115.4	7.0	10.1	2.7	1.1	3.6	4.7	8.7	4.9	5.8	7.1	6.6	1.7	4.2	1.5	7.0	1.8	14.7	19.4	3.0	7.7	6.7	6.6	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.8	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.7	6.7	6.5	9.1	6.5	6.7	6.8	7.0	7.0	6.6	7.0	6.6	55.0	0.0	0.0	0.0	0.5	6.4	0.3	0.0	2.2	0.4	0.9	1.9	2.7	0.0	0.0	0.0	0.0	1.1	0.3	0.1	0.0	0.0	0.2	0.1	0.7	23.5	0.0	0.0	0.0	0.0	0.3	9.5	0.0	0.1	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	7.5	0.7	3.7	0.5	8.8	2.8	0.0	3.7	0.0	0.0	0.0	0.1	0.0	0.7	0.0	0.3	0.0	0.0	0.0	0.7	414.2	4.6	191.6	0.1	1.0	0.8	6.7	2.5	1.0	1.0	0.0	0.3
CPNE8		ENSG00000139117	"Copine 8"	Q86YQ8	12	38646822-38907430	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 115.5;Microglial cells: 77.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"RPTEC TERT1: 66.8;THP-1: 38.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA038600	Approved					NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"HPA038600: AB_10674690"	"unprognostic (1.57e-1)"	"unprognostic (3.07e-1)"	"unprognostic (3.38e-1)"	"unprognostic (3.78e-3)"	"unprognostic (8.93e-3)"	"unprognostic (6.28e-3)"	"unprognostic (6.74e-2)"	"unprognostic (8.44e-2)"	"unprognostic (5.40e-3)"	"unprognostic (4.29e-1)"	"unprognostic (1.28e-2)"	"unprognostic (2.27e-1)"	"unprognostic (2.64e-2)"	"prognostic unfavorable (2.11e-4)"	"unprognostic (3.21e-1)"	"unprognostic (5.13e-2)"	"unprognostic (8.73e-3)"	12.0	8.3	7.0	5.4	7.6	4.6	9.6	3.1	11.5	7.8	9.2	8.1	3.3	5.1	3.5	5.4	5.0	9.0	12.2	10.1	8.9	11.2	15.5	10.1	5.4	5.0	6.5	5.7	3.2	2.5	3.3	12.0	4.6	3.7	10.2	6.0	3.2	8.9	2.9	6.1	4.6	9.1	8.8	10.6	3.7	5.8	8.0	3.1	7.8	5.3	3.2	10.1	5.3	5.5	3.1	18.7	1.3	18.5	17.0	14.3	8.6	1.6	0.1	0.0	0.0	9.4	18.2	0.0	26.3	12.7	6.8	1.0	10.8	5.6	0.0	0.0	11.3	9.9	26.3	2.2	11.3	0.0	7.8	6.7	14.2	4.2	14.9	12.9	14.3	0.0	6.0	0.0	0.0	0.0	0.0	0.1	13.8	11.5	19.0	0.0	0.0	4.3	66.8	0.5	0.0	0.5	26.0	4.7	14.1	18.8	2.3	38.8	13.6	0.0	12.7	21.6	0.1	6.5	19.3	0.2	17.2	17.8	11.0	2.7	12.0	0.0	1.6	9.4	0.3	0.2	2.1	1.8	7.7	0.6	0.9	1.5	0.7	4.5	6.3	2.5	2.1	2.5	7.0	7.6	3.1	11.5	10.1	8.9	5.0	6.5	4.6	8.8	8.0	5.5	68.8	12.8	8.2	66.3	1.6	31.1	5.9	40.8	19.9	2.1	0.6	6.5	20.3	15.7	23.3	12.9	0.0	29.2	6.9	35.8	15.6	7.6	68.9	2.7	9.4	55.9	11.5	7.4	115.5	4.9	27.2	27.1	0.0	3.0	3.8	18.5	36.0	16.5	25.7	0.0	36.3	9.1	6.1	34.1	42.4	14.5	9.6	19.4	46.2	77.8	19.8	36.4	2.1	25.6	2.9	3.6	51.3	8.2	3.3	7.4	0.0	20.9	17.0	2.7	0.0	24.5	16.9	2.7	2.1	6.1	11.2	7.8	4.3	8.6	8.9	3.5
DCBLD1	"dJ94G16.1, MGC46341"	ENSG00000164465	"Discoidin, CUB and LCCL domain containing 1"	Q8N8Z6	6	117453817-117569858	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA059667	Approved		Approved	Cytosol		NA	NA		22000000	"Cluster 32: T-cells - Unknown function"	"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 48: Smooth muscle cells - ECM organization"	Cytosol		"HPA059667: AB_2684099"	"unprognostic (1.00e-1)"	"prognostic unfavorable (6.44e-5)"	"unprognostic (1.08e-1)"	"unprognostic (3.23e-3)"	"unprognostic (2.47e-1)"	"unprognostic (2.29e-3)"	"unprognostic (1.53e-2)"	"unprognostic (5.94e-3)"	"unprognostic (3.74e-2)"	"unprognostic (8.99e-2)"	"unprognostic (5.69e-3)"	"unprognostic (6.33e-2)"	"prognostic unfavorable (8.57e-8)"	"unprognostic (6.99e-2)"	"unprognostic (4.72e-2)"	"unprognostic (7.44e-2)"	"unprognostic (1.36e-1)"	8.3	3.5	3.7	6.0	4.6	0.6	5.7	3.5	4.9	9.1	2.6	6.6	6.5	5.1	3.3	5.4	2.5	9.1	6.0	5.5	2.7	4.8	9.6	9.9	3.4	3.5	3.6	1.9	6.3	6.8	8.3	8.7	3.7	2.6	6.1	1.0	4.8	2.8	5.5	2.9	8.1	3.8	3.4	3.8	7.6	5.6	3.0	1.2	5.9	5.1	2.5	6.3	5.8	4.3	8.0	17.9	6.3	7.0	10.8	13.5	17.9	45.1	58.1	36.9	27.8	37.9	16.7	0.0	21.8	19.1	45.9	17.9	12.1	19.9	38.7	3.5	9.4	6.8	18.5	62.3	46.7	10.0	5.7	15.4	45.5	33.6	31.4	42.5	52.3	6.7	14.8	6.7	48.9	6.4	0.1	6.7	4.7	21.4	7.4	0.0	1.3	4.7	8.2	9.4	19.0	0.3	33.0	3.6	5.3	9.0	4.7	13.1	38.9	0.0	44.1	12.6	19.8	18.9	5.4	5.3	18.7	9.6	16.5	0.0	0.2	0.0	0.6	0.2	0.1	0.0	0.8	1.2	0.2	0.0	1.0	1.3	0.0	0.4	0.1	0.4	0.9	0.5	3.7	4.6	3.5	4.9	5.5	2.7	3.5	3.6	3.7	3.4	3.0	4.3	16.0	16.0	18.8	5.2	3.0	5.2	3.7	12.3	0.6	8.4	4.8	3.6	5.3	12.8	14.4	5.5	6.2	31.5	4.9	9.5	1.9	7.0	33.0	5.3	15.1	11.0	4.2	3.2	20.8	4.8	6.1	6.6	13.7	7.9	1.3	13.9	17.2	9.6	5.8	5.0	3.3	8.5	6.1	7.0	15.0	10.9	0.9	5.8	8.8	13.1	2.5	1.1	6.2	12.1	11.6	10.4	7.7	0.4	1.6	3.0	11.1	2.7	5.7	3.5	13.1	5.1	27.6	2.2	10.6	6.8	6.0	18.2	5.1	2.1	11.1	5.4
DLC1	"ARHGAP7, DLC-1, HP, p122-RhoGAP, STARD12"	ENSG00000164741	"DLC1 Rho GTPase activating protein"	Q96QB1	8	13083361-13604610	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"		"GTPase activation"	"Cancer-related genes, Tumor suppressor"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 250.0;Alveolar cells type 2: 225.9;Excitatory neurons: 208.8;Microglial cells: 317.6;Oligodendrocyte precursor cells: 244.3;Oligodendrocytes: 707.2;Sertoli cells: 223.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	9	"basophil: 4.3;non-classical monocyte: 1.1"	"Group enriched"	"Detected in many"	19	"granulocytes: 4.3;monocytes: 1.1"	"Cell line enhanced"	"Detected in many"		"HBF TERT88: 83.2;U-2197: 98.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017753	Uncertain		Approved	Nucleoplasm,Vesicles,Cytosol		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 18: U-2197 - ECM organization"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Vesicles, Cytosol"	Nucleoplasm	"HPA017753: AB_10600805"	"unprognostic (1.83e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.29e-1)"	"prognostic favorable (1.11e-4)"	"unprognostic (7.47e-2)"	"unprognostic (1.39e-1)"	"unprognostic (3.11e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.12e-1)"	"unprognostic (8.46e-3)"	"unprognostic (6.49e-2)"	"unprognostic (2.02e-2)"	"unprognostic (3.56e-3)"	"unprognostic (2.79e-2)"	"unprognostic (7.33e-2)"	"unprognostic (1.67e-1)"	52.5	10.6	17.8	8.8	28.7	2.6	29.6	21.8	18.2	13.5	4.8	19.6	5.6	16.1	5.3	6.3	14.7	19.1	21.5	22.9	21.3	13.7	20.4	42.9	3.8	27.8	23.5	9.5	9.0	6.1	5.3	24.2	29.0	6.7	6.2	1.5	5.6	4.2	7.2	7.1	11.5	19.1	18.8	16.4	13.6	4.0	22.5	2.1	15.7	10.3	1.8	15.4	11.1	38.0	0.1	0.7	6.6	0.0	69.4	35.5	20.3	39.3	33.7	40.7	48.6	11.5	6.6	0.0	9.7	51.4	39.4	6.6	4.3	7.4	83.2	0.0	7.2	39.5	0.1	21.7	31.8	0.0	13.7	36.6	0.6	62.6	46.7	43.3	46.7	0.1	2.7	0.0	33.6	0.8	0.0	0.0	0.7	1.4	4.7	0.0	0.0	0.0	19.7	24.4	0.0	2.9	0.0	1.1	31.8	27.4	0.0	0.0	61.7	45.5	18.8	98.7	15.3	0.1	0.0	0.0	31.6	0.3	63.4	4.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	17.8	28.7	21.8	18.2	22.9	21.3	27.8	23.5	29.0	18.8	22.5	38.0	171.7	250.0	225.9	177.3	2.3	14.8	2.5	4.8	5.2	0.9	9.3	8.3	37.8	24.3	19.7	3.7	0.0	7.8	0.6	0.4	1.9	3.1	8.4	15.3	36.1	138.4	1.2	25.2	208.8	4.4	2.3	74.2	4.6	27.3	68.2	0.1	193.1	25.7	3.6	13.5	151.8	1.2	0.0	18.6	17.0	4.3	72.4	6.2	24.9	317.6	0.2	1.0	0.0	244.3	707.2	3.0	1.3	36.1	1.9	1.4	6.1	1.9	3.0	1.9	223.5	50.0	138.0	6.2	11.4	1.8	9.2	2.7	3.6	31.1	2.9	1.7
DOC2B	DOC2BL	ENSG00000272636	"Double C2 domain beta"	Q14184	17	142789-181650	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 22.5;retina: 24.6"	"Group enriched"	"Detected in many"	5	"Adipocytes: 49.4;Cone photoreceptor cells: 175.2;Muller glia cells: 146.7;Rod photoreceptor cells: 100.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	11	"SH-SY5Y: 37.2"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"basal ganglia: 56.1"	HPA043168	Uncertain					NA	NA				"Cluster 58: Brain - Synaptic function"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 5: Muller glia cells - Visual perception"			"HPA043168: AB_2678349"	"prognostic favorable (3.45e-4)"	"unprognostic (2.28e-3)"	"unprognostic (3.17e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.08e-1)"	"prognostic favorable (8.68e-4)"	"unprognostic (1.25e-1)"	"unprognostic (3.61e-2)"	"unprognostic (2.62e-1)"	"unprognostic (8.78e-3)"	"unprognostic (3.49e-2)"	"unprognostic (2.18e-1)"	"unprognostic (2.27e-3)"	"unprognostic (2.06e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.27e-3)"	"unprognostic (4.87e-3)"	15.9	4.5	11.6	3.0	12.7	6.2	13.9	18.6	21.1	3.7	1.3	4.0	0.0	4.0	0.0	14.4	5.8	0.0	5.3	22.5	6.5	8.7	0.7	3.4	1.3	8.7	11.7	1.1	10.0	0.2	6.7	1.4	10.8	3.6	1.1	24.6	2.1	0.6	2.7	4.4	4.5	1.5	12.6	3.3	3.4	0.3	12.2	0.8	3.0	0.1	2.5	4.4	5.2	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	37.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.6	12.7	18.6	21.1	22.5	6.5	8.7	11.7	10.8	12.6	12.2	0.9	49.4	0.0	2.3	0.3	0.2	0.0	0.8	0.0	2.2	10.1	1.5	1.3	2.0	0.0	0.0	9.2	175.2	0.0	0.0	0.2	0.0	0.2	1.1	0.7	4.6	22.8	0.0	0.0	3.8	4.2	0.0	2.3	9.2	0.8	0.0	0.1	18.5	0.2	0.1	1.7	2.3	0.0	0.0	0.3	0.0	2.5	0.0	0.5	0.0	1.0	0.6	146.7	0.0	1.5	0.1	4.3	0.0	0.0	0.0	0.9	0.0	0.5	1.5	100.7	0.0	2.3	0.8	0.2	0.1	1.8	0.0	0.3	0.1	0.8	0.2	3.6
DOCK6	"KIAA1395, ZIR1"	ENSG00000130158	"Dedicator of cytokinesis 6"	Q96HP0	19	11199295-11262524	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 70.3;Cardiomyocytes: 185.4;Endothelial cells: 64.8;Hepatic stellate cells: 55.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 68.2;TIME: 68.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049423, HPA049424"	Approved		Supported	Cytosol		NA	NA				"Cluster 82: Adipose tissue - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 43: Cardiomyocytes - Nuclear processes"	Cytosol		"HPA049423: AB_2680760, HPA049424: AB_2680761"	"unprognostic (2.69e-2)"	"unprognostic (2.27e-1)"	"unprognostic (9.51e-2)"	"unprognostic (3.35e-2)"	"unprognostic (4.72e-3)"	"prognostic favorable (9.09e-4)"	"unprognostic (2.54e-2)"	"unprognostic (4.91e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.65e-2)"	"unprognostic (2.57e-1)"	"unprognostic (7.89e-2)"	"unprognostic (1.25e-3)"	"unprognostic (2.76e-1)"	"unprognostic (1.51e-1)"	"unprognostic (5.41e-2)"	"unprognostic (2.95e-1)"	31.2	9.9	7.4	5.4	6.3	0.4	27.5	4.5	9.7	15.4	3.6	16.8	14.2	14.7	4.6	16.8	11.6	12.0	29.6	4.6	5.1	26.3	13.2	46.3	4.9	7.8	7.1	12.0	14.4	5.4	11.9	15.0	6.9	14.8	6.2	1.8	11.4	7.5	15.1	25.2	15.4	7.1	5.7	14.5	15.8	5.8	11.4	2.1	29.0	9.3	2.6	14.2	16.6	5.6	14.6	8.9	9.9	8.1	7.3	10.5	15.9	4.2	6.9	4.1	6.3	16.9	11.2	0.9	25.4	7.1	3.9	8.3	4.3	22.3	2.5	12.4	7.0	2.8	2.2	12.8	11.8	4.3	13.7	8.1	13.0	7.5	17.0	7.9	68.2	0.3	15.7	0.0	9.1	32.7	0.1	14.7	12.5	13.2	16.6	0.9	6.7	14.0	6.8	20.0	0.6	17.6	4.2	4.2	7.6	6.5	4.9	7.6	68.8	7.5	7.8	17.1	7.6	1.2	0.2	14.1	6.3	3.2	6.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.4	6.3	4.5	9.7	4.6	5.1	7.8	7.1	6.9	5.7	11.4	5.6	70.3	3.2	12.6	6.8	0.9	6.5	6.2	8.5	4.6	1.4	4.3	3.8	185.4	5.7	11.3	25.8	0.0	0.3	0.9	15.6	1.9	5.4	3.5	3.9	8.9	64.8	12.1	0.0	2.9	6.8	1.3	19.6	35.2	7.2	5.1	4.7	55.3	5.6	4.6	0.0	5.9	15.9	8.2	2.5	4.4	1.3	22.4	1.6	3.6	35.6	0.0	4.6	0.0	7.1	3.5	11.9	10.9	9.4	1.9	8.4	11.9	1.9	9.2	2.6	19.7	8.4	30.8	1.5	4.3	7.4	11.5	0.5	1.2	7.8	9.7	9.0
EBF2	"COE2, FLJ11500"	ENSG00000221818	"EBF transcription factor 2"	Q9HAK2	8	25841725-26045413	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 17.8"	"Cell type enhanced"	"Detected in some"		"Adipocytes: 11.9;Fibroblasts: 23.2;Microglial cells: 13.1;Sertoli cells: 39.5;Smooth muscle cells: 53.4"	"Cancer enhanced"	"Detected in many"		"renal cancer: 1.8"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 22.7;ASC TERT1: 45.7;HSkMC: 46.9;hTEC/SVTERT24-B: 26.7;U-138 MG: 17.1;U-2197: 22.7;U-87 MG: 19.1"	"Group enriched"	"Detected in many"	4	"basal ganglia: 5.7;cerebellum: 3.1;hypothalamus: 2.0;midbrain: 4.4;pons and medulla: 2.8"	"Region enriched"	"Detected in many"	5	"spinal cord: 8.7"	"HPA003954, HPA055101"			Approved	"Nucleoplasm,Nuclear bodies"		NA	NA				"Cluster 82: Adipose tissue - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	Nucleoplasm	"Nuclear bodies"	"HPA003954: , HPA055101: "	"unprognostic (3.70e-1)"	"unprognostic (3.88e-3)"	"unprognostic (2.69e-2)"	"unprognostic (2.47e-3)"	"unprognostic (1.03e-1)"	"unprognostic (6.10e-2)"	"unprognostic (5.92e-2)"	"unprognostic (6.75e-2)"	"unprognostic (1.11e-2)"	"unprognostic (6.13e-3)"	"unprognostic (1.58e-1)"	"unprognostic (1.30e-1)"	"prognostic unfavorable (2.51e-6)"	"unprognostic (7.41e-4)"	"unprognostic (2.28e-1)"	"unprognostic (3.80e-2)"	"unprognostic (1.82e-2)"	17.8	0.7	0.2	0.9	0.5	0.0	8.0	0.2	0.1	0.7	0.1	1.4	0.0	0.8	1.9	0.8	4.0	2.6	9.8	0.0	0.7	0.5	0.0	0.6	0.6	1.3	3.1	1.0	0.8	2.2	0.4	0.5	2.7	0.5	0.4	0.2	1.4	0.4	4.7	1.5	0.7	1.7	3.8	0.0	0.8	1.1	0.9	1.4	6.2	9.6	0.2	1.9	1.2	0.3	0.0	0.0	0.8	0.0	22.7	45.7	0.5	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.2	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	46.9	0.0	26.7	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.1	0.0	0.0	1.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	17.1	0.2	22.7	0.0	0.0	0.0	0.0	19.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.2	0.1	0.0	0.7	1.3	3.1	2.7	3.8	0.9	0.3	11.9	0.0	0.5	0.0	0.0	0.1	0.1	0.0	0.6	0.1	0.2	0.3	5.3	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.7	0.0	0.1	5.6	0.0	0.0	0.5	0.0	0.0	23.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.4	3.2	5.9	0.6	0.0	13.1	0.0	0.2	0.0	0.0	0.2	0.1	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.2	39.5	2.6	53.4	1.0	0.2	0.4	0.3	0.0	0.2	0.1	0.0	0.1
ENPEP	"CD249, gp160"	ENSG00000138792	"Glutamyl aminopeptidase"	Q07075	4	110365733-110565285	"CD markers, Enzymes, Plasma proteins, Predicted membrane proteins"		"Aminopeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 163.6;kidney: 90.0"	"Cell type enhanced"	"Detected in many"		"Proximal enterocytes: 663.2;Proximal tubular cells: 177.6;Sertoli cells: 157.8"	"Cancer enriched"	"Detected in many"	8	"renal cancer: 41.0"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 2.7;HEK 293: 7.5;MOLT-4: 1.8;SuSa: 5.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA005128	Enhanced					NA	NA		55000000		"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 45: Enterocytes - Digestion"			"HPA005128: AB_1844795"	"unprognostic (2.73e-3)"	"unprognostic (2.84e-3)"	"unprognostic (5.16e-3)"	"unprognostic (3.48e-1)"	"unprognostic (2.90e-1)"	"unprognostic (8.74e-2)"	"unprognostic (3.34e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.35e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.93e-1)"	"unprognostic (9.47e-2)"	"unprognostic (4.49e-3)"	"unprognostic (3.43e-3)"	"unprognostic (1.52e-2)"	"unprognostic (8.46e-2)"	"unprognostic (2.49e-3)"	11.6	2.2	0.4	1.5	0.5	0.1	4.8	0.4	2.5	1.6	1.8	1.2	36.6	12.9	4.1	1.7	2.3	4.4	4.3	0.6	0.5	90.0	29.0	4.6	0.8	0.9	0.8	1.2	1.3	45.2	1.2	15.5	0.7	1.8	0.8	0.0	1.1	1.2	2.3	0.7	163.6	10.6	0.5	9.2	1.2	0.5	0.4	4.4	5.0	8.9	0.3	2.6	1.6	0.8	0.0	0.2	0.0	0.0	0.1	0.1	2.7	0.4	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	7.5	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.0	1.8	0.3	0.3	0.1	0.0	0.1	0.0	0.3	0.0	0.3	0.1	0.1	0.0	1.3	0.0	5.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.7	1.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.5	0.4	2.5	0.6	0.5	0.9	0.8	0.7	0.5	0.4	0.8	10.7	0.0	2.0	1.6	1.1	1.7	0.1	0.0	0.0	0.0	0.2	0.1	3.9	0.0	0.3	11.0	0.0	37.0	0.0	1.5	17.6	0.0	0.5	3.1	40.7	2.2	1.8	0.0	7.3	0.0	3.5	15.4	0.0	2.3	0.0	0.0	1.4	31.4	2.7	0.0	2.9	28.4	2.0	1.0	1.9	0.2	0.6	1.1	0.0	1.0	0.0	0.0	1.0	0.0	0.8	0.0	31.6	0.4	0.1	0.2	663.2	177.6	1.7	0.0	157.8	0.8	54.1	0.0	0.2	0.1	1.0	58.6	1.9	0.5	42.1	0.1
EPB41L4A	NBL4	ENSG00000129595	"Erythrocyte membrane protein band 4.1 like 4A"	Q9HCS5	5	112142441-112419313	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 64.3;Oligodendrocyte precursor cells: 164.4;Oligodendrocytes: 65.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"EFO-21: 30.1;HeLa: 36.5;RT4: 21.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA036580	Uncertain		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 68: Epididymis - Unknown function"	"Cluster 20: HeLa - Mitochondria"	"Cluster 68: Oligodendrocytes - Mixed function"	"Plasma membrane"	Nucleoplasm	"HPA036580: AB_10669908"	"unprognostic (1.40e-1)"	"unprognostic (1.90e-1)"	"unprognostic (1.92e-3)"	"unprognostic (3.64e-2)"	"unprognostic (4.73e-2)"	"unprognostic (5.59e-3)"	"unprognostic (4.40e-2)"	"unprognostic (8.38e-2)"	"unprognostic (1.90e-1)"	"unprognostic (3.97e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.23e-3)"	"prognostic favorable (3.65e-5)"	"unprognostic (1.68e-1)"	"unprognostic (3.35e-2)"	"unprognostic (2.73e-1)"	"unprognostic (1.92e-1)"	8.7	4.5	4.8	3.2	5.7	3.6	5.3	4.1	4.8	4.1	9.0	4.0	2.6	4.3	12.7	10.1	7.4	13.8	9.2	6.0	5.1	11.7	3.3	7.7	3.3	5.7	4.6	5.7	4.9	8.0	0.5	9.3	4.8	5.8	4.8	16.0	7.2	5.4	4.2	8.8	3.4	2.7	4.9	4.7	5.6	6.1	4.8	3.6	13.5	4.2	3.6	5.1	2.3	4.8	0.8	5.5	14.3	1.5	0.0	0.0	2.9	2.1	0.0	0.0	0.0	3.0	12.3	6.2	30.1	0.0	0.8	7.4	1.1	6.9	0.0	1.0	5.0	9.8	36.5	2.0	0.1	2.6	3.1	0.0	3.0	0.0	0.0	1.6	9.2	1.7	1.9	5.6	0.0	1.8	4.6	3.5	2.7	1.2	1.1	2.3	10.7	1.3	8.4	21.6	11.8	6.1	10.7	5.2	4.5	9.8	15.9	1.4	15.7	0.7	2.4	1.9	4.4	5.6	1.3	4.6	1.4	5.2	0.8	0.5	0.2	0.1	2.0	0.3	1.1	1.4	0.6	0.6	0.2	1.6	0.9	1.8	0.2	0.1	0.5	0.1	0.6	0.5	4.8	5.7	4.1	4.8	6.0	5.1	5.7	4.6	4.8	4.9	4.8	4.8	55.9	28.9	7.7	17.3	4.7	6.0	16.8	11.2	13.6	5.0	11.2	4.7	8.3	64.3	24.2	14.7	4.2	7.4	4.5	8.5	11.7	15.0	20.8	19.7	3.1	35.2	1.2	2.1	28.6	7.5	0.7	8.4	7.1	17.1	8.8	11.9	34.6	1.7	2.7	1.7	31.8	6.3	16.2	4.6	2.1	23.0	1.8	1.8	3.6	56.2	3.2	8.2	14.4	164.4	65.4	14.1	10.9	1.9	6.5	13.7	1.9	30.4	39.5	32.1	0.0	8.7	6.0	1.8	9.1	16.0	8.1	2.5	3.7	2.2	7.5	19.1
EPS8		ENSG00000151491	"Epidermal growth factor receptor pathway substrate 8"	Q12929	12	15620134-15882329	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"		Actin-binding	"Deafness, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 317.0;Sertoli cells: 401.0;Smooth muscle cells: 313.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"non-classical monocyte: 22.2"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 253.0;HHSteC: 218.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003897	Approved		Approved	"Golgi apparatus"		NA	NA		17000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Golgi apparatus"		"HPA003897: AB_1848224"	"unprognostic (6.16e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.27e-2)"	"unprognostic (5.43e-2)"	"unprognostic (2.46e-1)"	"unprognostic (1.04e-1)"	"unprognostic (5.81e-2)"	"unprognostic (1.68e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.57e-3)"	"prognostic unfavorable (3.33e-7)"	"unprognostic (2.68e-1)"	"prognostic favorable (1.45e-7)"	"unprognostic (7.47e-3)"	"unprognostic (7.20e-2)"	"prognostic favorable (5.11e-4)"	"unprognostic (1.79e-2)"	62.3	13.0	12.9	16.1	17.4	0.6	33.7	15.3	14.0	53.9	14.1	49.7	37.6	46.2	47.1	20.5	20.1	56.0	26.4	11.1	17.2	55.8	37.8	29.0	9.4	18.5	20.1	49.2	15.1	21.6	3.5	53.1	19.7	16.4	53.7	39.8	13.4	39.8	13.8	11.9	42.7	53.7	15.5	11.9	32.0	15.6	16.1	4.8	22.8	24.3	5.2	51.7	21.4	20.8	65.0	38.8	37.7	1.4	253.0	177.6	53.1	73.6	59.8	34.5	46.1	33.3	97.3	0.0	2.4	140.4	114.4	16.4	11.3	9.5	52.4	0.2	12.6	5.7	11.2	34.7	218.1	4.4	0.2	159.8	42.8	91.7	115.7	44.6	17.7	0.2	0.1	0.2	169.0	17.5	0.2	2.8	5.2	50.3	30.8	0.0	109.5	0.8	97.7	92.5	3.1	4.9	21.4	12.4	91.5	6.2	34.2	4.3	28.7	54.7	14.3	32.4	30.7	3.6	0.4	0.1	32.1	10.7	160.0	0.0	2.7	0.2	0.2	10.8	0.1	1.3	0.9	0.4	5.5	0.3	1.1	0.5	4.4	1.0	22.2	0.4	0.1	1.7	12.9	17.4	15.3	14.0	11.1	17.2	18.5	20.1	19.7	15.5	16.1	20.8	121.4	12.8	175.9	91.1	11.6	17.0	39.6	32.0	13.6	9.7	28.7	42.8	27.6	87.2	58.3	23.9	66.7	33.0	15.2	317.0	60.7	69.4	67.6	87.4	72.0	61.4	38.3	0.4	2.2	68.9	7.3	73.4	81.1	152.2	6.3	139.4	36.0	36.0	65.8	6.7	31.1	54.5	67.1	54.1	35.6	49.4	134.8	46.2	35.6	148.0	8.6	15.4	0.0	121.2	96.9	97.0	217.8	43.6	5.2	26.9	69.0	114.6	104.8	153.7	401.0	18.1	313.1	10.9	4.2	22.8	13.1	21.1	11.8	40.0	80.0	97.6
FAM124B	FLJ22746	ENSG00000124019	"Family with sequence similarity 124 member B"	Q9H5Z6	2	224378698-224402107	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 8.5"	"Group enriched"	"Detected in some"	4	"Adipocytes: 13.8;Endothelial cells: 10.8;Erythroid cells: 9.4;granulocytes: 4.5"	"Cancer enriched"	"Detected in many"	10	"testis cancer: 7.3"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 29.5;eosinophil: 17.2"	"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in some"	7	"HUVEC TERT2: 103.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA070240	Approved		Approved	Nucleoplasm,Mitochondria		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 28: Placenta - Pregnancy"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Nucleoplasm	Mitochondria	"HPA070240: AB_2686238"	"unprognostic (2.01e-1)"	"unprognostic (1.83e-1)"	"unprognostic (6.87e-3)"	"unprognostic (2.49e-1)"	"unprognostic (7.10e-2)"	"unprognostic (1.72e-2)"	"unprognostic (1.28e-2)"	"unprognostic (5.78e-2)"	"unprognostic (3.19e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.57e-1)"	"unprognostic (3.36e-1)"	"unprognostic (7.61e-3)"	"unprognostic (1.36e-2)"	"unprognostic (4.30e-1)"	"unprognostic (2.25e-1)"	"unprognostic (5.80e-3)"	5.2	0.5	1.4	1.1	1.2	4.7	4.3	1.4	1.7	1.5	0.9	0.9	1.0	1.6	0.3	1.4	1.2	1.2	1.8	1.3	1.6	0.6	1.9	2.3	0.7	1.8	1.7	0.4	0.4	2.4	0.2	8.5	1.5	0.5	1.0	0.2	0.8	0.5	1.2	1.8	1.0	2.3	1.6	0.5	0.6	0.3	1.7	1.1	1.0	4.6	0.7	1.5	1.4	1.1	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	5.5	0.1	0.0	0.0	0.0	15.0	0.0	0.1	0.0	0.0	0.0	103.4	0.0	4.8	0.2	0.0	0.1	0.0	0.1	6.1	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.7	7.5	0.2	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	29.5	3.0	17.2	0.2	2.3	0.0	0.0	0.7	0.0	7.9	0.0	0.0	0.0	0.1	5.4	0.8	0.0	2.5	1.1	1.4	1.2	1.4	1.7	1.3	1.6	1.8	1.7	1.5	1.6	1.7	1.1	13.8	0.0	0.0	0.0	0.1	0.8	0.0	0.0	0.0	0.3	0.1	0.1	0.5	0.0	0.0	0.0	0.0	0.4	0.7	0.0	0.0	0.0	1.2	0.3	0.2	10.8	0.0	9.4	0.2	0.0	0.1	0.4	0.0	0.8	4.5	0.0	2.2	0.4	0.4	0.0	0.2	0.0	0.0	0.9	0.6	0.0	0.0	0.7	0.0	1.0	0.5	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.3	0.0	0.1	0.1	0.0	0.1	1.1	0.1	0.0	0.0
FAM162B	"bA86F4.2, C6orf189"	ENSG00000183807	"Family with sequence similarity 162 member B"	Q5T6X4	6	116752197-116765719	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 65.2"	"Group enriched"	"Detected in some"	4	"Adipocytes: 34.6;Sertoli cells: 65.7;Smooth muscle cells: 105.1"	"Cancer enriched"	"Detected in many"	18	"testis cancer: 32.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ: 8.7;BJ hTERT+: 23.5;BJ hTERT+ SV40 Large T+ RasG12V: 22.1;HHSteC: 6.3;HSkMC: 7.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA036112, HPA060342"	Enhanced					NA	NA				"Cluster 28: Placenta - Pregnancy"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 48: Smooth muscle cells - ECM organization"			"HPA036112: AB_10696649, HPA060342: AB_2684258"	"unprognostic (1.81e-1)"	"unprognostic (5.65e-3)"	"unprognostic (1.54e-1)"	"unprognostic (3.38e-1)"	"unprognostic (5.45e-2)"	"unprognostic (1.86e-5)"	"unprognostic (8.29e-2)"	"unprognostic (1.24e-1)"	"unprognostic (4.19e-2)"	"unprognostic (2.44e-2)"	"unprognostic (7.32e-2)"	"unprognostic (6.27e-3)"	"prognostic unfavorable (2.48e-4)"	"unprognostic (1.22e-2)"	"unprognostic (1.72e-1)"	"unprognostic (2.73e-3)"	"unprognostic (4.34e-2)"	14.7	14.9	3.3	0.8	4.4	0.0	10.9	1.9	7.0	13.2	2.5	3.3	0.9	5.8	7.5	4.4	10.1	5.2	9.1	4.6	2.7	4.5	0.9	17.9	1.5	3.0	2.5	5.7	1.7	3.7	6.6	65.2	2.7	6.2	2.1	0.2	8.2	13.4	5.4	3.0	2.3	3.7	2.7	0.1	3.5	2.5	2.8	1.8	9.7	10.6	1.2	7.9	9.9	4.7	0.0	0.0	0.0	0.0	2.3	0.1	0.0	8.7	23.5	3.7	22.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	2.3	0.0	0.0	0.0	0.0	0.0	6.3	0.0	0.0	7.7	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	4.4	1.9	7.0	4.6	2.7	3.0	2.5	2.7	2.7	2.8	4.7	34.6	0.0	0.0	1.3	0.0	1.3	0.1	0.0	1.2	0.0	0.9	0.8	0.9	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	16.9	0.7	15.7	13.7	0.0	0.0	14.8	0.0	0.2	14.1	0.0	0.4	0.0	0.1	3.6	0.0	0.5	0.0	6.9	0.0	0.0	0.0	2.1	2.2	2.1	0.7	1.8	3.7	0.0	0.0	0.0	6.6	0.5	0.2	0.0	5.3	0.0	0.2	0.0	0.1	0.0	0.1	65.7	2.2	105.1	10.3	5.9	0.6	0.9	0.5	2.3	0.1	0.0	0.0
FCHSD2	"KIAA0769, SH3MD3"	ENSG00000137478	"FCH and double SH3 domains 2"	O94868	11	72836745-73142318	"Predicted intracellular proteins"	"Endocytosis, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Inhibitory neurons: 219.6;Microglial cells: 387.8;Oligodendrocyte precursor cells: 471.0;Oligodendrocytes: 198.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RPMI-8226: 164.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038545, HPA038546"	Uncertain		Approved	"Nuclear speckles,Plasma membrane,Actin filaments,Focal adhesion sites"		Yes	No			"Cluster 10: Basophils - Unknown function"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 68: Oligodendrocytes - Mixed function"	"Plasma membrane, Actin filaments"	"Nuclear speckles, Focal adhesion sites"	"HPA038545: AB_2676074, HPA038546: AB_10673013"	"unprognostic (1.80e-2)"	"unprognostic (1.50e-2)"	"prognostic favorable (1.71e-4)"	"unprognostic (1.63e-1)"	"unprognostic (3.14e-2)"	"unprognostic (2.62e-3)"	"unprognostic (1.41e-2)"	"unprognostic (2.62e-1)"	"unprognostic (1.27e-2)"	"unprognostic (2.56e-1)"	"unprognostic (3.69e-2)"	"unprognostic (6.16e-2)"	"unprognostic (2.89e-3)"	"unprognostic (2.02e-1)"	"unprognostic (4.70e-1)"	"unprognostic (2.92e-1)"	"unprognostic (1.23e-1)"	22.2	19.2	43.3	33.4	47.9	28.6	16.8	31.5	38.7	14.9	34.6	14.5	8.9	16.0	6.9	11.7	13.8	22.6	25.5	37.0	44.5	13.0	17.6	23.9	45.2	36.6	36.4	32.3	10.4	9.9	8.1	31.2	35.4	11.6	14.4	19.6	9.3	13.8	8.8	9.0	17.7	17.2	32.5	42.3	13.1	22.6	41.3	28.5	14.9	14.7	46.1	21.6	11.7	45.0	14.2	12.3	26.0	31.3	9.8	23.9	21.8	26.7	50.6	14.8	12.0	9.6	21.0	76.3	31.3	31.0	15.6	20.0	15.3	14.1	21.0	27.2	7.0	64.2	14.3	33.4	25.7	30.6	7.6	14.6	15.6	15.1	17.7	33.4	35.7	26.7	13.7	49.6	19.5	16.1	36.4	54.7	5.5	15.6	13.8	56.4	39.8	164.1	24.8	21.4	13.1	16.9	9.6	16.2	31.9	12.2	12.4	23.7	47.9	45.9	18.5	32.9	7.5	46.8	29.4	71.2	8.4	51.4	13.8	18.3	8.4	18.7	2.8	5.1	1.9	22.2	2.8	3.2	8.1	26.9	3.2	4.1	19.9	2.0	3.0	32.3	3.2	3.6	43.3	47.9	31.5	38.7	37.0	44.5	36.6	36.4	35.4	32.5	41.3	45.0	47.3	9.6	14.0	114.9	76.7	8.5	5.2	3.6	9.1	13.5	5.9	4.7	16.0	8.6	6.1	3.7	25.0	12.4	39.4	1.9	1.9	4.1	6.2	6.6	8.3	30.2	4.8	19.4	79.4	6.2	9.2	9.4	7.7	5.4	2.5	33.6	46.1	11.3	19.9	10.1	219.6	7.7	4.1	30.8	29.9	10.0	10.8	32.8	5.4	387.8	20.6	10.6	5.2	471.0	198.1	5.3	5.7	16.6	70.1	3.8	1.8	3.5	3.9	17.0	6.6	13.0	26.1	9.6	13.0	7.1	5.8	12.0	14.9	6.0	3.7	4.8
FEZ2		ENSG00000171055	"Fasciculation and elongation protein zeta 2"	Q9UHY8	2	36531805-36646087	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"plasmacytoid DC: 15.6"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035978	Uncertain		Approved	"Nucleoli,Nucleoli rim,Golgi apparatus,Cytosol"		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 22: Epithelial cell types - Mixed function"	"Nucleoli, Nucleoli rim"	"Golgi apparatus, Cytosol"	"HPA035978: AB_10672235"	"unprognostic (1.42e-1)"	"unprognostic (5.02e-3)"	"unprognostic (2.89e-1)"	"unprognostic (1.15e-2)"	"unprognostic (2.91e-2)"	"unprognostic (1.94e-3)"	"prognostic unfavorable (7.79e-6)"	"unprognostic (1.09e-1)"	"unprognostic (7.05e-2)"	"unprognostic (2.42e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.28e-1)"	"unprognostic (6.65e-2)"	"unprognostic (7.82e-3)"	"unprognostic (7.07e-2)"	"unprognostic (3.47e-2)"	"unprognostic (1.82e-1)"	53.0	39.1	48.2	21.0	51.6	16.5	35.9	48.2	68.6	26.9	42.8	34.5	22.1	33.1	18.9	31.7	23.8	23.6	46.7	49.2	48.4	33.6	29.4	27.1	24.3	49.5	46.3	27.6	10.8	20.3	14.2	46.8	48.2	23.5	27.9	26.5	17.1	32.5	108.1	17.0	28.5	41.1	50.1	30.3	21.9	20.8	49.6	18.2	23.9	78.5	19.5	29.1	24.3	56.3	64.9	37.1	49.4	22.3	91.3	122.1	39.5	157.1	76.5	90.7	56.0	24.6	21.5	39.1	94.7	199.2	41.0	25.1	42.4	54.3	98.5	9.3	24.7	31.7	12.2	43.5	44.4	32.9	8.5	119.9	44.2	57.8	69.6	61.2	131.0	9.5	35.4	12.0	170.2	22.7	19.6	27.5	27.1	33.9	57.8	16.9	44.3	14.0	72.9	57.6	1.9	45.7	38.7	31.9	37.8	51.7	11.3	39.1	161.2	59.7	32.9	33.4	92.9	9.8	11.5	26.6	58.9	22.4	84.8	2.5	3.5	5.1	1.7	3.4	1.0	1.6	1.3	1.0	3.5	1.0	1.5	0.7	4.2	3.2	2.3	15.6	1.4	0.8	48.2	51.6	48.2	68.6	49.2	48.4	49.5	46.3	48.2	50.1	49.6	56.3	109.4	54.5	37.5	25.8	23.7	31.4	94.7	45.5	41.5	52.5	31.7	33.1	43.1	17.2	70.2	58.8	45.9	96.4	61.1	57.6	56.7	80.3	5.6	38.4	44.7	100.9	24.0	15.3	45.4	30.6	87.6	50.7	27.0	64.3	24.1	66.0	97.5	37.2	93.7	21.9	22.9	28.8	38.7	88.1	65.4	10.7	54.3	64.6	56.9	45.0	56.0	97.1	35.0	23.1	50.5	74.4	41.4	66.2	17.9	99.1	65.6	45.1	35.9	36.3	59.2	64.0	51.2	12.1	34.9	24.0	32.1	180.1	24.2	47.2	37.7	140.6
FFAR2	"FFA2R, GPR43"	ENSG00000126262	"Free fatty acid receptor 2"	O15552	19	35443907-35451767	"G-protein coupled receptors, Predicted membrane proteins"	"Immunity, Inflammatory response"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 20.3;lymphoid tissue: 22.2"	"Cell type enhanced"	"Detected in some"		"Enteroendocrine cells: 24.1;Intestinal goblet cells: 8.9;Kupffer cells: 11.9;Macrophages: 15.4;Prostatic glandular cells: 7.7"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 6.0"	"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	25	"eosinophil: 85.0;neutrophil: 249.7"	"Lineage enriched"	"Detected in many"	38	"granulocytes: 249.7"	"Cell line enhanced"	"Detected in some"		"HMC-1: 3.9;OE19: 1.8;SK-BR-3: 1.1;THP-1: 1.2;U-937: 1.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA023985	Approved					NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 2: Immune cells - Immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"			"HPA023985: AB_1849302"	"unprognostic (7.75e-3)"	"unprognostic (5.65e-2)"	"unprognostic (4.33e-3)"	"unprognostic (1.68e-1)"	"unprognostic (2.18e-1)"	"unprognostic (2.55e-2)"	"unprognostic (6.16e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.92e-2)"	"unprognostic (9.04e-2)"	"unprognostic (2.30e-2)"	"unprognostic (4.60e-2)"	"unprognostic (5.17e-4)"	"unprognostic (1.48e-1)"	"unprognostic (4.76e-2)"	"unprognostic (9.42e-2)"	"unprognostic (1.03e-2)"	4.9	0.3	0.2	17.8	0.4	20.3	2.3	0.2	0.4	0.2	0.6	0.8	3.3	0.1	0.0	1.3	1.0	1.4	1.0	0.2	0.2	0.3	1.5	7.5	0.1	0.4	0.4	0.0	0.6	0.3	0.1	1.6	0.5	1.1	0.7	0.1	0.7	0.0	0.2	1.1	4.6	1.3	0.2	22.2	1.2	0.0	0.4	0.7	0.4	3.7	0.7	6.0	0.7	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	3.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.8	0.0	0.6	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.1	0.7	0.0	0.0	1.1	0.0	0.0	0.1	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	3.1	2.1	85.0	0.0	5.6	0.0	0.1	0.0	0.0	0.9	0.2	0.0	0.0	249.7	0.0	6.5	0.1	0.0	0.7	0.2	0.4	0.2	0.4	0.2	0.2	0.4	0.4	0.5	0.2	0.4	0.8	5.6	0.0	3.2	0.0	0.6	0.1	0.4	0.3	0.0	0.0	0.2	0.3	0.4	0.0	2.7	0.0	0.0	0.0	0.3	0.3	0.0	0.3	0.2	0.0	0.1	0.8	24.1	0.0	0.0	0.0	0.1	1.4	0.0	0.0	5.1	0.0	0.4	0.0	5.0	0.0	0.0	8.9	2.0	11.9	2.6	0.1	0.0	15.4	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	7.7	1.1	0.0	2.2	0.0	0.0	0.4	2.4	0.1	0.2	0.0	0.6	0.1	1.3	0.1	0.6	1.5
FGD5	"FLJ00274, FLJ39957, ZFYVE23"	ENSG00000154783	"FYVE, RhoGEF and PH domain containing 5"	Q6ZNL6	3	14810853-14934571	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 51.3;Endothelial cells: 44.7;Hepatic stellate cells: 55.6;Microglial cells: 25.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"HUVEC TERT2: 94.9;TIME: 81.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014436, HPA014536, HPA019191"	Uncertain		Supported	"Plasma membrane"		NA	NA				"Cluster 82: Adipose tissue - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Plasma membrane"		"HPA014436: , HPA014536: AB_1848518, HPA019191: AB_1848519"	"unprognostic (2.57e-1)"	"unprognostic (7.33e-2)"	"unprognostic (1.03e-1)"	"unprognostic (3.28e-2)"	"unprognostic (2.02e-2)"	"unprognostic (1.03e-3)"	"unprognostic (1.08e-1)"	"unprognostic (4.10e-2)"	"unprognostic (6.34e-2)"	"unprognostic (5.53e-2)"	"unprognostic (1.46e-1)"	"unprognostic (9.39e-2)"	"unprognostic (6.84e-3)"	"unprognostic (1.71e-2)"	"unprognostic (3.46e-1)"	"unprognostic (1.32e-2)"	"prognostic favorable (7.50e-4)"	19.8	4.4	4.8	5.6	4.3	0.3	15.0	4.1	4.9	10.4	3.4	5.3	9.2	11.3	2.3	5.7	8.5	11.9	11.5	3.0	2.9	10.1	3.1	20.6	4.2	4.5	11.5	5.3	2.2	3.5	3.2	17.7	4.8	5.3	4.6	0.2	3.7	4.4	6.8	5.4	7.0	11.4	3.2	25.0	4.6	4.3	6.7	2.0	7.5	13.4	3.6	7.7	5.6	3.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	94.9	0.1	0.0	0.0	0.0	0.0	0.4	0.2	5.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	6.6	0.4	0.0	81.1	0.0	6.6	21.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.8	4.3	4.1	4.9	3.0	2.9	4.5	11.5	4.8	3.2	6.7	3.0	51.3	0.0	4.6	0.0	0.9	3.1	0.2	0.0	1.2	0.1	1.3	1.9	4.4	1.5	0.6	0.0	0.0	0.3	0.4	0.1	1.9	0.2	7.3	0.4	5.3	44.7	0.0	5.3	3.4	0.2	0.1	11.3	1.1	0.3	0.0	0.0	55.6	1.3	10.5	0.0	8.6	0.2	0.0	2.2	5.9	9.9	11.5	3.3	1.8	25.3	0.0	0.0	1.0	0.5	0.3	4.8	2.5	4.5	0.0	0.3	1.0	7.0	0.0	0.2	0.0	4.9	2.4	0.2	3.6	0.1	1.8	0.5	0.7	2.3	0.5	0.2
FILIP1	"FILIP, KIAA1275"	ENSG00000118407	"Filamin A interacting protein 1"	Q7Z7B0	6	75291859-75493800	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 53.8;skeletal muscle: 35.8;tongue: 48.9"	"Cell type enriched"	"Detected in many"	4	"Cardiomyocytes: 582.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"EFO-21: 6.9;HUVEC TERT2: 1.7;RPTEC TERT1: 1.9;U-266/70: 6.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA053564	Enhanced		Approved	"Plasma membrane,Actin filaments"		No	NA				"Cluster 38: Heart - Muscle contraction"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 54: Cardiomyocytes - Muscle contraction"	"Plasma membrane, Actin filaments"		"HPA053564: AB_2682192"	"unprognostic (4.90e-2)"	"unprognostic (3.77e-2)"	"unprognostic (9.77e-3)"	"unprognostic (3.83e-1)"	"unprognostic (1.52e-1)"	"unprognostic (4.98e-1)"	"unprognostic (2.27e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.06e-1)"	"unprognostic (5.17e-3)"	"unprognostic (3.29e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.30e-3)"	"unprognostic (3.97e-3)"	"unprognostic (2.34e-1)"	"unprognostic (4.65e-2)"	"unprognostic (7.66e-3)"	6.8	1.5	1.5	2.9	1.8	0.2	2.4	0.1	2.5	1.8	0.7	11.7	1.8	8.5	0.9	9.5	4.8	5.7	53.8	4.1	0.5	1.8	3.2	7.6	1.2	0.2	0.5	1.3	1.4	12.4	1.4	5.1	0.3	3.9	3.3	0.4	1.2	3.4	35.8	0.6	2.6	13.2	0.5	0.3	3.2	2.1	0.8	1.1	2.3	48.9	0.9	10.9	1.6	1.5	0.0	1.3	0.2	0.1	0.0	0.2	0.1	0.2	0.0	0.0	0.0	0.0	0.1	0.1	6.9	0.0	0.1	0.0	0.1	0.0	0.0	0.2	0.2	0.1	0.2	0.0	0.0	0.1	0.1	0.9	0.0	0.1	0.0	0.0	1.7	0.2	0.0	0.2	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	1.9	0.4	0.1	0.1	0.0	0.1	0.0	1.5	0.0	0.2	0.0	0.0	0.0	0.0	0.0	6.9	0.7	0.0	0.0	0.3	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.2	0.0	0.1	0.1	0.0	0.0	1.5	1.8	0.1	2.5	4.1	0.5	0.2	0.5	0.3	0.5	0.8	1.5	82.1	128.2	82.6	5.9	0.5	0.6	0.5	2.8	0.0	3.5	0.5	0.8	582.5	0.0	9.1	0.0	0.0	0.8	0.5	0.1	1.9	0.1	54.2	18.2	1.7	45.9	0.0	2.7	9.7	0.4	0.3	60.3	0.0	19.2	1.3	1.7	72.1	0.7	1.3	0.0	12.8	0.1	8.2	1.9	1.2	17.6	2.5	1.8	1.8	5.6	0.0	2.5	1.0	6.0	10.0	0.0	0.0	4.5	0.0	0.8	0.4	0.1	62.4	3.5	92.1	70.2	114.2	7.1	7.9	0.7	0.9	0.8	1.8	11.9	0.1	0.4
FKBP1A	"FKBP-12, FKBP1, FKBP12, FKBP12C, PKC12, PPIASE"	ENSG00000088832	"FKBP prolyl isomerase 1A"	P62942	20	1368977-1393164	"Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		"Isomerase, Rotamase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Paneth cells: 977.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"dendritic cells: 675.2;granulocytes: 974.2;monocytes: 1013.4"	"Cell line enhanced"	"Detected in all"		"HUVEC TERT2: 1749.2;TIME: 1929.6"									"CAB004639, HPA051798"	Uncertain					NA	NA		12000000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 28: Placenta - Pregnancy"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"			"CAB004639: AB_425434, HPA051798: AB_2681615"	"unprognostic (4.09e-2)"	"unprognostic (2.29e-1)"	"unprognostic (5.22e-3)"	"unprognostic (1.28e-2)"	"unprognostic (2.66e-1)"	"unprognostic (7.18e-3)"	"prognostic unfavorable (3.44e-7)"	"unprognostic (7.05e-3)"	"unprognostic (2.76e-1)"	"unprognostic (8.81e-2)"	"unprognostic (5.12e-3)"	"unprognostic (6.65e-2)"	"prognostic unfavorable (6.69e-5)"	"unprognostic (1.97e-2)"	"unprognostic (2.06e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.47e-1)"	272.7	185.0	138.4	178.8	177.5	167.0	188.2	88.5	163.2	123.0	112.6	158.6	108.9	165.4	150.1	169.8	131.7	104.5	171.4	166.7	115.8	186.7	98.1	235.2	162.7	92.4	98.9	135.1	114.6	123.0	79.5	218.7	95.6	125.4	188.5	11.8	111.0	119.8	110.3	127.3	117.0	225.1	97.8	185.7	118.3	56.9	120.5	188.1	190.9	150.6	202.2	206.8	126.2	118.9	718.1	299.5	172.9	240.3	654.1	771.3	202.9	423.9	337.1	382.7	354.2	278.4	295.2	272.5	149.3	555.7	656.3	337.7	255.1	1007.2	419.7	68.8	170.5	284.2	113.9	473.3	406.4	390.5	168.0	484.7	332.0	410.3	412.6	513.3	1749.2	401.0	271.0	145.8	443.3	125.8	401.9	453.7	307.1	335.3	276.4	307.0	254.1	351.9	540.0	243.4	248.7	173.8	208.0	479.3	728.8	231.8	177.2	293.0	1929.6	1363.6	201.8	278.1	329.5	76.4	168.1	292.9	248.1	332.3	307.5	316.3	870.8	974.2	112.9	1005.8	104.3	128.1	135.5	133.2	675.2	136.2	140.1	132.6	805.0	160.6	1013.4	312.7	195.0	1153.8	138.4	177.5	88.5	163.2	166.7	115.8	92.4	98.9	95.6	97.8	120.5	118.9	779.1	86.6	77.2	0.0	160.6	263.1	211.2	393.3	152.0	17.6	175.6	156.5	59.7	170.1	179.5	172.9	0.0	281.8	148.3	456.2	238.7	432.4	47.7	98.7	183.8	814.8	330.6	196.4	0.0	337.5	702.0	212.2	160.0	122.5	143.5	95.3	623.6	113.5	746.7	35.3	0.0	245.9	329.6	541.8	436.5	52.2	200.0	428.8	241.9	0.0	527.4	52.2	152.4	0.0	0.0	483.6	977.5	162.9	214.8	221.1	210.8	332.1	123.0	11.7	138.1	87.4	224.7	169.3	141.8	329.4	299.3	231.5	150.1	347.3	318.0	245.7
GBP4	Mpa2	ENSG00000162654	"Guanylate binding protein 4"	Q96PP9	1	89181144-89198942	"Plasma proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 84.4;Endothelial cells: 81.2;Hepatic stellate cells: 92.4;Theca cells: 122.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 12.1;HDLM-2: 9.9;HEL: 13.0;REH: 11.1;RT4: 18.3;U-266/70: 16.0"									"HPA030101, HPA062039"	Enhanced		Supported	"Golgi apparatus,Plasma membrane"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 16: Immune cells - Immune response"	"Cluster 15: RT4 - Unknown function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Golgi apparatus"	"Plasma membrane"	"HPA030101: AB_10601654, HPA062039: "	"unprognostic (1.32e-2)"	"unprognostic (3.89e-3)"	"unprognostic (1.02e-2)"	"unprognostic (1.07e-3)"	"unprognostic (3.22e-1)"	"unprognostic (9.93e-3)"	"unprognostic (5.65e-2)"	"unprognostic (1.09e-1)"	"unprognostic (3.22e-1)"	"prognostic favorable (9.29e-5)"	"unprognostic (1.91e-3)"	"unprognostic (3.38e-1)"	"prognostic unfavorable (1.30e-5)"	"unprognostic (1.22e-1)"	"unprognostic (3.91e-2)"	"unprognostic (2.68e-2)"	"unprognostic (2.02e-3)"	11.3	5.2	4.0	29.5	3.9	6.6	6.7	4.4	4.8	4.2	2.6	6.6	12.4	8.8	4.5	7.2	9.1	8.8	11.0	3.8	4.3	9.8	14.1	31.2	34.3	7.1	3.7	16.4	1.6	6.5	2.7	11.9	7.7	5.8	7.2	3.4	7.1	6.7	7.1	2.1	11.8	7.7	3.9	29.0	11.9	2.9	4.4	10.0	7.8	9.4	11.0	13.1	4.5	3.9	0.8	0.0	0.1	0.3	0.1	0.1	0.6	1.8	7.6	8.0	7.2	0.1	12.1	0.6	1.0	2.3	0.6	0.9	0.0	0.3	0.4	9.9	0.1	13.0	0.4	0.3	1.0	0.2	0.3	0.4	0.0	0.1	0.0	1.2	1.9	0.3	0.4	2.3	0.0	0.2	6.6	0.3	0.4	0.1	0.1	11.1	0.2	0.4	0.1	18.3	0.2	0.5	0.3	0.7	0.3	0.6	0.5	1.4	0.4	0.3	1.6	0.2	0.2	16.0	0.3	0.3	0.3	0.1	2.3	0.6	4.1	0.4	7.1	14.1	6.1	2.5	7.6	7.9	2.2	3.3	5.6	5.2	5.6	13.8	14.5	0.9	9.0	5.5	4.0	3.9	4.4	4.8	3.8	4.3	7.1	3.7	7.7	3.9	4.4	3.9	84.4	32.1	39.3	0.0	28.3	4.6	9.1	20.7	1.8	2.8	3.5	2.4	3.6	8.6	25.3	5.5	8.4	0.9	29.0	5.1	0.0	2.2	1.9	4.8	8.4	81.2	0.0	11.2	0.5	3.3	1.6	22.2	9.2	7.4	21.5	17.9	92.4	6.5	8.3	0.0	2.5	4.3	4.1	29.2	10.9	1.2	3.7	33.7	5.4	15.9	33.8	15.5	36.0	1.0	0.6	36.3	1.9	1.9	7.2	24.4	4.4	1.5	43.3	12.2	0.0	5.3	11.3	2.4	3.4	2.9	3.0	1.5	34.2	122.6	2.4	13.6
GIMAP1	"HIMAP1, IAN2, IMAP1, IMAP38"	ENSG00000213203	"GTPase, IMAP family member 1"	Q8WWP7	7	150716606-150724284	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 24.7"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 189.8;Endothelial cells: 109.9;Hepatic stellate cells: 117.8;Kupffer cells: 109.1;monocytes: 74.9;NK-cells: 185.3;T-cells: 97.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"HUVEC TERT2: 14.7;MOLT-4: 9.2;TIME: 3.9"	"Low region specificity"	"Detected in many"							"HPA044887, HPA053441"	Uncertain		Supported	"Endoplasmic reticulum"		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 16: Immune cells - Immune response"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 63: NK-cells & T-cells - Immune response"	"Endoplasmic reticulum"		"HPA044887: AB_10960351, HPA053441: AB_2682152"	"unprognostic (1.60e-2)"	"unprognostic (6.58e-3)"	"unprognostic (8.21e-3)"	"unprognostic (2.54e-3)"	"unprognostic (1.10e-1)"	"unprognostic (2.33e-3)"	"prognostic favorable (1.09e-4)"	"unprognostic (1.66e-2)"	"unprognostic (3.54e-2)"	"unprognostic (3.44e-1)"	"unprognostic (4.60e-3)"	"unprognostic (7.89e-2)"	"unprognostic (1.77e-3)"	"unprognostic (2.18e-1)"	"prognostic unfavorable (6.12e-4)"	"unprognostic (7.49e-2)"	"unprognostic (1.96e-1)"	9.8	2.5	3.0	11.0	3.0	1.0	7.9	2.9	3.5	3.8	3.0	3.7	3.5	4.6	1.1	2.1	4.4	3.2	9.3	2.8	2.9	3.5	2.4	8.9	19.6	3.5	3.2	1.5	1.4	1.5	1.1	7.1	3.4	2.3	2.2	0.1	2.5	2.0	5.4	2.5	6.9	3.8	3.5	24.7	3.3	0.8	3.6	6.6	5.3	7.1	8.4	3.5	3.0	3.2	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	14.7	1.9	0.0	0.0	0.0	0.0	9.2	0.8	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	3.0	32.2	0.1	43.8	29.6	51.1	0.3	47.5	54.2	13.5	0.6	68.2	56.2	2.7	42.6	30.6	0.8	34.0	35.0	3.0	3.0	2.9	3.5	2.8	2.9	3.5	3.2	3.4	3.5	3.6	3.2	189.8	3.2	1.5	0.0	5.1	5.5	0.6	0.0	1.2	0.6	1.9	3.6	5.9	2.8	0.6	0.0	0.0	0.3	51.5	0.1	0.0	0.3	0.3	0.4	0.6	109.9	0.0	10.5	0.0	0.4	0.3	3.7	1.5	0.2	8.2	0.2	117.8	2.0	37.9	0.0	0.0	0.0	0.0	109.1	7.6	1.3	1.5	48.0	8.8	0.0	74.9	0.3	185.3	0.0	0.0	0.1	0.1	0.0	7.6	0.7	0.2	0.5	0.0	1.0	0.0	2.5	3.5	0.3	0.5	0.7	3.1	0.4	97.3	1.0	0.0	0.7
GJA4	CX37	ENSG00000187513	"Gap junction protein alpha 4"	P35212	1	34792999-34795747	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"Hepatic stellate cells: 234.2;Sertoli cells: 664.0;Smooth muscle cells: 306.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	8	"EFO-21: 74.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA047981	Approved					NA	NA				"Cluster 82: Adipose tissue - ECM organization"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 48: Smooth muscle cells - ECM organization"			"HPA047981: AB_2680228"	"unprognostic (2.22e-2)"	"unprognostic (2.05e-1)"	"unprognostic (1.12e-2)"	"unprognostic (2.67e-2)"	"unprognostic (4.48e-1)"	"unprognostic (5.24e-3)"	"prognostic favorable (3.28e-4)"	"unprognostic (2.01e-2)"	"unprognostic (2.23e-1)"	"unprognostic (8.17e-2)"	"unprognostic (6.83e-2)"	"unprognostic (8.81e-2)"	"prognostic unfavorable (7.44e-4)"	"unprognostic (3.47e-2)"	"unprognostic (3.74e-2)"	"unprognostic (3.82e-3)"	"unprognostic (7.96e-3)"	79.4	20.4	10.1	9.3	11.0	0.3	61.5	9.8	15.1	26.6	9.0	14.7	2.8	33.8	5.5	7.5	40.0	17.3	83.6	10.5	9.6	35.8	17.3	40.7	11.3	10.3	10.2	18.0	7.0	10.6	6.4	61.6	10.6	18.8	3.8	0.8	10.1	10.7	34.7	14.8	13.9	15.2	10.2	9.9	12.9	5.4	10.2	2.7	39.8	35.2	5.4	28.1	22.4	9.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	74.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	9.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	8.5	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.3	0.0	0.1	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	10.1	11.0	9.8	15.1	10.5	9.6	10.3	10.2	10.6	10.2	10.2	9.9	90.4	0.0	0.0	0.3	0.6	9.7	1.9	0.2	1.2	0.2	1.1	1.5	9.0	1.5	0.6	3.7	0.0	0.2	0.7	0.0	0.0	11.0	0.1	3.1	0.5	81.4	15.6	2.7	0.0	0.0	0.1	7.7	2.6	4.9	0.0	0.5	234.2	1.8	0.3	0.0	0.0	0.0	0.0	6.3	10.7	1.1	0.9	2.2	19.6	1.0	0.6	0.1	0.0	0.0	0.0	1.0	0.0	12.8	0.2	3.0	0.0	0.1	1.2	0.7	664.0	4.4	306.3	0.2	1.2	0.7	8.7	0.0	1.3	1.6	0.1	5.2
GMFG		ENSG00000130755	"Glia maturation factor gamma"	O60234	19	39328353-39342372	"Plasma proteins, Predicted intracellular proteins"		"Growth factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"bone marrow: 577.4;lymphoid tissue: 460.7"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 304.3;Hofbauer cells: 467.5;Kupffer cells: 523.4;Langerhans cells: 343.2;Macrophages: 409.6;monocytes: 409.4;NK-cells: 423.3;T-cells: 370.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HL-60: 356.7;HMC-1: 602.6;JURKAT: 464.5;Karpas-707: 494.4;NB-4: 361.6;REH: 409.8;THP-1: 641.5;U-937: 482.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002954	Uncertain	Approved	Approved	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA		810000	"Cluster 5: Granulocytes - Unknown function"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	"Nucleoplasm, Cytosol"	"Nuclear bodies"	"HPA002954: AB_1078997"	"unprognostic (1.22e-2)"	"prognostic favorable (7.35e-4)"	"unprognostic (2.37e-2)"	"unprognostic (1.21e-3)"	"unprognostic (9.93e-2)"	"unprognostic (2.14e-2)"	"unprognostic (1.19e-1)"	"unprognostic (4.84e-2)"	"unprognostic (1.00e-1)"	"unprognostic (2.09e-1)"	"unprognostic (3.09e-1)"	"unprognostic (1.15e-1)"	"prognostic unfavorable (9.11e-6)"	"unprognostic (3.01e-1)"	"unprognostic (8.76e-3)"	"unprognostic (1.06e-1)"	"unprognostic (5.27e-3)"	111.6	26.3	27.1	188.6	27.4	577.4	71.3	26.9	41.6	26.0	29.3	45.6	33.8	20.7	19.6	19.7	29.0	60.8	25.1	27.9	29.1	36.8	65.9	117.7	299.5	30.7	30.1	9.2	14.4	15.6	10.8	102.4	30.5	18.5	53.2	2.0	18.9	15.0	11.4	16.2	75.0	47.8	29.1	325.3	41.5	7.4	28.6	460.7	37.6	23.6	262.7	93.5	18.3	32.6	1.4	0.0	2.0	0.4	0.0	0.0	0.7	1.1	0.3	0.3	0.2	0.3	33.1	309.6	2.4	0.3	0.1	1.5	0.0	0.7	1.2	99.7	0.5	329.7	0.4	3.5	5.1	356.7	602.6	0.7	0.6	0.5	0.8	0.8	19.2	464.5	12.3	494.4	2.4	0.0	316.6	361.6	0.6	0.1	0.2	409.8	3.2	196.8	0.5	40.9	0.8	0.5	1.3	1.9	2.1	0.6	0.8	641.5	175.7	0.2	3.2	0.8	1.1	26.9	107.3	340.0	1.7	482.4	2.7	4389.0	1574.5	3622.3	720.9	1447.6	773.8	812.5	1058.2	894.4	1139.9	742.7	1044.5	858.2	5262.9	908.0	1686.2	459.6	1840.4	2617.7	27.1	27.4	26.9	41.6	27.9	29.1	30.7	30.1	30.5	29.1	28.6	32.6	304.3	28.9	97.6	0.0	211.7	18.6	4.4	0.3	2.8	0.0	4.2	9.4	3.2	11.5	17.3	0.0	0.0	3.6	273.5	0.9	0.0	1.1	11.8	0.6	2.2	176.4	0.0	119.4	0.5	0.7	4.0	18.2	9.7	0.8	238.0	0.3	272.4	11.8	467.5	0.0	0.4	0.3	2.0	523.4	343.2	30.4	1.8	409.6	74.7	1.9	409.4	0.7	423.3	0.5	0.3	0.3	0.0	0.4	216.8	1.1	0.3	4.6	8.9	0.3	46.0	4.2	26.4	8.6	3.3	1.4	14.8	5.5	370.6	2.3	1.1	4.1
GNAI2	"GIP, GNAI2B"	ENSG00000114353	"G protein subunit alpha i2"	P04899	3	50226292-50259362	"Human disease related genes, Predicted intracellular proteins"	"Cell cycle, Cell division"	Transducer		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Adipocytes: 656.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007704	Approved		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA		4000000	"Cluster 52: Eosinophils - Transcription"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 7: Non-specific - Mitochondria"	Cytosol	"Nucleoplasm, Plasma membrane"	"HPA007704: AB_1849230"	"prognostic favorable (1.03e-4)"	"unprognostic (3.89e-1)"	"unprognostic (3.35e-2)"	"unprognostic (8.40e-3)"	"unprognostic (2.58e-1)"	"unprognostic (2.32e-2)"	"unprognostic (2.59e-2)"	"unprognostic (3.23e-1)"	"unprognostic (1.08e-3)"	"unprognostic (6.01e-2)"	"unprognostic (7.00e-3)"	"unprognostic (1.12e-1)"	"unprognostic (6.24e-3)"	"unprognostic (1.44e-1)"	"unprognostic (4.30e-2)"	"unprognostic (4.33e-2)"	"unprognostic (1.38e-1)"	210.2	100.3	155.2	217.9	167.3	367.1	152.8	166.3	181.6	146.0	120.2	142.1	69.9	141.7	66.9	124.4	136.9	152.5	157.1	144.3	184.6	79.4	126.5	214.5	251.3	199.8	170.2	147.7	64.1	66.9	99.2	241.8	194.8	103.6	64.3	35.6	71.9	156.9	69.3	87.0	103.0	154.0	173.6	262.1	73.6	69.6	173.3	160.3	101.3	89.4	170.4	169.7	108.4	193.2	128.2	63.0	186.3	197.6	220.7	277.5	35.5	271.1	399.6	354.9	361.1	70.4	173.2	149.1	119.2	567.0	193.4	100.1	132.8	350.3	222.8	331.2	50.9	364.8	158.0	110.2	219.8	329.2	479.8	270.3	152.9	319.1	129.8	289.6	837.8	124.1	26.1	307.1	357.5	155.7	313.6	433.0	109.7	59.0	302.4	185.0	89.8	219.7	232.6	130.9	48.4	86.1	189.5	57.1	124.4	150.4	94.3	346.1	792.3	330.9	187.5	309.2	274.7	199.4	278.3	127.0	373.6	466.9	398.1	16.6	59.3	113.7	33.7	80.9	20.2	28.8	26.8	34.3	57.3	26.1	20.2	25.8	145.2	23.5	74.5	47.2	34.0	27.3	155.2	167.3	166.3	181.6	144.3	184.6	199.8	170.2	194.8	173.6	173.3	193.2	656.8	41.7	32.1	25.1	119.5	56.7	59.7	32.3	45.5	29.0	61.6	83.8	22.9	55.8	26.6	44.1	14.6	79.5	311.4	11.7	5.9	124.3	203.3	57.8	115.7	340.3	92.2	52.1	12.4	60.5	84.4	101.9	21.9	71.8	89.9	150.0	221.3	79.7	336.0	6.7	14.8	24.6	18.3	342.7	291.7	302.0	90.7	386.1	83.6	58.1	356.6	292.6	151.4	26.7	45.4	160.3	40.9	95.5	104.8	46.1	30.3	24.5	24.4	21.9	52.6	85.3	163.1	16.6	22.6	37.6	62.9	116.4	164.9	156.3	20.5	70.1
GNAZ		ENSG00000128266	"G protein subunit alpha z"	P19086	22	23070519-23125032	"Predicted intracellular proteins"		Transducer		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 36.2"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 32.1;Horizontal cells: 124.5;Rod photoreceptor cells: 37.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 18.3;SCLC-21H: 39.0;SH-SY5Y: 24.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003011	Enhanced		Approved	Vesicles		NA	NA		180000	"Cluster 14: Monocytes - Unknown function"	"Cluster 77: Retina - Visual perception"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 51: Myeloid cells - Hemostasis"	Vesicles		"HPA003011: AB_1078918"	"unprognostic (7.61e-2)"	"unprognostic (1.63e-2)"	"unprognostic (3.13e-2)"	"prognostic unfavorable (4.85e-4)"	"unprognostic (1.01e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.51e-3)"	"unprognostic (3.45e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.26e-3)"	"unprognostic (1.68e-2)"	"unprognostic (9.69e-2)"	"unprognostic (2.29e-1)"	"unprognostic (6.63e-2)"	"unprognostic (2.82e-1)"	"unprognostic (1.30e-1)"	9.2	6.6	30.7	2.8	35.9	1.6	8.4	27.4	36.2	5.4	27.8	14.8	1.7	10.1	2.8	5.0	10.2	11.2	2.4	33.6	24.5	2.0	0.5	1.4	1.8	29.6	30.7	8.9	1.6	7.5	24.1	0.3	32.0	8.5	1.6	33.0	1.8	17.2	1.4	1.4	3.2	11.9	27.0	4.7	11.5	4.3	29.0	0.5	1.5	2.1	1.2	8.0	3.6	35.7	0.1	2.0	6.8	14.3	0.0	0.0	0.4	9.2	18.3	8.9	6.0	0.1	0.1	17.7	0.6	0.8	12.2	0.3	8.4	0.3	6.4	2.2	7.0	1.1	10.2	13.1	0.6	0.0	1.4	0.0	0.3	0.2	0.5	2.2	0.2	1.0	0.2	5.4	0.2	6.4	0.1	0.1	4.1	0.5	5.5	0.1	6.8	2.7	0.1	0.1	39.0	24.0	2.0	4.4	1.9	0.8	1.9	0.2	0.0	7.2	8.2	2.0	0.2	6.6	12.0	9.2	3.7	0.6	2.8	0.9	0.1	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.2	0.3	0.0	0.6	0.0	0.0	2.0	30.7	35.9	27.4	36.2	33.6	24.5	29.6	30.7	32.0	27.0	29.0	35.7	32.1	3.2	0.0	4.9	0.7	0.3	0.3	0.4	0.0	12.6	0.8	1.7	1.6	7.2	0.7	3.7	8.4	0.0	0.7	0.3	0.0	2.0	1.5	1.6	0.5	5.0	4.8	2.7	11.0	1.6	0.0	1.1	1.5	0.4	0.0	2.1	2.2	0.4	0.1	124.5	11.0	0.3	2.0	0.0	1.7	2.1	4.1	18.6	1.8	1.0	1.2	19.3	1.0	2.0	16.5	0.7	0.0	4.1	0.1	0.3	0.1	0.9	1.3	37.7	0.0	9.0	2.1	2.0	4.2	0.0	0.4	0.0	0.6	0.9	0.2	0.1
GPR176	Gm1012	ENSG00000166073	"G protein-coupled receptor 176"	Q14439	15	39799008-39920266	"G-protein coupled receptors, Predicted membrane proteins"	"Biological rhythms"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 22.3;Excitatory neurons: 32.0;Inhibitory neurons: 56.8;Oligodendrocyte precursor cells: 40.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 276.1;fHDF/TERT166: 186.5;U-138 MG: 119.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039943, HPA039979"	Approved					NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA039943: AB_10697711, HPA039979: AB_2676782"	"unprognostic (4.02e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.99e-1)"	"unprognostic (1.11e-1)"	"unprognostic (4.24e-1)"	"unprognostic (1.04e-2)"	"unprognostic (2.75e-2)"	"unprognostic (1.38e-3)"	"unprognostic (9.32e-2)"	"unprognostic (3.23e-2)"	"unprognostic (2.74e-2)"	"unprognostic (2.33e-2)"	"prognostic unfavorable (9.38e-7)"	"prognostic unfavorable (6.84e-5)"	"unprognostic (2.23e-1)"	"unprognostic (1.95e-1)"	"unprognostic (3.26e-2)"	13.2	6.1	10.0	4.1	10.6	0.3	6.6	11.2	10.5	6.8	1.1	3.9	2.0	5.6	2.0	1.7	4.4	7.0	4.2	10.1	10.4	3.9	1.9	7.5	6.3	9.7	8.8	1.8	1.6	1.9	5.0	2.4	12.3	7.1	2.3	6.3	2.9	3.6	1.7	3.5	3.4	4.6	6.0	4.1	2.2	7.2	8.8	2.1	5.0	1.1	5.8	6.4	5.3	5.9	52.3	2.6	3.2	0.6	36.9	64.6	0.0	108.3	276.1	64.3	99.5	3.7	8.3	0.7	8.7	186.5	37.1	1.6	7.7	8.4	100.7	1.7	11.2	7.7	7.7	0.1	41.1	0.0	0.4	50.7	1.0	56.7	47.6	65.7	24.6	2.4	1.0	1.1	91.8	2.1	0.1	0.0	3.2	0.4	9.3	2.7	32.3	0.3	1.6	0.6	12.0	47.8	27.9	0.0	4.4	0.7	9.0	0.5	31.8	119.5	33.9	7.2	40.7	1.1	3.6	0.1	24.9	0.0	47.5	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.0	10.6	11.2	10.5	10.1	10.4	9.7	8.8	12.3	6.0	8.8	5.9	3.0	0.0	0.0	8.5	0.9	1.8	0.2	0.8	0.0	1.1	0.4	0.6	0.9	1.5	0.1	0.0	0.0	0.0	0.3	0.1	0.0	9.3	22.3	0.1	3.1	1.8	0.0	0.0	32.0	3.9	0.0	3.4	0.0	0.2	0.0	0.1	0.7	0.1	0.1	1.7	56.8	0.0	0.0	0.0	1.8	13.5	1.2	0.7	1.8	3.7	0.0	14.9	0.0	40.7	1.4	12.0	0.0	1.2	3.1	3.0	0.0	1.2	0.0	1.1	13.1	3.8	15.2	2.9	3.8	0.5	1.0	0.0	0.4	0.8	0.0	0.1
HDAC9	"HD7, HDAC, HDAC7B, KIAA0744, MITR"	ENSG00000048052	"Histone deacetylase 9"	Q9UKV0	7	18086949-19002416	"Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, Hydrolase, Repressor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"choroid plexus: 47.5"	"Group enriched"	"Detected in many"	4	"Early spermatids: 244.6;Excitatory neurons: 376.2;Inhibitory neurons: 442.3;Microglial cells: 334.5;Oligodendrocyte precursor cells: 322.7;Oligodendrocytes: 233.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"myeloid DC: 74.1"	"Group enriched"	"Detected in all"	9	"B-cells: 52.6;dendritic cells: 74.1;monocytes: 24.4"	"Cell line enhanced"	"Detected in many"		"HAP1: 163.6;hTERT-HME1: 79.4;SH-SY5Y: 65.7;U-698: 64.5;WM-115: 69.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028926	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 20: Retina & Lymphoid tissues - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm		"HPA028926: AB_10602327"	"unprognostic (2.06e-2)"	"unprognostic (2.67e-1)"	"unprognostic (2.30e-1)"	"unprognostic (1.17e-1)"	"unprognostic (2.74e-1)"	"unprognostic (5.54e-2)"	"unprognostic (2.20e-2)"	"unprognostic (2.32e-1)"	"unprognostic (2.21e-1)"	"unprognostic (2.45e-1)"	"unprognostic (5.01e-1)"	"unprognostic (7.58e-2)"	"unprognostic (1.29e-1)"	"unprognostic (3.94e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.02e-1)"	"unprognostic (6.87e-3)"	8.2	12.3	5.8	8.8	6.6	5.9	5.1	4.8	7.9	10.1	47.5	5.4	3.4	13.2	6.0	2.9	9.3	6.7	14.3	5.5	3.8	2.8	2.8	5.1	18.9	6.0	6.7	2.4	1.5	1.8	6.5	6.3	6.0	11.0	5.5	25.4	7.1	14.5	16.7	2.2	4.5	13.0	3.8	17.5	8.7	5.6	12.9	6.8	2.9	5.8	18.7	5.2	4.9	7.3	40.2	0.2	6.3	0.1	0.9	8.4	0.2	2.4	23.0	9.5	16.1	0.3	12.7	16.7	41.9	26.0	51.6	5.8	163.6	3.2	24.2	0.2	1.1	0.0	0.2	0.0	0.2	3.5	0.1	3.0	3.1	29.7	79.4	8.4	0.4	2.7	0.0	25.1	13.3	0.0	1.6	3.5	20.3	0.0	3.9	4.7	2.5	10.2	5.2	10.6	11.6	65.7	0.5	0.3	12.7	9.7	0.6	15.2	1.8	34.4	11.1	1.9	22.3	28.8	13.3	64.5	9.0	1.6	69.2	0.3	24.4	0.1	4.2	16.5	4.1	52.6	1.4	2.0	74.1	43.2	0.0	2.1	1.4	5.5	10.3	15.9	5.6	12.9	5.8	6.6	4.8	7.9	5.5	3.8	6.0	6.7	6.0	3.8	12.9	7.3	31.4	6.4	2.8	28.1	46.1	2.4	0.7	6.8	6.2	33.0	1.4	0.8	15.2	0.0	12.9	0.0	16.7	0.1	16.3	15.3	3.9	6.8	244.6	24.2	2.3	16.5	7.2	5.7	376.2	0.7	0.2	5.3	13.7	26.1	1.3	0.0	8.9	1.0	12.9	20.2	442.3	0.7	4.1	51.2	64.2	80.1	1.5	34.8	16.0	334.5	21.0	5.1	11.3	322.7	233.1	10.6	6.7	0.7	46.7	1.6	0.0	0.1	17.5	26.2	6.6	2.3	9.0	34.3	8.7	0.7	2.0	0.1	7.8	0.1	0.3	12.1
HEG1	"HEG, KIAA1237"	ENSG00000173706	"Heart development protein with EGF like domains 1"	Q9ULI3	3	124965710-125055997	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 90.1;Cardiomyocytes: 90.5;Cone photoreceptor cells: 264.8;Endothelial cells: 121.5;Hepatic stellate cells: 130.3;Microglial cells: 92.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 174.1;HHSteC: 241.5;hTERT-RPE1: 351.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA010952, HPA011559"	Approved		Approved	"Vesicles,Plasma membrane"	"Intracellular and membrane"	NA	NA		510000000	"Cluster 15: NK-cells - Transcription"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Vesicles	"Plasma membrane"	"HPA010952: AB_2668389, HPA011559: AB_1850580"	"unprognostic (1.10e-1)"	"unprognostic (2.21e-1)"	"unprognostic (6.52e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.30e-1)"	"unprognostic (5.40e-2)"	"unprognostic (6.48e-2)"	"unprognostic (2.89e-2)"	"unprognostic (2.36e-1)"	"unprognostic (9.80e-2)"	"unprognostic (1.69e-1)"	"unprognostic (8.33e-2)"	"prognostic unfavorable (1.93e-5)"	"unprognostic (1.11e-2)"	"unprognostic (4.99e-2)"	"unprognostic (6.20e-3)"	"prognostic unfavorable (1.16e-4)"	30.1	9.9	19.3	19.2	23.2	1.9	14.8	27.0	15.0	20.8	28.3	11.9	8.0	19.2	6.2	16.1	13.2	38.9	67.3	14.3	22.7	15.2	7.5	55.1	16.5	32.0	28.1	12.4	31.6	16.1	3.6	33.4	28.6	13.9	12.2	46.8	7.7	14.6	14.3	5.2	9.4	25.4	27.3	17.9	9.8	13.5	30.3	8.6	52.2	24.2	15.7	30.0	10.1	30.6	7.0	7.1	54.7	4.2	73.2	58.7	21.1	64.9	90.1	72.6	83.5	58.5	1.0	2.8	43.8	174.1	52.3	15.3	7.4	31.6	97.9	6.5	3.7	1.3	42.3	8.4	241.5	1.8	80.6	77.8	10.1	87.4	21.5	351.3	69.3	5.0	0.1	1.0	25.7	1.3	2.8	0.1	10.1	0.1	5.5	4.8	41.0	0.2	14.6	1.2	1.0	5.6	134.8	10.6	6.4	55.1	24.2	4.3	93.9	37.7	41.3	150.5	29.1	6.9	19.7	0.4	76.8	6.5	82.4	1.1	0.1	0.0	1.9	1.7	1.1	0.5	0.6	1.7	0.4	0.3	1.2	0.8	0.0	3.9	1.9	0.4	0.2	0.5	19.3	23.2	27.0	15.0	14.3	22.7	32.0	28.1	28.6	27.3	30.3	30.6	90.1	86.6	5.8	28.7	4.9	5.0	8.0	25.4	6.8	6.1	2.4	5.7	90.5	7.2	6.5	27.6	264.8	1.8	19.2	0.5	0.0	32.0	7.0	4.0	20.1	121.5	0.0	6.1	0.9	6.4	65.3	44.8	1.1	2.2	26.6	24.9	130.3	3.5	6.8	1.7	14.9	0.5	4.1	18.4	7.3	9.4	5.0	7.1	7.2	92.8	4.0	6.0	35.0	13.0	57.6	6.4	0.1	13.9	8.6	5.2	0.8	1.3	1.0	66.8	0.0	24.0	28.7	1.0	1.1	2.7	4.4	3.3	14.2	3.1	0.1	1.3
HLX	"HB24, HLX1"	ENSG00000136630	"H2.0 like homeobox"	Q14774	1	220879431-220885059	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 86.5"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 35.7;Endothelial cells: 32.5;Hepatic stellate cells: 47.5;Hofbauer cells: 34.1;Kupffer cells: 24.8;Langerhans cells: 23.5;monocytes: 44.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 65.1;neutrophil: 55.9"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 65.1"	"Cell line enhanced"	"Detected in many"		"SK-MEL-30: 32.4;THP-1: 100.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA005968	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Nucleoplasm, Cytosol"		"HPA005968: AB_1079066"	"unprognostic (6.18e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.88e-3)"	"unprognostic (2.57e-2)"	"unprognostic (9.19e-3)"	"unprognostic (1.76e-1)"	"unprognostic (1.40e-1)"	"unprognostic (5.14e-3)"	"unprognostic (1.06e-1)"	"unprognostic (9.73e-2)"	"unprognostic (3.19e-2)"	"unprognostic (1.39e-1)"	"prognostic unfavorable (7.28e-6)"	"unprognostic (8.44e-3)"	"unprognostic (3.68e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.36e-1)"	35.2	4.7	1.4	10.3	1.3	86.5	18.6	1.4	2.0	7.5	1.5	44.4	4.8	5.5	0.5	3.9	9.3	9.6	18.9	2.0	1.6	6.8	21.8	23.1	8.5	1.9	1.7	4.2	4.3	1.3	3.0	13.8	2.0	6.3	2.0	0.0	3.5	0.4	9.2	8.7	18.9	5.6	1.9	15.7	5.2	1.8	2.6	2.1	9.5	4.2	2.3	11.0	8.8	1.9	0.0	2.1	0.0	3.2	9.2	14.7	3.0	11.4	18.9	12.8	10.6	0.2	0.3	0.0	0.1	6.8	2.5	0.0	0.5	0.0	5.3	3.0	5.9	0.0	1.1	0.3	15.1	3.9	0.8	15.4	0.2	14.7	0.8	1.1	5.7	0.0	4.0	0.0	1.6	0.0	0.0	10.3	0.3	0.0	5.2	0.3	9.0	0.1	0.8	0.1	0.0	2.4	0.7	0.0	32.4	0.1	0.0	100.4	1.8	8.7	0.0	1.3	9.3	0.0	0.0	0.0	14.1	12.3	3.6	65.1	10.4	22.3	0.0	3.4	0.0	5.7	0.0	0.0	13.0	2.7	0.0	0.0	55.9	0.7	0.7	8.7	0.4	3.3	1.4	1.3	1.4	2.0	2.0	1.6	1.9	1.7	2.0	1.9	2.6	1.9	35.7	9.6	5.3	1.0	4.3	2.8	0.1	0.0	0.6	0.1	0.5	1.3	5.7	0.0	0.0	0.0	0.0	0.6	3.0	0.4	0.0	0.5	0.5	0.2	2.6	32.5	0.0	8.4	0.3	0.4	0.7	8.4	0.5	0.3	3.8	0.1	47.5	10.8	34.1	0.0	0.2	0.3	0.0	24.8	23.5	0.4	2.5	17.8	0.0	4.7	44.2	0.0	0.0	0.0	0.1	0.1	0.0	1.5	0.2	0.2	0.0	0.1	0.0	0.0	6.6	7.5	10.6	0.1	2.2	0.3	3.1	0.4	1.1	0.4	0.3	0.4
HSPA12B	"C20orf60, dJ1009E24.2"	ENSG00000132622	"Heat shock protein family A (Hsp70) member 12B"	Q96MM6	20	3732685-3753111	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Adipocytes: 65.0;Endothelial cells: 50.1;Hepatic stellate cells: 16.1;Late spermatids: 16.8;Microglial cells: 15.0;Peritubular cells: 15.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CACO-2: 4.9;EFO-21: 4.9;HUVEC TERT2: 9.5;TIME: 5.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA013659, HPA015639"	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Nucleoplasm		"HPA013659: AB_1234541, HPA015639: AB_1851192"	"unprognostic (1.00e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.30e-1)"	"unprognostic (6.99e-2)"	"unprognostic (4.53e-2)"	"unprognostic (2.09e-1)"	"unprognostic (1.21e-1)"	"unprognostic (6.40e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.07e-2)"	"unprognostic (6.45e-2)"	"unprognostic (8.74e-2)"	"unprognostic (2.61e-2)"	"unprognostic (1.75e-2)"	"unprognostic (1.47e-1)"	"unprognostic (4.05e-1)"	"unprognostic (1.66e-2)"	23.1	4.1	9.3	3.0	8.9	1.3	23.0	6.6	7.8	15.0	4.2	6.6	1.8	12.5	1.2	4.2	10.3	4.7	29.3	6.6	7.0	11.8	1.7	20.6	1.7	8.2	7.9	8.2	2.6	1.5	2.9	11.3	8.4	4.9	1.2	0.4	5.4	1.9	12.3	7.7	6.1	4.0	6.8	25.3	5.1	5.2	10.4	0.7	9.2	10.2	0.9	10.2	10.2	6.0	0.5	1.7	0.7	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	4.9	0.1	0.2	4.9	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.6	0.1	0.0	2.6	0.1	0.1	0.0	0.1	0.0	0.1	0.0	1.4	9.5	0.4	0.3	0.2	0.0	1.0	0.4	0.9	1.0	0.0	0.8	1.8	0.2	0.5	0.0	0.0	0.9	0.7	0.3	0.2	0.1	0.1	0.2	0.5	5.3	0.1	2.2	0.7	0.4	0.4	0.3	0.5	0.1	0.8	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	9.3	8.9	6.6	7.8	6.6	7.0	8.2	7.9	8.4	6.8	10.4	6.0	65.0	0.0	0.0	0.3	0.4	1.9	0.1	0.0	0.0	0.5	0.7	0.3	5.1	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	9.8	0.2	3.2	50.1	0.0	0.0	0.5	0.0	0.2	10.5	0.0	0.1	0.0	0.1	16.1	0.3	0.5	0.0	0.4	0.0	0.0	1.4	2.5	16.8	7.5	0.2	0.0	15.0	0.0	3.1	0.0	0.0	0.3	0.0	0.0	15.4	0.0	0.0	0.0	0.0	0.0	0.9	0.0	1.2	2.0	3.5	1.7	0.3	1.1	0.4	0.3	0.7	0.0	0.2
IL3RA	CD123	ENSG00000185291	"Interleukin 3 receptor subunit alpha"	P26951	X	1336616-1382689	"CD markers, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins"		Receptor	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 79.0;dendritic cells: 137.5;Endothelial cells: 83.2;Langerhans cells: 47.6;monocytes: 72.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	4	"basophil: 2665.0"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 2665.0"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 128.8;NB-4: 24.9;RPMI-8226: 54.1"									"HPA003539, CAB018374"	Uncertain					NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 65: Plasmacytoid DCs - Unknown function"			"CAB018374: AB_2233620, HPA003539: AB_1078438"	"prognostic favorable (9.78e-4)"	"prognostic favorable (4.27e-4)"	"unprognostic (8.13e-2)"	"unprognostic (9.32e-2)"	"unprognostic (2.09e-1)"	"unprognostic (1.29e-3)"	"unprognostic (1.32e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.38e-1)"	"unprognostic (3.73e-2)"	"unprognostic (5.77e-3)"	"unprognostic (1.43e-1)"	"unprognostic (1.50e-3)"	"unprognostic (9.41e-2)"	"unprognostic (2.85e-3)"	"unprognostic (2.49e-1)"	"unprognostic (1.46e-1)"	25.2	2.9	7.1	15.8	13.6	25.0	20.6	16.1	11.7	6.4	0.2	8.1	5.5	8.7	1.6	5.4	8.0	11.3	13.0	5.9	8.1	9.2	1.8	25.0	25.1	11.7	10.6	8.8	5.4	3.4	2.8	6.2	11.1	7.0	6.6	22.0	9.5	3.2	12.1	12.7	9.2	12.3	7.5	11.1	6.9	3.5	10.1	4.4	10.3	8.6	13.0	12.4	6.3	20.5	0.2	9.4	3.6	1.3	0.1	0.0	1.1	1.2	0.3	0.0	0.1	0.9	1.5	1.2	7.2	0.2	0.6	9.6	0.0	0.0	0.0	128.8	3.9	0.6	2.1	0.4	0.0	0.8	15.6	0.0	0.0	0.0	0.0	4.1	8.2	0.9	0.3	6.1	0.0	1.4	0.7	24.9	3.1	0.8	0.5	1.4	4.2	54.1	0.0	1.4	0.6	0.4	0.6	0.3	2.8	1.8	1.2	17.8	0.4	0.5	1.5	0.5	0.3	12.5	3.9	1.1	9.8	2.8	0.1	2665.0	5.6	83.9	0.6	31.7	1.0	2.5	0.9	0.5	14.9	8.9	0.7	0.7	4.6	14.2	42.5	628.5	0.5	12.0	7.1	13.6	16.1	11.7	5.9	8.1	11.7	10.6	11.1	7.5	10.1	20.5	79.0	3.2	1.8	11.8	6.8	5.9	0.7	0.9	1.2	2.3	0.5	0.9	2.2	1.5	1.0	0.0	10.4	0.1	137.5	4.7	0.0	0.4	0.2	2.7	1.4	83.2	0.0	3.0	7.3	0.2	0.1	4.3	0.5	1.5	11.4	0.4	24.3	0.7	4.6	0.0	14.3	7.3	0.0	2.8	47.6	0.1	0.3	32.9	8.8	13.1	72.6	0.6	1.0	6.0	18.2	0.1	3.4	0.7	4.0	0.7	0.2	0.0	0.4	3.2	0.0	3.6	3.2	0.1	0.7	0.7	5.5	0.3	1.6	1.3	0.6	2.1
JCAD	KIAA1462	ENSG00000165757	"Junctional cadherin 5 associated"	Q9P266	10	30012803-30115494	"Predicted intracellular proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"Adipocytes: 106.8;Endothelial cells: 30.3;Granulosa cells: 72.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 29.3;HUVEC TERT2: 29.9;LHCN-M2: 24.9;TIME: 67.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017956	Enhanced		Approved	"Vesicles,Cell Junctions"		NA	NA				"Cluster 82: Adipose tissue - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 40: Granulosa cells - Unknown function"	"Vesicles, Cell Junctions"		"HPA017956: AB_1852408"	"unprognostic (1.78e-1)"	"unprognostic (8.33e-2)"	"unprognostic (5.37e-2)"	"unprognostic (8.07e-2)"	"unprognostic (6.32e-2)"	"unprognostic (7.09e-2)"	"unprognostic (9.36e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.16e-1)"	"unprognostic (4.93e-2)"	"unprognostic (1.33e-1)"	"unprognostic (3.08e-2)"	"prognostic unfavorable (2.54e-4)"	"prognostic unfavorable (2.01e-4)"	"unprognostic (1.41e-1)"	"unprognostic (1.13e-2)"	"unprognostic (1.34e-2)"	31.2	7.5	13.5	5.2	21.2	0.1	13.0	5.1	13.0	6.5	3.1	36.0	1.4	17.3	7.5	5.9	12.5	10.4	18.3	10.8	7.2	6.7	1.8	24.2	3.5	12.5	8.4	10.9	16.9	4.9	4.5	33.6	10.1	7.8	3.9	13.1	2.4	9.5	9.9	3.7	3.7	17.3	7.3	0.9	4.5	14.0	13.3	6.1	13.6	14.8	1.8	18.3	4.4	8.1	15.3	6.7	5.9	0.0	3.7	0.9	8.6	8.1	8.5	1.2	2.0	2.6	0.1	0.0	0.6	29.3	1.7	0.3	1.6	0.5	3.3	1.7	3.6	0.0	0.0	0.1	16.0	0.0	1.0	9.1	0.2	19.9	1.5	0.5	29.9	0.4	0.0	0.0	24.9	0.5	0.0	0.7	1.2	0.9	10.2	0.0	3.3	0.0	1.2	0.3	0.8	0.1	0.3	0.1	0.0	8.4	0.0	1.4	67.8	14.9	3.6	4.7	0.7	6.2	0.8	0.0	3.5	10.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.5	21.2	5.1	13.0	10.8	7.2	12.5	8.4	10.1	7.3	13.3	8.1	106.8	0.0	3.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.6	0.0	0.0	0.0	0.0	0.0	2.7	0.4	0.0	0.0	16.4	0.0	1.3	8.5	30.3	0.0	0.0	0.0	0.4	0.9	2.2	0.0	0.8	1.3	72.5	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.3	2.9	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	3.4	0.2	7.1	0.0	0.0
KCNJ8	Kir6.1	ENSG00000121361	"Potassium inwardly rectifying channel subfamily J member 8"	Q15842	12	21764955-21775600	"Disease related genes, FDA approved drug targets, Metabolic proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Voltage-gated channel"	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 71.3"	"Group enriched"	"Detected in many"	4	"Sertoli cells: 197.2;Smooth muscle cells: 61.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	15	"eosinophil: 1.5"	"Lineage enriched"	"Detected in single"	15	"granulocytes: 1.5"	"Cell line enhanced"	"Detected in some"		"BJ: 11.1;CACO-2: 58.4;SH-SY5Y: 30.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA031066	Uncertain					NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 48: Smooth muscle cells - ECM organization"			"HPA031066: AB_10602240"	"unprognostic (8.12e-3)"	"unprognostic (1.89e-1)"	"prognostic unfavorable (9.29e-4)"	"unprognostic (7.81e-2)"	"unprognostic (8.71e-2)"	"unprognostic (2.34e-1)"	"unprognostic (3.15e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.36e-2)"	"unprognostic (3.90e-2)"	"unprognostic (3.66e-3)"	"unprognostic (2.88e-2)"	"prognostic unfavorable (1.62e-6)"	"unprognostic (4.70e-3)"	"unprognostic (9.61e-2)"	"unprognostic (1.73e-2)"	"unprognostic (3.54e-3)"	28.6	17.3	4.9	3.2	5.4	0.0	22.1	4.8	5.7	17.0	11.6	15.6	1.2	18.8	0.7	3.6	14.8	1.8	71.3	4.7	5.0	13.9	41.9	13.8	2.5	5.2	5.3	16.8	42.4	1.8	7.8	3.0	5.1	13.0	0.3	0.8	6.4	8.4	17.1	5.8	5.9	5.5	5.2	8.0	12.7	1.0	7.2	0.6	16.1	4.5	0.4	15.1	11.5	4.7	0.0	0.1	0.9	0.0	1.4	3.2	0.0	11.1	4.4	6.5	1.9	58.4	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	1.1	0.0	4.3	2.9	0.0	0.0	0.0	0.0	0.0	4.5	0.0	3.2	0.0	0.7	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	5.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	30.2	0.0	0.0	0.0	5.0	0.0	0.0	0.0	6.6	2.7	0.0	3.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.9	5.4	4.8	5.7	4.7	5.0	5.2	5.3	5.1	5.2	7.2	4.7	18.7	3.2	29.5	2.9	0.0	1.3	0.4	0.0	0.6	0.0	9.2	3.0	28.3	0.0	0.6	1.8	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.7	10.8	12.8	1.2	0.0	3.6	1.3	0.0	9.8	0.0	0.9	0.0	1.0	2.9	23.0	0.3	0.0	0.2	0.0	0.0	0.8	1.5	0.1	0.3	0.3	1.8	0.0	0.0	13.2	0.0	0.5	0.4	1.2	0.0	0.7	0.1	0.4	0.0	0.0	0.0	2.0	197.2	3.3	61.6	0.0	1.0	0.1	0.9	0.3	0.3	0.5	0.2	0.6
KCTD12	"C13orf2, KIAA1778, PFET1"	ENSG00000178695	"Potassium channel tetramerization domain containing 12"	Q96CX2	13	76880175-76886405	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 281.2;Endothelial cells: 192.2;Enteroendocrine cells: 386.7;Hofbauer cells: 218.9;Kupffer cells: 395.9;Macrophages: 221.3;monocytes: 206.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"classical monocyte: 3.9;myeloid DC: 3.7"	"Group enriched"	"Detected in many"	17	"dendritic cells: 3.7;granulocytes: 1.0;monocytes: 3.9"	"Cell line enhanced"	"Detected in many"		"ASC diff: 111.4;HUVEC TERT2: 229.0;TIME: 186.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA056987, HPA077376"		Supported	Approved	Mitochondria		NA	NA		21000000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 28: Placenta - Pregnancy"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 4: Macrophages - Innate immune response"	Mitochondria		"HPA056987: , HPA077376: "	"unprognostic (6.42e-2)"	"unprognostic (2.67e-1)"	"unprognostic (5.13e-1)"	"unprognostic (1.04e-3)"	"unprognostic (5.82e-2)"	"unprognostic (3.98e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.32e-3)"	"unprognostic (1.35e-2)"	"unprognostic (1.90e-1)"	"unprognostic (9.83e-3)"	"unprognostic (1.23e-1)"	"prognostic favorable (1.14e-4)"	"unprognostic (2.11e-2)"	"unprognostic (1.65e-2)"	"unprognostic (1.07e-1)"	"unprognostic (9.25e-2)"	76.1	27.8	21.4	55.7	20.1	12.0	52.4	27.0	20.8	44.5	12.4	39.5	22.5	51.3	17.8	38.3	75.0	55.0	22.6	26.9	27.8	31.0	13.9	58.0	39.4	36.2	33.5	47.1	12.5	25.2	6.4	83.9	31.4	14.7	42.5	3.4	20.0	18.5	16.6	22.9	28.1	65.3	37.0	64.8	28.0	26.9	31.4	18.3	16.4	37.1	33.4	39.2	17.4	34.4	1.7	1.5	15.3	0.0	111.4	52.5	4.3	6.9	1.5	4.2	5.5	0.5	0.3	0.0	3.8	18.8	4.9	53.9	6.6	66.4	3.5	1.5	35.1	0.2	38.3	0.0	4.7	18.6	0.1	21.4	21.5	2.7	48.9	8.5	229.0	13.2	0.3	0.2	53.9	1.4	8.5	0.3	7.8	16.6	7.7	0.4	7.4	19.6	17.7	0.2	4.3	7.9	17.3	0.5	2.2	18.5	1.0	12.1	186.0	2.7	4.9	0.4	14.0	2.7	0.5	0.0	42.5	4.0	16.1	0.0	3.9	0.7	0.0	2.5	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.1	1.0	0.0	1.5	1.9	0.0	0.9	21.4	20.1	27.0	20.8	26.9	27.8	36.2	33.5	31.4	37.0	31.4	34.4	281.2	25.6	8.4	2.9	7.5	40.0	2.7	11.9	28.5	4.4	11.2	27.3	21.8	4.3	16.3	97.5	14.6	3.0	30.4	19.7	17.6	6.5	3.6	4.9	44.6	192.2	386.7	6.1	4.8	0.6	90.6	80.0	12.2	3.3	7.0	53.1	61.1	2.5	218.9	0.0	11.5	71.5	12.2	395.9	75.4	11.8	157.2	221.3	51.6	45.9	206.7	4.8	7.2	0.5	0.9	0.5	15.7	44.8	7.6	4.5	0.7	7.5	72.8	1.5	26.3	153.2	32.2	1.9	7.0	16.9	34.4	4.2	5.5	24.0	46.6	1.9
LRMDA	"C10orf11, CDA017, OCA7"	ENSG00000148655	"Leucine rich melanocyte differentiation associated"	Q9H2I8	10	75431624-76560168	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	Differentiation		Albinism	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adrenal gland: 61.5;epididymis: 59.5"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 42.4;Distal tubular cells: 33.2;Endometrial ciliated cells: 27.8;Hofbauer cells: 56.9;Proximal tubular cells: 113.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"classical monocyte: 57.6;eosinophil: 22.1;intermediate monocyte: 28.8;myeloid DC: 67.5;non-classical monocyte: 17.1"	"Group enriched"	"Detected in many"	7	"dendritic cells: 67.5;granulocytes: 22.1;monocytes: 57.6"	"Cell line enhanced"	"Detected in many"		"Hep G2: 46.3;HMC-1: 34.0;NB-4: 65.6;SK-MEL-30: 93.0;THP-1: 48.7;U-937: 43.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA047446, HPA050419"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm	Cytosol	"HPA047446: AB_2680050, HPA050419: AB_2756316"	"unprognostic (1.04e-1)"	"unprognostic (8.03e-2)"	"unprognostic (2.40e-1)"	"unprognostic (7.97e-2)"	"unprognostic (2.03e-1)"	"unprognostic (1.58e-2)"	"unprognostic (1.31e-1)"	"unprognostic (8.57e-3)"	"unprognostic (5.86e-2)"	"unprognostic (6.80e-2)"	"unprognostic (8.34e-2)"	"unprognostic (1.26e-1)"	"unprognostic (7.34e-3)"	"unprognostic (7.26e-2)"	"unprognostic (6.50e-2)"	"unprognostic (4.98e-3)"	"unprognostic (3.64e-2)"	16.1	61.5	8.0	5.4	8.6	27.5	10.3	7.7	7.7	12.0	4.7	8.1	5.8	6.4	59.5	7.5	9.7	10.2	13.3	7.8	8.4	20.6	35.8	12.8	5.2	11.5	9.6	13.0	24.9	20.6	10.1	12.7	11.8	10.7	7.2	2.4	9.2	10.0	2.7	3.1	4.5	9.0	10.2	10.5	16.8	3.7	10.9	4.1	18.6	4.8	5.1	11.4	4.5	11.5	0.3	5.7	0.2	0.1	2.9	3.5	0.1	0.7	0.0	0.3	0.5	7.6	13.4	0.0	25.8	0.0	0.1	0.3	0.0	0.0	0.1	0.5	1.6	1.6	2.9	46.3	1.1	9.4	34.0	1.4	1.0	0.6	0.1	5.5	0.8	0.1	0.0	1.4	0.1	1.0	0.1	65.6	0.3	3.9	2.2	0.1	0.2	0.1	0.6	8.3	0.3	0.4	8.1	0.0	93.0	0.2	0.5	48.7	0.9	0.3	3.1	2.4	5.3	0.4	0.2	0.2	22.6	43.6	11.3	6.4	57.6	22.1	0.1	28.8	0.3	0.1	0.0	0.0	67.5	0.1	0.1	0.1	3.2	7.1	17.1	0.5	0.2	18.9	8.0	8.6	7.7	7.7	7.8	8.4	11.5	9.6	11.8	10.2	10.9	11.5	42.4	22.4	19.8	0.0	0.3	0.0	0.0	0.0	0.0	0.0	4.1	5.7	0.0	0.0	3.7	12.9	0.0	1.1	0.8	0.0	33.2	16.6	0.0	27.8	2.5	13.2	0.0	0.0	0.0	15.8	0.8	4.5	0.0	10.0	7.6	16.1	0.0	0.0	56.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.3	0.0	0.0	6.7	0.0	0.0	0.0	0.0	13.9	0.0	0.0	0.1	0.0	0.0	113.4	6.6	0.0	0.0	0.0	5.9	0.0	0.0	0.0	0.0	1.2	0.6	25.7	0.0	0.0
MCTP1	FLJ22344	ENSG00000175471	"Multiple C2 and transmembrane domain containing 1"	Q6DN14	5	94703741-95284575	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 45.3;brain: 37.1"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 113.3;Excitatory neurons: 510.6;Inhibitory neurons: 412.2;Oligodendrocyte precursor cells: 263.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	46	"basophil: 37.0;classical monocyte: 28.6;eosinophil: 13.2;intermediate monocyte: 41.4;myeloid DC: 22.3;neutrophil: 40.5;non-classical monocyte: 40.6;plasmacytoid DC: 11.4"	"Group enriched"	"Detected in many"	54	"dendritic cells: 22.3;granulocytes: 40.5;monocytes: 41.4"	"Cell line enhanced"	"Detected in many"		"Karpas-707: 71.4;RPMI-8226: 73.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019018			Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Nucleoplasm, Cytosol"		"HPA019018: AB_1853665"	"unprognostic (1.20e-2)"	"unprognostic (6.70e-4)"	"unprognostic (1.77e-2)"	"unprognostic (1.03e-2)"	"unprognostic (1.16e-4)"	"unprognostic (1.88e-1)"	"unprognostic (1.16e-2)"	"unprognostic (2.47e-2)"	"unprognostic (1.86e-1)"	"unprognostic (6.99e-2)"	"unprognostic (5.31e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.91e-6)"	"unprognostic (5.38e-2)"	"unprognostic (3.65e-2)"	"unprognostic (2.89e-3)"	"unprognostic (4.43e-2)"	21.3	2.3	12.8	12.5	37.1	45.3	15.9	27.7	19.4	6.0	0.0	7.7	5.1	5.9	2.0	6.4	4.9	17.4	3.8	20.9	10.0	4.4	3.7	12.9	6.1	3.8	0.5	1.7	3.2	1.9	4.0	7.3	5.7	3.5	7.2	1.7	3.7	2.2	3.2	4.3	4.9	11.2	0.5	8.8	5.5	2.1	1.4	7.9	4.6	7.9	4.4	21.3	6.1	13.4	0.3	5.2	3.3	0.1	49.0	19.6	0.2	0.3	25.1	2.3	8.1	0.1	13.3	18.7	19.2	0.0	51.1	0.2	0.4	0.2	2.8	0.0	3.6	11.4	13.3	0.2	6.4	23.6	14.6	7.3	0.0	9.0	32.5	21.2	52.7	7.6	0.3	71.4	18.7	0.6	1.4	17.9	4.1	0.3	20.7	0.9	0.2	73.7	52.7	29.0	10.0	0.5	1.7	0.1	37.1	1.4	0.0	21.8	0.3	9.0	13.9	0.4	4.2	5.0	0.1	0.2	41.8	38.5	9.1	37.0	28.6	13.2	0.1	41.4	0.0	0.6	0.1	0.2	22.3	0.3	0.4	0.0	40.5	0.3	40.6	11.4	0.0	8.5	12.8	37.1	27.7	19.4	20.9	10.0	3.8	0.5	5.7	0.5	1.4	13.4	113.3	3.2	10.8	15.3	3.2	18.1	0.2	6.9	3.4	2.2	1.7	1.1	3.1	0.0	6.6	3.7	0.0	0.3	9.8	0.1	0.0	0.0	27.8	5.5	1.2	97.9	0.0	5.0	510.6	0.2	0.2	18.5	5.6	11.6	63.3	0.1	2.2	0.3	12.2	3.3	412.2	0.0	4.1	42.4	76.5	16.2	0.6	63.5	12.4	67.5	32.9	3.2	2.1	263.4	9.0	1.3	0.0	0.0	2.4	0.8	0.0	0.5	3.5	3.5	0.0	1.8	2.0	1.8	1.4	0.7	13.4	0.3	3.7	0.3	0.0	0.6
MEOX1	MOX1	ENSG00000005102	"Mesenchyme homeobox 1"	P50221	17	43640389-43661922	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 36.0;breast: 26.1;heart muscle: 24.9"	"Group enriched"	"Detected in some"	9	"Adipocytes: 63.5;Endothelial cells: 41.3"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 6.9"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in some"	4	"T-reg: 17.5"	"Lineage enriched"	"Detected in single"	48	"T-cells: 17.5"	"Cell line enriched"	"Detected in some"	14	"HeLa: 25.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA045214, HPA063788"	Uncertain		Approved	"Nucleoplasm,Cytokinetic bridge,Cytosol"		Yes	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 20: HeLa - Mitochondria"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Nucleoplasm	"Cytokinetic bridge, Cytosol"	"HPA045214: AB_10959299, HPA063788: "	"unprognostic (1.36e-3)"	"unprognostic (2.15e-4)"	"unprognostic (1.25e-1)"	"unprognostic (2.58e-3)"	"unprognostic (2.01e-2)"	"unprognostic (5.65e-3)"	"unprognostic (1.25e-1)"	"unprognostic (4.55e-3)"	"unprognostic (6.71e-2)"	"unprognostic (2.64e-1)"	"unprognostic (1.46e-1)"	"unprognostic (9.36e-2)"	"unprognostic (3.44e-6)"	"unprognostic (2.40e-2)"	"unprognostic (2.66e-1)"	"unprognostic (1.82e-1)"	"unprognostic (7.47e-3)"	36.0	0.5	0.0	4.7	0.0	0.0	26.1	0.0	0.1	8.0	0.0	4.7	1.6	5.5	1.1	3.7	9.0	5.7	24.9	0.0	0.0	0.2	0.1	1.4	6.6	0.0	0.0	1.0	1.5	1.2	0.5	0.1	0.0	2.6	2.4	0.0	4.9	1.9	8.3	6.6	5.1	10.6	0.0	10.8	3.0	1.1	0.0	3.0	1.9	17.1	5.3	7.7	7.3	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.4	0.1	0.0	0.0	1.8	0.1	0.5	0.0	0.1	0.0	0.0	0.1	0.1	0.0	25.9	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	4.3	2.7	0.0	0.0	1.7	0.5	0.0	0.3	0.0	0.0	17.5	0.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	63.5	0.0	0.0	1.0	0.3	4.1	0.0	0.0	1.2	0.0	0.4	0.6	2.5	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.2	41.3	0.0	0.0	0.7	0.0	0.3	4.8	0.0	0.1	0.0	0.0	0.4	0.0	0.1	0.0	0.6	0.0	0.0	0.0	4.0	0.0	0.0	0.3	5.4	0.0	0.0	0.0	0.0	0.5	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.3	1.0	0.0	0.1	0.3	1.8	0.1	1.5	0.3	0.0	0.0
MEOX2	"GAX, MOX2"	ENSG00000106511	"Mesenchyme homeobox 2"	P50222	7	15611212-15686683	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 37.9;placenta: 42.1"	"Cell type enhanced"	"Detected in some"		"Adipocytes: 84.7;Endothelial cells: 37.2;Leydig cells: 40.4;Peritubular cells: 25.2;Sertoli cells: 26.3;Smooth muscle cells: 27.0"	"Cancer enriched"	"Detected in many"	8	"glioma: 15.2"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"AN3-CA: 248.8;U-138 MG: 62.9"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	9	"medulla oblongata: 3.5;spinal cord: 9.5"	HPA053793	Enhanced					NA	NA				"Cluster 82: Adipose tissue - ECM organization"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"			"HPA053793: AB_2682264"	"unprognostic (1.10e-1)"	"unprognostic (4.72e-2)"	"unprognostic (9.82e-3)"	"unprognostic (4.22e-2)"	"unprognostic (2.35e-2)"	"unprognostic (1.36e-1)"	"unprognostic (3.12e-2)"	"unprognostic (1.21e-1)"	"unprognostic (5.56e-2)"	"unprognostic (1.47e-3)"	"unprognostic (4.44e-1)"	"unprognostic (2.34e-1)"	"unprognostic (1.65e-5)"	"unprognostic (3.67e-3)"	"unprognostic (1.13e-1)"	"unprognostic (5.86e-2)"	"unprognostic (1.46e-4)"	37.9	1.1	0.6	2.9	0.3	0.0	26.2	0.3	0.7	4.3	0.2	5.7	0.4	2.9	2.4	2.4	5.0	6.1	11.8	0.3	0.7	0.5	0.7	12.9	9.1	2.2	0.9	2.4	1.6	1.2	1.2	42.1	1.0	1.9	1.9	0.2	4.4	1.5	9.9	6.9	2.2	4.5	0.7	0.9	2.3	2.3	1.0	3.3	8.6	13.3	5.3	6.1	4.8	0.5	0.0	0.0	0.0	248.8	2.4	8.5	0.0	0.0	0.3	0.0	0.0	0.0	0.3	0.0	0.0	11.3	0.0	0.0	0.0	0.0	0.0	0.0	11.9	0.0	0.0	0.0	0.0	0.0	0.0	15.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	2.0	0.0	0.1	32.5	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	62.9	0.0	25.4	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.3	0.3	0.7	0.3	0.7	2.2	0.9	1.0	0.7	1.0	0.5	84.7	0.0	0.5	0.7	0.3	8.2	0.0	0.0	0.6	0.0	0.5	1.3	2.6	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.3	0.0	0.0	37.2	0.0	0.0	3.8	0.0	0.0	15.4	0.0	0.0	0.0	0.0	0.7	0.2	0.1	0.0	3.7	0.0	0.0	0.0	9.6	0.2	40.4	0.3	3.6	0.0	0.0	0.0	0.0	0.5	0.2	0.0	0.0	25.2	0.0	0.1	0.0	0.0	0.0	0.0	26.3	1.5	27.0	0.1	0.1	0.1	7.0	0.1	0.8	0.7	0.0	0.0
MFAP3		ENSG00000037749	"Microfibril associated protein 3"	P55082	5	154038959-154220478	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 24.3;Inhibitory neurons: 24.5;Microglial cells: 17.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015883, HPA049198"	Approved		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Golgi apparatus"	Nucleoplasm	"HPA015883: AB_1853840, HPA049198: AB_2680672"	"unprognostic (6.02e-2)"	"prognostic unfavorable (4.28e-4)"	"unprognostic (1.58e-3)"	"unprognostic (2.40e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.21e-1)"	"unprognostic (6.33e-2)"	"unprognostic (6.58e-3)"	"unprognostic (1.21e-1)"	"unprognostic (3.07e-2)"	"unprognostic (1.53e-2)"	"unprognostic (7.00e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.33e-2)"	"unprognostic (2.05e-1)"	"unprognostic (7.16e-3)"	"unprognostic (9.35e-3)"	16.0	8.5	5.4	13.2	5.4	12.1	12.5	8.1	7.0	13.2	10.1	10.8	9.5	12.0	9.8	14.7	9.7	11.8	14.1	5.3	6.3	13.5	13.7	11.3	10.6	5.8	6.2	9.4	7.1	24.4	3.1	19.6	6.3	9.4	10.8	12.2	7.2	9.0	10.4	7.6	9.6	16.6	6.5	11.4	9.6	5.7	5.7	11.8	13.4	17.1	13.0	16.1	6.5	6.0	14.9	19.7	36.5	37.7	29.8	24.7	31.5	26.4	28.0	27.0	37.1	27.4	34.1	25.0	30.6	26.3	25.8	33.5	32.5	35.6	41.9	9.5	21.0	15.7	26.5	12.9	29.5	27.7	16.0	29.2	32.4	35.0	29.1	22.6	38.4	19.9	17.5	20.5	21.4	11.0	15.2	9.9	20.0	16.0	9.9	14.6	40.7	20.8	20.8	21.0	32.1	40.3	27.4	35.0	31.1	30.1	34.6	14.8	32.9	34.3	26.4	19.4	26.9	25.7	33.5	21.4	18.7	19.2	27.4	6.7	7.5	11.9	5.0	7.9	6.9	2.4	4.0	3.5	8.1	2.5	5.2	4.1	6.8	6.5	5.6	3.7	3.9	4.3	5.4	5.4	8.1	7.0	5.3	6.3	5.8	6.2	6.3	6.5	5.7	6.0	9.7	0.0	0.5	14.0	3.5	6.0	1.0	6.1	6.2	3.2	1.6	1.5	2.7	0.0	3.9	5.5	6.2	4.3	2.7	1.9	1.9	1.4	7.1	1.4	4.3	7.6	0.0	9.1	24.3	1.1	3.0	3.9	4.1	2.2	4.5	2.1	1.4	1.9	1.9	3.3	24.5	1.2	8.2	0.6	4.4	4.9	1.8	2.7	8.8	17.8	0.7	6.9	1.0	12.1	15.1	1.1	0.3	0.0	9.5	1.3	2.1	1.1	4.6	4.6	0.0	1.5	3.3	3.9	2.0	4.3	5.5	6.0	4.0	1.2	1.0	1.5
MYCT1	"FLJ21269, MTLC"	ENSG00000120279	"MYC target 1"	Q8N699	6	152697895-152724567	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 49.6"	"Group enriched"	"Detected in some"	5	"Adipocytes: 123.0;Endothelial cells: 141.3;Hepatic stellate cells: 230.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	33	"eosinophil: 30.7"	"Lineage enriched"	"Detected in single"	248	"granulocytes: 30.7"	"Group enriched"	"Detected in some"	5	"HUVEC TERT2: 124.6;TIME: 104.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA047992			Approved	Nucleoplasm,Vesicles		NA	NA		120000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Nucleoplasm	Vesicles	"HPA047992: "	"unprognostic (2.92e-1)"	"unprognostic (1.82e-1)"	"unprognostic (5.95e-2)"	"unprognostic (2.06e-1)"	"unprognostic (6.73e-2)"	"unprognostic (6.80e-2)"	"unprognostic (4.64e-3)"	"unprognostic (6.78e-2)"	"unprognostic (9.90e-2)"	"unprognostic (2.10e-1)"	"unprognostic (2.66e-2)"	"unprognostic (2.18e-2)"	"prognostic unfavorable (4.73e-4)"	"unprognostic (1.26e-3)"	"unprognostic (1.08e-1)"	"unprognostic (1.25e-1)"	"unprognostic (3.36e-2)"	26.6	3.2	6.8	5.2	6.9	1.2	21.4	6.9	10.2	9.0	5.2	6.1	3.5	10.1	4.5	4.6	9.2	10.5	17.1	6.3	7.1	6.6	13.1	15.6	6.2	7.7	6.9	3.6	2.7	4.3	2.2	20.7	8.6	4.4	5.8	1.0	3.7	3.8	12.8	4.7	5.6	12.4	6.8	49.6	4.5	1.8	10.0	2.5	12.2	20.5	3.0	8.1	7.3	7.5	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.9	0.0	17.7	0.1	0.0	0.2	0.0	0.1	0.0	23.0	0.3	0.0	0.7	0.1	0.1	0.0	0.2	0.2	0.3	0.0	124.6	0.0	0.3	0.3	0.4	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.0	2.1	0.0	0.0	104.4	0.5	0.8	1.5	0.0	1.1	0.0	15.6	0.0	0.0	0.0	0.9	0.0	30.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.1	0.0	0.1	0.0	0.6	6.8	6.9	6.9	10.2	6.3	7.1	7.7	6.9	8.6	6.8	10.0	7.5	123.0	0.0	5.2	0.7	0.8	7.1	0.2	0.1	2.8	0.2	0.4	0.9	3.1	2.8	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.2	10.2	1.3	0.2	141.3	0.0	13.7	0.1	0.2	0.0	4.0	0.0	0.1	1.3	0.0	230.6	2.1	0.1	0.0	0.1	0.0	0.0	7.3	7.3	3.7	0.3	13.3	14.2	30.9	0.1	0.0	0.0	0.5	0.2	0.1	0.0	0.0	0.6	0.5	0.0	0.0	17.7	0.0	0.0	1.5	2.2	0.1	0.1	0.5	5.5	0.0	0.9	0.5	0.0	0.7
NAV1	"DKFZp781D0314, FLJ12560, FLJ14203, KIAA1151, MGC14961, POMFIL3, steerin-1"	ENSG00000134369	"Neuron navigator 1"	Q8NEY1	1	201622885-201826969	"Predicted intracellular proteins"	"Differentiation, Neurogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 169.1;Inhibitory neurons: 161.7;Oligodendrocyte precursor cells: 713.8;Oligodendrocytes: 224.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"basophil: 3.4;myeloid DC: 2.1"	"Group enriched"	"Detected in many"	5	"dendritic cells: 2.1;granulocytes: 3.4"	"Cell line enhanced"	"Detected in many"		"TIME: 187.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012302, HPA018127, HPA027887"	Enhanced		Approved	Microtubules		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 68: Oligodendrocytes - Mixed function"	Microtubules		"CAB012302: AB_776716, HPA018127: AB_1854317, HPA027887: AB_10601040"	"unprognostic (2.14e-1)"	"unprognostic (1.82e-1)"	"unprognostic (4.12e-2)"	"unprognostic (3.33e-2)"	"unprognostic (1.14e-1)"	"unprognostic (3.87e-1)"	"unprognostic (1.79e-1)"	"unprognostic (3.45e-1)"	"unprognostic (9.10e-2)"	"unprognostic (5.63e-2)"	"unprognostic (4.68e-1)"	"unprognostic (8.24e-2)"	"prognostic unfavorable (3.10e-6)"	"unprognostic (3.45e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.89e-1)"	"unprognostic (1.44e-1)"	19.6	2.7	17.4	8.2	18.3	1.6	15.2	8.0	17.7	11.7	0.0	12.3	3.7	10.1	4.3	8.6	7.2	7.5	26.6	17.5	20.3	4.6	1.9	11.1	4.1	24.6	17.9	3.7	4.4	5.2	5.2	11.8	15.1	7.5	5.4	5.4	7.8	6.7	4.8	7.7	6.2	10.3	9.9	3.6	5.3	4.4	21.8	2.8	9.4	6.7	3.7	14.9	12.6	32.5	1.6	2.9	29.0	3.8	84.3	69.5	51.7	44.6	43.0	35.5	30.9	0.0	15.7	0.6	0.7	61.4	19.4	21.5	22.0	14.9	28.4	2.5	3.2	1.4	5.6	0.0	22.5	0.2	19.1	30.6	5.4	62.4	36.0	94.9	80.7	1.8	0.8	2.6	29.8	0.4	0.0	0.1	42.4	0.7	1.7	3.9	65.0	9.3	4.8	4.3	21.9	4.5	11.1	47.6	14.5	19.2	0.4	1.2	187.8	54.5	11.1	54.7	39.4	8.1	2.3	0.2	59.2	5.9	47.5	3.4	0.5	0.1	0.2	0.3	0.1	0.3	0.2	0.0	2.1	0.3	0.2	0.1	0.0	0.1	0.3	0.5	0.0	0.3	17.4	18.3	8.0	17.7	17.5	20.3	24.6	17.9	15.1	9.9	21.8	32.5	77.4	3.2	1.5	169.1	3.1	11.0	2.2	5.9	8.0	34.6	4.8	4.3	29.2	1.5	4.8	12.9	0.0	14.9	0.9	4.7	0.0	13.0	3.6	1.6	6.4	39.3	52.8	1.7	98.2	8.3	54.1	45.8	8.2	4.4	17.7	54.5	21.0	0.7	14.5	25.2	161.7	3.4	6.1	18.3	15.8	3.8	10.8	15.1	23.2	69.3	60.6	11.8	1.0	713.8	224.6	21.7	4.2	0.7	4.9	2.3	0.9	0.6	3.5	4.0	6.6	119.3	18.8	0.6	2.6	16.9	7.0	15.7	2.0	6.6	5.0	3.2
NEURL1B	"DKFZP761M1511, Neur2, RNF67B"	ENSG00000214357	"Neuralized E3 ubiquitin protein ligase 1B"	A8MQ27	5	172641263-172691540	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Notch signaling pathway, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 82.8;Distal enterocytes: 82.5;Endothelial cells: 53.8;Leydig cells: 54.7;Paneth cells: 42.1;Proximal enterocytes: 53.4;Smooth muscle cells: 58.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"REH: 43.7;T-47d: 20.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA037612	Approved		Supported	"Actin filaments,Cytosol"		NA	Yes				"Cluster 46: Fibroblasts - ECM organization"	"Cluster 14: REH - Unknown function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Cytosol	"Actin filaments"	"HPA037612: AB_10795573"	"unprognostic (3.56e-2)"	"unprognostic (8.46e-2)"	"unprognostic (6.72e-3)"	"unprognostic (2.70e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.55e-1)"	"unprognostic (6.58e-2)"	"unprognostic (2.95e-1)"	"unprognostic (2.86e-1)"	"unprognostic (1.09e-1)"	"unprognostic (7.13e-3)"	"unprognostic (6.81e-2)"	"prognostic unfavorable (3.00e-6)"	"unprognostic (1.79e-1)"	"unprognostic (1.40e-1)"	"unprognostic (4.67e-2)"	"unprognostic (3.22e-3)"	25.0	16.0	8.4	5.2	10.3	2.0	21.1	2.3	24.1	18.3	3.4	28.4	6.9	24.7	24.1	13.5	22.0	11.7	32.2	17.1	6.9	11.0	6.0	12.6	3.7	3.5	4.6	14.7	5.3	3.2	8.2	6.1	3.8	17.6	13.7	0.3	6.6	32.1	14.0	18.1	17.6	20.4	3.6	0.7	7.7	4.3	6.3	5.9	10.3	16.0	3.9	25.7	17.3	6.5	7.2	3.7	2.0	8.9	0.6	0.3	0.1	8.0	3.5	4.1	6.0	13.7	3.2	0.0	2.1	5.2	5.0	2.1	0.7	3.6	2.8	13.2	0.5	9.8	13.3	0.1	0.6	0.0	2.9	0.0	15.1	0.9	4.1	1.2	0.6	1.4	0.0	3.0	8.9	8.0	2.3	0.2	1.3	3.1	0.3	43.7	9.4	1.4	0.1	1.6	1.6	8.9	7.6	11.9	0.3	3.5	20.0	1.5	1.3	3.1	18.1	2.2	5.1	1.2	0.4	0.0	9.0	0.2	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.4	10.3	2.3	24.1	17.1	6.9	3.5	4.6	3.8	3.6	6.3	6.5	82.8	0.0	1.9	0.3	0.6	4.8	0.7	3.0	0.6	0.6	1.5	1.3	9.3	1.5	4.8	0.0	0.0	0.3	0.4	82.5	0.0	0.7	2.6	1.9	2.5	53.8	13.9	11.4	5.2	0.7	0.2	10.3	2.0	0.6	0.0	4.9	30.4	0.3	0.3	0.0	1.0	10.2	2.0	1.9	2.6	6.6	54.7	2.2	7.2	4.7	0.7	0.7	0.0	5.0	13.0	4.5	42.1	12.4	0.1	1.9	53.4	0.8	12.8	0.3	26.3	11.6	58.8	2.5	3.4	7.7	5.4	0.1	0.7	2.5	20.0	1.2
NOCT	"Ccr4c, CCR4L, CCRN4L, NOC"	ENSG00000151014	Nocturnin	Q9UK39	4	139015781-139045939	"Predicted intracellular proteins"	"Biological rhythms"	"Hydrolase, Repressor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 36.3"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 14.6;Glandular and luminal cells: 20.6;Syncytiotrophoblasts: 12.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012287, HPA053714"	Uncertain		Supported	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 32: U-937 - Innate immune response"	"Cluster 41: Macrophages - Immune response"	"Nuclear bodies"	"Nucleoplasm, Cytosol"	"HPA012287: AB_2668640, HPA053714: AB_2682238"	"unprognostic (2.16e-1)"	"unprognostic (2.16e-3)"	"unprognostic (1.47e-1)"	"unprognostic (2.29e-1)"	"unprognostic (3.36e-3)"	"unprognostic (2.00e-3)"	"unprognostic (3.24e-1)"	"prognostic unfavorable (5.28e-5)"	"unprognostic (1.86e-1)"	"unprognostic (5.64e-3)"	"unprognostic (4.63e-2)"	"unprognostic (1.01e-3)"	"prognostic unfavorable (1.05e-5)"	"unprognostic (2.54e-1)"	"unprognostic (1.14e-1)"	"unprognostic (3.52e-4)"	"prognostic unfavorable (6.23e-4)"	8.2	2.0	2.8	3.2	2.6	36.3	4.5	1.7	7.1	1.4	0.0	1.8	1.2	1.6	0.5	1.9	1.0	5.5	2.9	5.0	2.9	3.6	13.9	2.9	2.1	1.5	3.4	0.6	3.0	1.7	2.2	5.6	2.6	1.0	1.6	3.4	1.6	0.5	6.5	2.2	2.2	3.0	1.4	1.7	1.7	2.2	4.4	1.9	1.5	6.1	2.6	4.9	1.3	2.9	6.5	7.1	2.9	5.7	6.6	2.7	17.2	9.4	6.9	13.7	10.0	10.3	2.8	22.7	7.4	7.3	18.4	4.5	15.8	8.9	13.7	9.5	6.1	10.3	4.4	8.7	6.2	15.3	6.0	3.2	4.4	15.4	10.4	2.7	6.3	4.3	18.6	7.0	6.6	8.0	10.0	7.8	10.1	3.0	8.1	8.5	8.6	7.7	9.4	4.3	11.3	7.3	6.0	6.8	5.6	11.2	5.0	11.2	8.7	7.7	9.4	7.2	11.8	5.9	5.5	14.0	7.0	29.8	9.9	0.8	0.5	0.3	1.0	0.6	0.5	0.4	0.4	0.5	0.2	0.7	0.3	0.6	2.7	0.6	1.6	0.6	0.3	0.1	2.8	2.6	1.7	7.1	5.0	2.9	1.5	3.4	2.6	1.4	4.4	2.9	10.9	9.6	1.1	0.0	2.8	0.0	2.7	0.0	5.7	5.6	2.7	2.5	0.0	1.5	0.6	0.0	14.6	6.1	4.7	0.6	1.9	2.3	0.7	10.4	6.3	2.6	0.0	1.7	0.0	0.2	11.8	2.9	6.1	20.6	2.5	0.8	1.1	2.6	1.5	1.7	0.0	0.4	0.0	1.6	0.0	0.1	0.9	6.9	0.0	0.0	0.1	0.6	4.1	0.0	0.0	2.5	0.0	0.0	5.5	2.5	2.6	4.0	0.7	5.2	0.0	5.4	4.3	1.0	3.9	6.5	0.0	12.0	4.3	0.8	0.2	2.3
NOSTRIN	MGC20702	ENSG00000163072	"Nitric oxide synthase trafficking"	Q8IVI9	2	168786539-168865514	"Predicted intracellular proteins"	Endocytosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 167.0;Endothelial cells: 129.6;Hepatic stellate cells: 172.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 10.1;HEL: 41.9;K-562: 31.8;OE19: 20.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044384, HPA076885"	Approved		Approved	Vesicles,Cytosol		NA	NA				"Cluster 82: Adipose tissue - ECM organization"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Cytosol	Vesicles	"HPA044384: AB_2678922, HPA076885: "	"unprognostic (4.74e-2)"	"unprognostic (2.42e-1)"	"unprognostic (8.73e-2)"	"unprognostic (2.27e-1)"	"unprognostic (3.15e-3)"	"unprognostic (3.02e-6)"	"unprognostic (4.89e-3)"	"unprognostic (3.15e-1)"	"unprognostic (3.14e-4)"	"unprognostic (5.47e-3)"	"unprognostic (1.19e-1)"	"unprognostic (2.51e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.75e-1)"	"unprognostic (2.33e-1)"	"unprognostic (6.47e-2)"	"unprognostic (4.98e-2)"	32.6	20.4	6.1	4.6	5.8	0.3	31.4	5.0	7.6	17.5	4.2	15.3	14.0	14.9	4.3	5.1	16.4	14.0	16.1	4.9	5.6	32.6	7.3	30.8	4.6	6.6	6.0	10.6	22.6	3.8	3.8	25.4	6.5	13.3	16.4	0.8	48.9	6.8	5.1	7.3	14.3	12.8	5.5	5.5	23.0	14.4	6.6	1.9	13.5	3.6	3.0	8.1	11.3	5.0	0.0	3.6	1.1	0.0	0.0	0.0	10.1	0.4	0.0	0.0	0.0	6.3	6.5	0.1	4.3	0.0	0.0	0.2	0.0	1.6	0.0	0.0	0.0	41.9	1.8	0.0	0.2	0.4	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	31.8	0.0	0.0	0.1	0.1	0.1	0.1	20.5	0.3	0.4	1.9	0.0	3.4	1.6	0.0	0.1	0.2	1.9	0.0	0.2	0.5	0.0	0.0	0.0	0.7	0.2	0.6	0.6	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.1	5.8	5.0	7.6	4.9	5.6	6.6	6.0	6.5	5.5	6.6	5.0	167.0	9.6	10.3	2.0	1.6	1.0	0.6	0.3	0.6	0.1	20.0	11.0	7.1	15.7	3.3	3.7	0.0	18.9	0.4	57.3	13.7	8.0	26.6	16.3	3.3	129.6	11.4	2.7	0.4	21.8	7.0	6.1	41.3	23.2	0.0	72.4	172.5	1.0	1.6	0.0	0.5	35.9	0.0	6.3	0.9	60.9	8.7	1.2	24.9	55.3	0.7	1.6	0.0	2.0	0.0	17.7	53.4	5.7	0.2	3.3	43.1	59.0	1.5	0.3	72.3	1.3	11.3	13.7	1.8	0.4	0.4	26.3	0.9	71.9	20.7	1.2
NRARP	MGC61598	ENSG00000198435	"NOTCH regulated ankyrin repeat protein"	Q7Z6K4	9	137299631-137302271	"Predicted intracellular proteins"		"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 47.9"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 75.3;Basal keratinocytes: 97.0;Langerhans cells: 97.9;Squamous epithelial cells: 101.8;Suprabasal keratinocytes: 381.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HaCaT: 45.1;MCF7: 23.3;NTERA-2: 31.9;OE19: 30.8;T-47d: 23.1;TIME: 31.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA025729	Approved		Approved	Nucleoplasm,Cytosol		NA	NA				"Cluster 37: Intestine - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 28: Keratinocytes - Keratinization"	Cytosol	Nucleoplasm	"HPA025729: AB_1854633"	"unprognostic (9.92e-2)"	"unprognostic (1.75e-2)"	"unprognostic (1.56e-1)"	"unprognostic (7.17e-3)"	"unprognostic (1.78e-1)"	"unprognostic (1.15e-1)"	"unprognostic (3.42e-2)"	"unprognostic (1.89e-2)"	"unprognostic (1.00e-2)"	"unprognostic (6.42e-2)"	"unprognostic (4.73e-2)"	"unprognostic (1.33e-1)"	"prognostic unfavorable (6.73e-6)"	"unprognostic (2.85e-3)"	"unprognostic (1.34e-1)"	"unprognostic (4.90e-2)"	"unprognostic (3.28e-3)"	8.9	1.7	7.8	7.6	7.9	1.5	6.9	8.8	7.8	6.5	4.2	47.9	22.0	4.4	1.2	22.6	3.6	12.0	12.5	7.3	10.8	6.1	2.7	7.1	1.6	11.5	12.6	2.0	16.8	2.7	7.6	10.3	10.5	9.5	30.5	1.5	3.0	2.1	2.9	26.3	17.8	3.4	9.8	4.2	8.7	10.2	14.8	2.7	4.9	6.5	4.1	10.4	13.5	6.6	4.8	1.0	8.0	8.8	0.0	0.0	2.6	0.1	0.2	0.0	0.1	6.8	3.0	0.0	10.2	0.0	0.4	45.1	13.9	0.4	0.1	0.3	20.6	1.4	2.1	7.6	0.8	2.8	4.3	0.0	2.3	0.0	0.6	0.2	11.8	0.1	11.8	0.3	0.0	23.3	0.2	6.4	31.9	30.8	6.7	8.4	1.5	17.7	1.2	0.6	4.9	8.1	1.4	2.4	0.1	1.7	23.1	5.8	31.9	0.0	0.1	0.1	1.9	0.3	0.2	3.0	0.1	5.2	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.8	7.9	8.8	7.8	7.3	10.8	11.5	12.6	10.5	9.8	14.8	6.6	75.3	0.0	0.0	33.3	17.6	97.0	5.9	20.1	15.9	0.6	24.4	39.2	4.4	5.7	14.3	0.0	0.0	0.1	9.7	22.4	0.0	0.5	17.3	35.2	4.4	21.9	10.2	0.0	2.5	1.1	0.0	2.1	19.4	43.0	0.0	0.3	8.9	0.1	0.4	0.0	0.4	20.5	8.2	0.6	97.9	5.2	0.0	18.6	17.8	9.4	0.0	6.8	0.0	2.0	0.6	0.6	28.3	0.4	3.9	6.2	5.0	0.1	3.2	2.8	6.6	4.0	32.1	0.1	0.6	101.8	381.0	0.0	6.7	3.7	23.4	6.0
NRN1	NRN	ENSG00000124785	"Neuritin 1"	Q9NPD7	6	5997999-6007605	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 98.9;parathyroid gland: 81.0"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 262.9;Endothelial cells: 115.3;Excitatory neurons: 71.9;Extravillous trophoblasts: 64.7;Hepatic stellate cells: 160.3"	"Cancer enhanced"	"Detected in all"		"glioma: 38.7"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	7	"MAIT T-cell: 2.6;neutrophil: 2.2"	"Group enriched"	"Detected in many"	7	"granulocytes: 2.2;T-cells: 2.6"	"Cell line enhanced"	"Detected in many"		"ASC diff: 140.0;ASC TERT1: 107.6;fHDF/TERT166: 147.5;JURKAT: 134.8;REH: 196.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA		23000	"Cluster 16: MAIT-cells - Unknown function"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 14: REH - Unknown function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"				"unprognostic (6.24e-2)"	"unprognostic (2.47e-2)"	"unprognostic (1.35e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.26e-2)"	"unprognostic (5.57e-2)"	"unprognostic (4.70e-3)"	"unprognostic (2.02e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.67e-2)"	"unprognostic (3.35e-1)"	"prognostic unfavorable (4.79e-5)"	"unprognostic (1.26e-1)"	"unprognostic (2.04e-1)"	"unprognostic (2.90e-1)"	"unprognostic (4.37e-3)"	66.4	5.1	49.1	6.4	44.9	0.5	64.2	46.0	80.8	16.2	17.0	21.3	3.7	9.4	4.0	8.2	13.6	11.2	19.7	98.9	27.7	8.2	4.4	15.6	9.6	30.4	29.9	4.7	2.9	81.0	12.3	42.1	32.5	10.1	4.7	23.4	8.7	7.4	17.3	18.8	10.8	10.5	22.1	15.7	10.3	0.6	60.1	3.6	9.4	16.1	3.5	13.8	17.0	45.9	16.7	0.6	1.4	0.1	140.0	107.6	19.1	2.6	0.0	11.8	16.1	0.2	0.1	0.0	2.5	147.5	25.0	0.5	43.3	0.0	11.4	26.1	21.2	13.7	0.0	0.0	0.0	58.0	43.7	17.3	0.0	10.5	0.0	0.1	57.4	134.8	0.2	0.6	42.5	0.1	89.7	2.6	0.1	0.0	0.0	196.3	47.7	0.4	0.2	0.2	24.9	9.2	0.0	0.8	13.9	0.2	0.4	16.4	12.1	56.4	1.6	21.4	36.5	0.1	2.2	0.9	85.8	0.2	8.9	0.0	0.1	0.0	0.1	0.1	2.6	0.3	0.2	0.3	0.0	0.0	0.0	0.0	2.2	0.0	0.1	0.2	0.0	0.1	49.1	44.9	46.0	80.8	98.9	27.7	30.4	29.9	32.5	22.1	60.1	45.9	262.9	0.0	1.3	7.2	1.6	10.5	0.1	0.0	1.2	6.7	1.4	2.4	2.5	1.5	0.0	0.0	2.1	1.5	1.0	0.0	0.0	0.1	0.1	0.0	0.1	115.3	0.0	0.0	71.9	0.5	64.7	15.9	0.0	0.1	0.0	0.0	160.3	0.9	1.8	3.3	3.0	0.0	0.0	4.1	21.5	0.4	0.9	1.4	16.0	8.4	0.5	4.5	0.0	13.6	8.3	0.2	0.0	0.0	1.4	0.4	0.0	0.0	0.0	20.2	0.0	4.4	18.3	0.4	0.3	0.6	11.2	1.4	1.9	0.1	0.0	0.7
PARM1	"Cipar1, DKFZP564O0823, WSC4"	ENSG00000169116	"Prostate androgen-regulated mucin-like protein 1"	Q6UWI2	4	74933095-75050115	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 181.9;Distal enterocytes: 398.3;Intestinal goblet cells: 109.7;Paneth cells: 132.1"	"Cancer enhanced"	"Detected in all"		"thyroid cancer: 56.3"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	15	"memory B-cell: 8.1;myeloid DC: 4.0;naive B-cell: 5.6"	"Group enriched"	"Detected in many"	15	"B-cells: 8.1;dendritic cells: 4.0"	"Cell line enhanced"	"Detected in many"		"ASC diff: 44.6;Karpas-707: 44.9;U-266/70: 49.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038236	Approved		Approved	Nucleoplasm,Vesicles,Cytosol		NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Nucleoplasm, Vesicles, Cytosol"		"HPA038236: AB_10675789"	"unprognostic (2.57e-2)"	"unprognostic (5.20e-2)"	"unprognostic (1.26e-3)"	"unprognostic (8.61e-2)"	"unprognostic (1.44e-1)"	"unprognostic (8.49e-3)"	"unprognostic (3.08e-1)"	"unprognostic (2.42e-2)"	"unprognostic (2.73e-1)"	"unprognostic (9.74e-2)"	"unprognostic (9.44e-2)"	"unprognostic (3.51e-2)"	"unprognostic (5.21e-2)"	"unprognostic (1.96e-1)"	"unprognostic (2.16e-1)"	"prognostic unfavorable (1.78e-4)"	"unprognostic (2.23e-1)"	45.1	51.8	4.1	27.7	5.4	0.4	29.3	0.0	19.3	43.3	2.1	91.3	7.0	34.7	14.0	13.5	23.3	28.6	103.6	10.4	26.0	55.9	1.3	33.7	18.2	1.3	3.9	19.6	34.1	73.1	41.0	40.7	21.2	83.8	113.4	6.0	39.4	64.5	21.0	11.1	15.7	48.2	0.0	15.3	13.4	12.0	4.1	17.3	123.7	18.1	20.9	44.9	25.0	0.0	1.1	1.9	1.7	0.0	44.6	0.3	0.2	0.0	0.2	0.0	0.0	3.9	0.3	0.0	0.2	0.0	0.1	0.1	15.1	0.0	0.0	0.2	3.3	0.0	0.0	0.0	7.4	0.0	1.3	1.0	0.0	0.0	0.0	0.1	0.0	3.8	0.0	44.9	0.8	0.5	5.2	0.2	4.3	0.0	2.7	0.0	4.1	11.8	0.2	9.5	2.8	0.1	0.1	0.3	0.0	1.8	0.0	0.0	0.0	2.7	2.9	0.3	4.2	49.8	5.1	12.9	4.7	0.0	0.7	0.0	0.1	0.0	0.0	0.3	0.0	8.1	0.0	0.0	4.0	5.6	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.5	4.1	5.4	0.0	19.3	10.4	26.0	1.3	3.9	21.2	0.0	4.1	0.0	44.8	16.0	84.1	2.9	11.6	3.2	27.2	6.5	4.0	7.0	4.0	3.4	181.9	31.5	10.4	0.0	0.0	0.3	0.1	398.3	3.9	0.5	10.1	3.0	73.5	6.4	19.9	2.7	51.3	49.2	0.7	13.2	2.0	2.8	1.3	61.9	2.9	0.0	1.5	0.0	77.8	109.7	14.2	0.3	34.7	28.6	36.7	4.9	8.8	1.0	0.7	0.1	0.0	6.0	3.6	23.5	132.1	74.4	42.9	32.6	2.5	27.7	7.2	1.7	46.0	5.4	61.5	1.6	3.2	0.3	1.8	0.8	1.9	14.9	81.6	9.1
PEA15	"HMAT1, HUMMAT1H, MAT1, MAT1H, PEA-15, PED, PED-PEA15, PED/PEA15"	ENSG00000162734	"Proliferation and apoptosis adaptor protein 15"	Q15121	1	160205380-160215376	"Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Sugar transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 1106.4"	"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 246.3;monocytes: 267.6;Muller glia cells: 315.8"	"Cancer enhanced"	"Detected in all"		"glioma: 466.1"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"intermediate monocyte: 78.2"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028356, HPA070820"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA		300000	"Cluster 7: Monocytes - Unknown function"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 3: Monocytes - Immune response regulation"	Cytosol	Nucleoplasm	"HPA028356: AB_10602814, HPA070820: AB_2732166"	"unprognostic (1.29e-1)"	"unprognostic (4.78e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.57e-1)"	"unprognostic (2.53e-1)"	"unprognostic (1.64e-2)"	"unprognostic (1.99e-3)"	"unprognostic (6.10e-2)"	"unprognostic (4.57e-1)"	"unprognostic (1.25e-1)"	"unprognostic (6.31e-2)"	"unprognostic (4.07e-2)"	"prognostic unfavorable (6.53e-7)"	"unprognostic (2.60e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.82e-3)"	"unprognostic (1.24e-1)"	190.2	82.2	863.3	121.7	900.6	16.6	142.7	908.1	949.4	110.1	612.5	146.5	31.7	124.5	83.4	119.2	104.2	88.2	241.9	884.6	939.2	112.0	41.2	147.9	75.5	1028.2	1010.2	80.4	39.6	85.4	80.0	102.3	981.5	112.2	58.5	461.4	80.8	119.4	61.1	105.6	64.8	194.6	933.0	103.2	75.8	80.5	915.2	40.7	83.5	84.5	96.9	133.4	110.2	1106.4	139.2	46.8	190.5	82.5	344.5	191.5	63.6	593.2	503.3	471.6	328.5	103.7	72.3	63.4	210.9	729.4	226.6	146.4	71.5	181.7	365.3	34.4	40.2	52.4	32.5	26.7	423.9	17.8	62.0	161.8	100.7	260.2	328.5	259.6	360.7	45.7	55.1	111.8	640.6	68.3	21.0	41.1	127.0	160.9	134.3	34.4	200.6	43.8	173.0	71.0	38.0	100.0	310.4	207.6	179.9	409.4	128.1	122.6	487.7	311.3	246.4	234.4	254.5	88.1	59.5	118.7	287.1	33.2	450.8	1.3	39.3	5.2	8.4	78.2	6.5	18.9	6.2	6.9	56.7	13.5	3.8	4.2	1.8	7.9	38.7	25.0	7.9	14.9	863.3	900.6	908.1	949.4	884.6	939.2	1028.2	1010.2	981.5	933.0	915.2	1106.4	137.8	16.0	29.9	40.5	38.6	80.2	124.2	21.8	33.6	172.1	76.9	60.2	246.3	11.5	24.7	5.5	73.0	21.8	13.7	12.7	29.4	74.7	65.4	36.4	33.7	125.1	12.0	7.4	24.8	46.3	61.1	81.5	17.9	85.9	31.1	17.2	89.3	6.5	63.3	92.5	19.1	12.0	8.2	42.6	234.6	55.4	66.8	68.9	74.7	14.0	267.6	315.8	8.2	12.1	48.3	102.5	4.7	109.9	14.8	119.4	5.4	18.3	13.8	129.2	46.0	69.4	78.3	16.5	4.1	42.7	73.3	45.3	19.4	18.5	12.8	178.8
PEAR1	"FLJ00193, JEDI, MEGF12"	ENSG00000187800	"Platelet endothelial aggregation receptor 1"	Q5VY43	1	156893698-156916434	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 44.6;Endothelial cells: 30.6;Hepatic stellate cells: 40.0;Leydig cells: 44.4;Peritubular cells: 35.7;Sertoli cells: 26.3;Smooth muscle cells: 34.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 19.5;HBEC3-KT: 29.9;HHSteC: 21.6;HUVEC TERT2: 52.2;TIME: 85.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035217	Approved		Approved	"Nucleoplasm,Cell Junctions,Centrosome"		NA	NA		62000000		"Cluster 82: Adipose tissue - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 48: Smooth muscle cells - ECM organization"	"Nucleoplasm, Cell Junctions"	Centrosome	"HPA035217: AB_10669902"	"unprognostic (1.02e-1)"	"unprognostic (1.84e-5)"	"unprognostic (4.77e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.48e-1)"	"unprognostic (5.62e-2)"	"unprognostic (5.93e-2)"	"unprognostic (1.04e-2)"	"unprognostic (3.99e-1)"	"unprognostic (2.17e-1)"	"unprognostic (5.04e-1)"	"prognostic unfavorable (4.31e-4)"	"unprognostic (1.20e-2)"	"unprognostic (3.37e-3)"	"unprognostic (8.51e-2)"	"unprognostic (2.64e-2)"	19.0	5.0	2.5	2.3	3.0	2.3	12.9	1.2	4.1	12.3	2.0	4.5	1.6	10.0	1.1	2.6	9.1	7.4	8.7	1.2	1.7	4.8	2.1	11.8	3.8	2.0	2.3	9.1	2.3	1.7	3.4	11.7	2.3	4.7	0.9	0.4	2.9	3.7	5.7	4.2	4.1	4.6	1.1	7.0	3.7	3.0	2.9	1.4	9.7	7.6	1.1	6.0	7.3	1.4	0.5	2.9	0.8	0.0	0.0	3.7	0.1	11.7	19.5	4.8	2.8	0.3	0.5	0.0	0.6	8.7	0.4	0.2	0.0	29.9	1.3	0.2	0.0	14.8	0.7	0.8	21.6	0.1	0.0	11.3	0.1	6.5	1.5	1.0	52.2	0.5	0.0	0.0	0.2	0.0	0.0	0.0	0.7	0.0	11.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.1	0.0	6.9	0.0	0.0	85.2	0.1	6.4	2.6	0.5	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	2.5	3.0	1.2	4.1	1.2	1.7	2.0	2.3	2.3	1.1	2.9	1.4	44.6	0.0	3.2	0.0	0.4	0.9	0.1	0.7	1.2	2.4	0.6	1.3	7.5	1.5	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.5	1.2	0.2	2.5	30.6	1.8	5.7	0.0	0.4	0.1	10.1	1.5	0.4	1.3	0.1	40.0	0.4	0.5	0.0	0.0	2.3	0.0	1.6	1.5	3.5	44.4	3.0	5.4	12.2	0.4	0.2	0.0	0.0	0.0	1.2	0.0	35.7	0.0	0.2	0.0	0.1	0.2	0.2	26.3	1.7	34.2	1.5	1.5	0.2	1.1	0.3	0.3	1.1	0.3	0.2
PICALM	"CALM, CLTH"	ENSG00000073921	"Phosphatidylinositol binding clathrin assembly protein"	Q13492	11	85957175-86069882	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	Endocytosis		"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Microglial cells: 500.3;Oligodendrocytes: 709.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 40.6"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019053, HPA019061"	Enhanced		Enhanced	Vesicles		NA	NA		40000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 10: Non-specific - Unknown function"	Vesicles		"HPA019053: AB_1855361, HPA019061: AB_1855362"	"unprognostic (9.27e-3)"	"unprognostic (7.29e-2)"	"unprognostic (3.51e-1)"	"unprognostic (6.83e-2)"	"unprognostic (5.13e-2)"	"unprognostic (1.93e-1)"	"unprognostic (5.36e-3)"	"unprognostic (9.02e-3)"	"unprognostic (9.80e-2)"	"unprognostic (6.27e-3)"	"prognostic unfavorable (6.61e-4)"	"unprognostic (4.31e-1)"	"prognostic favorable (2.02e-6)"	"unprognostic (1.26e-2)"	"unprognostic (5.21e-3)"	"unprognostic (2.52e-1)"	"unprognostic (1.02e-1)"	183.5	62.5	97.1	120.4	162.1	111.4	111.5	119.3	118.7	86.4	43.8	86.3	106.3	79.3	52.4	109.1	66.1	127.0	87.9	91.7	110.8	168.5	147.0	99.4	82.7	125.2	130.7	94.4	80.6	120.6	36.5	157.2	131.6	73.1	83.1	71.5	62.3	93.6	75.8	74.2	115.5	135.3	106.0	126.5	73.0	64.9	120.7	93.1	75.7	101.9	96.7	139.5	73.5	194.7	167.0	78.4	121.1	85.9	185.5	188.8	228.5	211.7	274.7	164.4	143.0	310.7	222.4	126.0	210.8	342.6	171.1	134.6	129.4	154.2	232.8	38.6	45.0	364.9	101.5	98.9	185.6	87.2	158.3	166.6	161.7	308.7	253.3	275.1	178.7	85.9	239.1	103.0	305.2	98.2	103.9	76.8	66.9	269.0	42.7	69.8	182.2	91.1	312.5	139.2	72.9	58.7	258.4	85.4	68.7	156.5	115.6	67.0	196.9	298.6	104.1	355.0	170.2	36.7	107.1	118.4	70.8	64.6	206.6	6.4	13.5	7.5	5.7	11.7	4.9	3.1	4.2	8.0	11.4	2.1	4.2	4.0	40.6	7.1	12.5	3.9	6.4	5.3	97.1	162.1	119.3	118.7	91.7	110.8	125.2	130.7	131.6	106.0	120.7	194.7	147.1	35.3	58.9	134.5	33.3	116.0	44.4	33.0	30.1	20.8	34.8	28.6	46.4	42.9	34.3	71.7	12.5	42.9	43.9	64.2	31.3	57.7	59.3	32.3	32.8	98.7	25.1	88.8	144.7	37.6	127.1	44.6	34.1	50.9	48.2	23.2	71.4	52.3	85.0	40.4	140.7	30.1	30.5	142.8	229.2	95.4	35.8	127.4	60.5	500.3	92.1	22.6	32.0	188.0	709.3	90.2	55.3	43.6	39.1	49.5	71.4	84.0	41.0	16.3	78.9	36.4	92.7	17.3	14.1	34.4	96.5	41.3	38.9	23.6	30.6	77.7
PLA1A	ps-PLA1	ENSG00000144837	"Phospholipase A1 member A"	Q53H76	3	119597875-119629811	"Predicted intracellular proteins, Predicted secreted proteins, RAS pathway related proteins"	"Lipid degradation, Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 138.4;parathyroid gland: 65.8;seminal vesicle: 67.2"	"Cell type enhanced"	"Detected in many"		"Collecting duct cells: 14.7;Endothelial cells: 14.3;Hepatocytes: 26.0;Langerhans cells: 15.6;Peritubular cells: 14.3"	"Group enriched"	"Detected in many"	5	"liver cancer: 14.8;melanoma: 55.4;prostate cancer: 24.2;renal cancer: 21.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	18	"SK-MEL-30: 25.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059740			Approved	"Nucleoplasm,Nuclear speckles,Cytoplasmic bodies"	"Secreted in other tissues"	NA	NA		420000	"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 68: Epididymis - Unknown function"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 10: Non-specific - Unknown function"	"Nuclear speckles, Cytoplasmic bodies"	Nucleoplasm	"HPA059740: AB_2684118"	"unprognostic (1.35e-1)"	"prognostic favorable (2.81e-7)"	"unprognostic (2.24e-2)"	"unprognostic (3.46e-2)"	"unprognostic (3.18e-2)"	"unprognostic (1.94e-2)"	"unprognostic (1.11e-2)"	"unprognostic (2.43e-1)"	"unprognostic (3.87e-1)"	"unprognostic (1.43e-2)"	"unprognostic (1.25e-1)"	"unprognostic (9.09e-2)"	"unprognostic (1.55e-3)"	"unprognostic (9.53e-3)"	"unprognostic (3.94e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.67e-1)"	4.9	0.7	12.1	3.5	11.3	0.3	3.4	11.6	16.3	4.7	26.8	2.7	1.1	4.7	138.4	1.5	5.7	2.8	4.9	12.5	12.0	7.7	39.6	21.2	15.6	13.2	12.3	1.1	3.7	65.8	1.7	9.8	13.2	9.1	2.5	1.0	3.5	67.2	16.2	0.8	3.5	8.8	13.4	1.0	4.4	3.7	14.7	1.6	6.9	3.1	8.7	3.9	1.9	12.4	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.2	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.0	0.8	0.3	0.5	0.1	0.0	0.2	0.0	0.0	25.0	0.0	0.0	0.0	1.3	0.0	0.1	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	12.1	11.3	11.6	16.3	12.5	12.0	13.2	12.3	13.2	13.4	14.7	12.4	6.5	0.0	1.7	0.0	0.0	0.6	0.5	0.4	0.6	0.0	0.1	0.1	2.8	2.8	1.0	14.7	0.0	0.2	0.1	0.0	1.9	4.7	6.6	0.1	0.1	14.3	1.8	0.0	0.2	2.2	0.0	1.6	0.0	0.9	1.3	0.7	7.9	26.0	1.6	0.0	0.1	0.1	0.0	1.0	15.6	3.2	0.3	5.4	1.8	4.7	4.2	0.0	0.0	0.0	0.0	1.3	0.6	14.3	0.0	0.5	0.0	5.1	7.5	0.1	0.0	0.9	5.9	0.0	0.2	0.0	0.6	1.9	0.1	0.0	0.1	0.2
PLCXD3		ENSG00000182836	"Phosphatidylinositol specific phospholipase C X domain containing 3"	Q63HM9	5	41306952-41510628	"Predicted intracellular proteins"	"Lipid degradation, Lipid metabolism"	"Hydrolase, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 17.8;heart muscle: 33.2;ovary: 22.5"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 138.2;Endometrial stromal cells: 58.7;Enteroendocrine cells: 42.4;Inhibitory neurons: 163.5;Microglial cells: 52.5"	"Cancer enhanced"	"Detected in some"		"pancreatic cancer: 2.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 8.5;PC-3: 7.5;SH-SY5Y: 34.3;TIME: 18.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046849	Uncertain		Approved	"Golgi apparatus"		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 35: Non-specific - Unknown function"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Golgi apparatus"		"HPA046849: AB_2679838"	"unprognostic (1.71e-1)"	"unprognostic (3.84e-2)"	"unprognostic (2.00e-1)"	"unprognostic (7.04e-3)"	"unprognostic (1.43e-1)"	"unprognostic (2.44e-1)"	"unprognostic (4.90e-2)"	"unprognostic (1.34e-1)"	"unprognostic (2.63e-2)"	"unprognostic (3.12e-1)"	"unprognostic (6.38e-3)"	"unprognostic (2.57e-1)"	"unprognostic (2.73e-2)"	"unprognostic (2.15e-3)"	"unprognostic (5.91e-5)"	"unprognostic (5.11e-2)"	"unprognostic (6.75e-2)"	3.9	12.7	4.5	0.5	4.1	0.0	2.4	17.8	4.2	2.9	1.1	0.9	0.5	1.1	0.9	0.6	3.4	2.4	33.2	3.4	9.5	5.9	1.6	1.8	1.6	8.2	10.4	22.5	3.6	0.3	5.3	0.1	16.0	1.0	0.6	0.7	0.4	1.0	0.5	0.7	1.2	1.2	7.7	0.2	5.0	0.4	12.1	0.5	1.5	0.7	0.2	1.4	4.0	6.3	0.0	3.7	0.0	0.0	0.0	0.0	0.0	1.8	8.5	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.0	4.4	0.0	0.6	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.5	0.0	0.0	0.0	0.0	0.0	0.4	34.3	0.0	0.0	0.0	0.0	0.0	0.0	18.4	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	4.5	4.1	17.8	4.2	3.4	9.5	8.2	10.4	16.0	7.7	12.1	6.3	8.7	0.0	0.0	7.5	0.1	0.1	0.1	0.0	0.0	0.7	0.1	0.0	138.2	5.7	0.0	0.0	0.0	0.1	0.0	0.1	3.9	0.3	0.9	1.7	58.7	13.6	42.4	5.3	27.8	0.0	2.0	10.3	0.0	1.1	0.0	33.4	33.2	0.4	0.1	1.7	163.5	2.2	0.0	0.6	0.3	4.4	7.8	0.2	0.0	52.5	0.0	0.4	0.0	7.5	1.3	0.9	0.0	0.4	0.0	0.3	0.1	10.4	0.0	0.2	6.6	0.2	2.9	0.2	0.0	0.2	0.0	0.1	0.3	9.7	0.1	0.1
PLVAP	"FELS, gp68, PV-1, PV1"	ENSG00000130300	"Plasmalemma vesicle associated protein"	Q9BX97	19	17351450-17377342	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"			"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"thyroid gland: 436.2"	"Group enriched"	"Detected in many"	4	"Adipocytes: 439.2;Endothelial cells: 344.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	6	"plasmacytoid DC: 35.2"	"Lineage enriched"	"Detected in many"	6	"dendritic cells: 35.2"	"Cell line enriched"	"Detected in some"	27	"EFO-21: 549.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002279	Supported		Approved	"Plasma membrane,Centrosome,Cytosol"		NA	NA		53000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Cytosol	"Plasma membrane, Centrosome"	"HPA002279: AB_1079636"	"unprognostic (3.19e-1)"	"unprognostic (8.22e-2)"	"unprognostic (7.87e-2)"	"unprognostic (2.38e-2)"	"unprognostic (1.93e-2)"	"unprognostic (2.49e-3)"	"unprognostic (4.17e-3)"	"unprognostic (1.01e-1)"	"unprognostic (2.35e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.53e-2)"	"unprognostic (8.96e-2)"	"unprognostic (4.24e-3)"	"unprognostic (4.70e-3)"	"unprognostic (1.51e-1)"	"unprognostic (2.58e-1)"	"unprognostic (8.17e-2)"	283.0	51.1	2.7	54.6	3.1	1.7	210.5	2.9	4.2	102.7	18.2	95.7	86.7	90.0	5.1	48.9	83.3	139.2	92.5	3.3	3.1	153.0	6.9	31.0	50.5	3.7	3.5	16.7	96.1	98.6	64.3	48.8	3.6	68.4	22.3	0.0	77.9	38.0	32.7	58.9	103.3	50.5	3.6	166.7	116.6	4.4	3.5	18.9	436.2	12.9	16.2	104.4	80.8	4.1	0.3	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.1	549.1	0.0	0.0	0.2	0.0	0.0	0.0	1.2	0.0	9.5	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.6	0.0	0.7	0.0	0.0	0.0	0.0	0.8	0.3	0.0	0.1	0.3	0.0	0.2	0.0	0.0	0.0	0.2	0.1	0.0	0.1	0.0	0.0	1.1	20.0	0.0	2.3	0.1	0.3	0.5	2.2	2.5	0.0	0.2	0.0	0.0	0.2	0.0	0.0	6.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	2.7	35.2	0.0	0.6	2.7	3.1	2.9	4.2	3.3	3.1	3.7	3.5	3.6	3.6	3.5	4.1	439.2	6.4	0.0	0.3	0.7	22.9	1.0	0.0	8.0	0.0	2.7	3.3	3.7	0.0	0.0	0.0	0.0	0.1	5.1	0.0	0.0	1.7	3.6	0.4	0.3	344.9	0.0	0.4	0.4	2.5	0.1	48.9	0.0	0.3	0.0	0.4	79.6	0.2	1.8	0.0	0.3	0.0	0.0	3.5	28.8	0.8	0.0	5.5	23.2	6.5	0.0	0.5	0.0	0.0	0.3	0.1	0.0	0.0	7.6	1.5	0.0	0.0	0.0	0.1	0.0	1.4	6.1	0.5	0.7	2.9	16.8	0.1	1.4	0.7	0.0	2.3
PML	"MYL, RNF71, TRIM19"	ENSG00000140464	"PML nuclear body scaffold"	P29590	15	73994673-74047827	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Antiviral defense, Apoptosis, Biological rhythms, Host-virus interaction, Immunity, Innate immunity, Transcription, Transcription regulation"	"Activator, DNA-binding, Transferase"	"Cancer-related genes, Proto-oncogene, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Adipocytes: 127.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008312, CAB010194, CAB016304"	Supported		Enhanced	"Nuclear bodies"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Nuclear bodies"		"CAB010194: AB_2166848, CAB016304: AB_628162, HPA008312: AB_1079643"	"prognostic favorable (3.24e-4)"	"unprognostic (4.83e-2)"	"unprognostic (5.76e-2)"	"unprognostic (1.58e-3)"	"unprognostic (7.53e-3)"	"unprognostic (1.58e-1)"	"unprognostic (2.35e-2)"	"unprognostic (5.30e-3)"	"unprognostic (4.54e-3)"	"unprognostic (1.15e-1)"	"prognostic unfavorable (3.29e-4)"	"unprognostic (2.67e-2)"	"prognostic unfavorable (6.27e-8)"	"unprognostic (1.58e-2)"	"unprognostic (4.17e-2)"	"unprognostic (1.02e-1)"	"unprognostic (8.99e-2)"	84.4	29.4	14.4	25.6	13.8	38.1	77.0	11.8	16.4	53.7	11.6	46.7	18.4	47.1	7.5	38.3	44.6	21.6	39.3	13.8	13.1	35.4	25.4	75.2	25.6	18.2	13.8	37.5	20.3	8.3	26.8	23.7	14.8	41.5	8.5	3.9	44.2	17.2	22.5	47.4	39.0	19.5	14.6	48.6	35.3	11.3	15.2	17.0	48.1	7.9	15.2	42.7	44.5	13.1	37.2	13.8	11.8	11.4	30.2	43.2	40.6	18.5	31.6	55.9	63.3	14.6	64.2	16.4	63.7	31.6	53.3	66.6	16.3	37.1	7.6	58.0	25.1	35.8	21.3	16.3	36.9	33.9	31.1	83.7	24.8	37.5	19.2	39.3	38.3	26.1	30.6	28.3	32.7	17.3	28.3	52.6	12.8	7.7	25.0	21.6	13.4	30.8	60.3	59.5	10.1	11.1	29.7	16.3	44.8	10.3	12.8	28.7	66.1	56.6	15.5	28.5	38.1	29.4	20.0	8.0	38.9	42.2	18.2	7.4	14.7	23.4	13.0	20.2	9.8	12.4	10.4	14.1	14.5	10.2	8.2	8.5	12.0	14.5	22.6	9.2	14.3	10.1	14.4	13.8	11.8	16.4	13.8	13.1	18.2	13.8	14.8	14.6	15.2	13.1	127.8	16.0	12.2	8.8	24.9	22.9	14.3	30.4	37.5	8.1	13.5	12.8	10.0	5.7	16.7	5.5	2.1	9.4	18.8	13.1	7.9	25.8	3.4	16.0	16.7	48.0	14.3	29.3	4.7	19.1	15.0	20.7	58.1	26.0	12.0	11.5	32.2	11.3	30.8	8.4	4.8	14.3	14.2	20.1	18.5	4.0	27.7	19.6	7.2	7.5	24.6	8.5	20.6	4.5	6.0	62.8	15.5	24.0	21.6	26.2	22.8	10.4	18.3	5.4	39.5	7.7	20.4	1.1	4.0	27.1	19.6	4.9	20.4	16.8	12.1	26.0
PRR29	"C17orf72, DKFZp761M2312, FLJ11724"	ENSG00000224383	"Proline rich 29"	P0C7W0	17	63998351-64004305	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 58.2"	"Group enriched"	"Detected in some"	4	"Endometrial ciliated cells: 57.4;Respiratory ciliated cells: 89.6"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 4.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 3.5;REH: 3.7;TIME: 2.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA051264			Uncertain	Nucleoli		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 49: Ciliated cells - Cilium organization"	Nucleoli		"HPA051264: "	"unprognostic (2.05e-2)"	"unprognostic (6.46e-2)"	"unprognostic (2.87e-2)"	"unprognostic (2.92e-3)"	"unprognostic (4.71e-3)"	"unprognostic (3.22e-2)"	"unprognostic (3.84e-1)"	"unprognostic (3.95e-2)"	"unprognostic (1.04e-2)"	"unprognostic (1.44e-1)"	"unprognostic (2.63e-3)"	"unprognostic (5.76e-2)"	"unprognostic (1.30e-3)"	"unprognostic (6.48e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.32e-1)"	"unprognostic (9.98e-3)"	2.0	0.3	3.2	0.5	2.5	0.3	2.2	1.8	1.2	6.1	12.7	0.4	0.2	0.6	0.3	0.2	58.2	0.7	1.5	4.1	4.2	1.9	0.2	10.4	0.4	12.7	16.0	0.6	0.3	0.9	10.7	0.3	7.3	0.7	0.0	0.0	0.5	0.6	0.6	0.4	0.7	0.2	9.0	5.7	0.3	13.9	4.0	0.2	4.7	0.0	0.3	0.8	0.6	3.9	0.0	0.0	0.0	0.0	0.0	0.6	0.2	0.1	0.0	0.0	0.2	0.0	3.5	0.0	0.3	0.0	0.7	0.0	0.0	0.2	0.1	0.0	0.0	1.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.1	1.0	0.5	0.0	0.0	0.0	1.3	0.0	0.1	0.7	0.1	3.7	0.0	1.5	0.3	0.0	0.2	1.0	0.0	0.1	0.2	0.5	0.5	0.0	2.8	0.1	1.1	0.4	0.1	0.4	0.1	0.2	0.4	0.1	0.0	0.9	0.2	0.0	0.4	0.5	0.1	0.1	0.4	0.2	0.1	0.2	0.7	0.4	0.2	0.2	0.4	0.0	0.2	0.3	3.2	2.5	1.8	1.2	4.1	4.2	12.7	16.0	7.3	9.0	4.0	3.9	3.3	0.0	2.8	0.0	0.8	0.0	0.1	0.0	0.0	0.0	0.5	0.6	0.2	1.5	9.9	3.7	0.0	0.0	0.7	0.0	0.0	0.1	12.4	57.4	0.5	2.1	0.0	0.0	0.5	0.0	0.1	0.6	0.0	1.1	0.0	1.6	1.8	0.5	0.3	0.0	0.4	0.0	0.0	0.0	0.0	10.5	0.0	0.9	0.0	1.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.7	2.0	0.0	0.0	0.1	89.6	0.0	0.0	0.3	0.3	18.1	1.4	0.0	0.0	0.3	0.7	3.5	0.0	0.1
PTPRB	PTPB	ENSG00000127329	"Protein tyrosine phosphatase receptor type B"	P23467	12	70515870-70637440	"Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	Angiogenesis	"Hydrolase, Protein phosphatase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 215.9;Endothelial cells: 211.5;Hepatic stellate cells: 504.0;Microglial cells: 164.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"EFO-21: 24.3;hTERT-RPE1: 19.7;HUVEC TERT2: 61.4;TIME: 90.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004782, HPA067868"	Uncertain		Approved	"Vesicles,Plasma membrane,Cell Junctions"		NA	NA		14000000	"Cluster 43: B-cells - Humoral immune response"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Plasma membrane"	"Vesicles, Cell Junctions"	"CAB004782: , HPA067868: AB_2685911"	"unprognostic (3.18e-1)"	"unprognostic (2.99e-6)"	"unprognostic (1.56e-1)"	"unprognostic (1.80e-1)"	"unprognostic (3.55e-2)"	"unprognostic (1.77e-2)"	"prognostic favorable (6.05e-4)"	"unprognostic (4.59e-1)"	"unprognostic (2.22e-2)"	"unprognostic (1.85e-1)"	"unprognostic (2.28e-2)"	"unprognostic (1.40e-1)"	"prognostic favorable (1.02e-4)"	"unprognostic (2.91e-2)"	"unprognostic (7.18e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.38e-1)"	26.7	9.4	16.0	4.7	14.1	0.1	18.8	12.3	12.1	12.8	7.1	10.9	7.5	12.3	4.4	6.8	10.8	14.7	23.2	10.1	12.4	22.5	16.7	35.7	3.2	15.9	14.2	4.0	6.2	7.8	4.7	32.6	18.1	6.3	11.1	1.4	3.3	8.0	17.1	4.1	9.3	18.1	12.4	30.0	6.2	2.5	19.0	3.0	14.8	38.8	3.4	7.7	5.3	11.9	4.4	0.3	1.9	0.2	0.0	0.1	0.9	0.9	4.2	2.2	5.2	0.1	3.4	1.7	24.3	0.6	0.4	15.2	0.2	0.7	7.8	1.3	0.7	0.4	1.7	1.1	0.2	0.7	0.0	0.1	0.7	6.1	0.0	19.7	61.4	0.0	3.6	1.0	1.3	0.0	0.1	0.0	2.3	4.4	0.9	0.1	1.6	0.9	11.3	1.8	0.0	0.8	1.6	0.0	3.5	0.4	0.0	1.5	90.3	0.9	0.9	0.4	5.4	1.1	0.9	0.8	0.4	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	16.0	14.1	12.3	12.1	10.1	12.4	15.9	14.2	18.1	12.4	19.0	11.9	215.9	0.0	13.2	2.0	3.1	3.7	0.8	1.0	0.0	7.1	0.9	0.9	12.3	11.5	1.3	3.7	0.0	0.0	2.0	12.8	0.0	1.5	4.6	2.2	0.7	211.5	0.0	16.0	52.5	0.9	0.0	7.3	1.5	4.0	25.2	0.5	504.0	4.7	0.4	5.0	68.8	6.4	0.0	20.0	4.6	3.0	1.2	1.2	5.4	164.9	0.0	0.4	0.0	2.5	2.9	12.2	11.1	0.0	0.1	0.8	3.2	0.1	0.2	0.9	0.0	6.4	5.2	0.7	0.7	0.9	1.6	0.0	1.0	1.8	6.8	0.7
RAPGEF5	"GFR, KIAA0277, MR-GEF"	ENSG00000136237	"Rap guanine nucleotide exchange factor 5"	Q92565	7	22118236-22357154	"Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 152.1;parathyroid gland: 387.8"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 504.6;Inhibitory neurons: 193.4;Microglial cells: 138.7;Oligodendrocytes: 640.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"Daudi: 21.1;HUVEC TERT2: 45.0;SCLC-21H: 34.1;TIME: 25.8;U-698: 37.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA057821, HPA076772"	Uncertain		Supported	"Nucleoplasm,Nuclear bodies"	"Intracellular and membrane"	NA	NA				"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Nucleoplasm	"Nuclear bodies"	"HPA057821: AB_2683538, HPA076772: AB_2686814"	"unprognostic (1.00e-1)"	"unprognostic (1.57e-1)"	"unprognostic (3.17e-2)"	"prognostic unfavorable (9.44e-4)"	"unprognostic (5.22e-2)"	"prognostic favorable (3.52e-5)"	"unprognostic (1.16e-1)"	"unprognostic (2.10e-2)"	"unprognostic (1.64e-1)"	"unprognostic (2.10e-1)"	"unprognostic (1.97e-1)"	"unprognostic (1.31e-1)"	"unprognostic (3.76e-2)"	"unprognostic (6.36e-3)"	"unprognostic (6.57e-2)"	"unprognostic (2.55e-1)"	"unprognostic (8.26e-3)"	21.0	12.7	30.7	7.0	82.9	0.9	16.4	76.1	58.5	8.9	2.9	9.5	7.5	8.8	4.8	13.9	8.3	16.8	16.8	45.7	46.9	16.7	21.8	37.5	14.3	115.3	71.8	6.5	20.1	387.8	7.4	67.2	107.1	5.1	11.0	4.2	7.6	5.7	5.1	9.2	8.3	12.1	82.0	50.9	7.0	6.4	59.8	15.7	11.7	11.1	10.7	9.3	11.9	152.1	2.8	0.0	4.6	0.0	0.2	0.2	0.0	0.0	0.3	0.0	0.0	5.5	1.4	21.1	1.1	0.3	0.7	13.0	2.8	1.9	0.0	0.0	4.2	0.3	0.0	5.4	0.1	0.0	0.1	0.5	2.4	1.3	0.7	0.7	45.0	5.9	4.8	0.1	0.0	1.2	3.0	0.1	3.6	5.4	4.0	5.2	0.0	7.4	4.2	1.9	34.1	9.0	0.5	6.0	0.1	0.7	3.0	0.1	25.8	0.0	1.0	0.4	1.1	10.9	2.5	37.4	0.5	0.0	10.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	30.7	82.9	76.1	58.5	45.7	46.9	115.3	71.8	107.1	82.0	59.8	152.1	125.5	9.6	16.5	13.4	3.1	11.0	4.2	2.4	86.0	30.6	8.8	5.5	10.0	15.7	3.8	0.0	0.0	0.3	0.6	16.0	1.9	6.5	61.5	3.3	1.2	70.1	7.2	0.4	504.6	7.0	0.1	5.3	16.3	10.8	8.2	0.1	86.0	6.3	0.2	23.5	193.4	18.3	2.0	3.1	2.0	65.2	1.8	0.9	7.2	138.7	0.0	0.6	0.0	28.1	640.8	5.0	20.3	4.9	12.9	3.0	18.1	0.3	0.5	1.6	85.5	1.4	21.5	1.2	1.6	19.8	11.2	0.3	2.4	1.9	10.1	4.4
RBP7	CRBPIV	ENSG00000162444	"Retinol binding protein 7"	Q96R05	1	9997206-10016021	"Predicted intracellular proteins"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adipose tissue: 401.0;breast: 394.6"	"Cell type enriched"	"Detected in many"	7	"Adipocytes: 3631.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"classical monocyte: 311.5;neutrophil: 344.7"	"Group enriched"	"Detected in many"	31	"granulocytes: 344.7;monocytes: 311.5"	"Group enriched"	"Detected in some"	4	"EFO-21: 13.0;SK-MEL-30: 9.8;T-47d: 34.8"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in single"			HPA034749	Enhanced		Uncertain	"Nuclear speckles,Cytosol"		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 6: T47d - Mammary gland"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Nuclear speckles, Cytosol"		"HPA034749: AB_10602084"	"unprognostic (1.93e-3)"	"unprognostic (1.50e-1)"	"prognostic unfavorable (2.49e-4)"	"unprognostic (9.59e-2)"	"unprognostic (2.31e-1)"	"unprognostic (6.28e-2)"	"unprognostic (1.39e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.05e-3)"	"unprognostic (2.24e-1)"	"unprognostic (1.46e-2)"	"unprognostic (7.90e-2)"	"unprognostic (5.07e-2)"	"unprognostic (2.38e-2)"	"unprognostic (2.93e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.61e-2)"	401.0	15.0	20.7	8.9	27.0	28.6	394.6	23.8	38.3	22.6	23.4	15.0	2.6	20.4	4.2	34.4	14.7	51.6	86.6	20.4	22.4	72.9	9.6	8.8	8.3	23.7	24.0	12.7	11.9	68.9	16.7	15.9	23.7	18.6	4.4	5.0	22.3	8.1	16.0	35.4	11.5	14.9	23.5	112.1	17.2	9.2	22.4	12.6	36.2	24.9	5.6	23.6	27.9	36.4	0.0	0.6	0.3	0.0	0.0	0.5	0.0	0.0	0.0	2.5	0.9	2.5	3.2	0.0	13.0	1.3	0.0	0.0	0.1	1.0	4.4	0.0	2.8	0.0	0.1	1.3	1.6	0.0	0.0	0.0	2.0	2.1	0.0	2.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.1	0.0	3.4	0.0	0.0	0.0	0.7	0.0	0.2	0.5	2.6	0.2	9.8	3.5	34.8	2.3	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	3.4	311.5	2.8	0.4	138.4	0.2	0.1	0.0	0.1	10.6	0.2	0.2	0.1	344.7	0.0	68.3	2.0	0.7	96.8	20.7	27.0	23.8	38.3	20.4	22.4	23.7	24.0	23.7	23.5	22.4	36.4	3631.8	0.0	1.3	0.7	9.5	20.6	9.5	2.6	9.1	0.2	43.0	73.9	22.9	10.0	1.2	1.8	0.0	5.0	16.2	0.1	23.5	2.0	3.2	2.5	15.8	349.2	0.0	5.7	0.4	2.8	1.9	36.1	0.0	4.8	3.8	7.1	69.7	3.7	63.7	0.0	0.4	0.4	2.0	502.5	14.1	6.1	6.2	42.5	21.4	1.0	149.7	2.1	3.1	0.0	13.4	2.7	0.1	0.7	2.7	20.7	0.0	1.4	0.9	1.5	0.0	3.9	20.5	1.8	2.8	26.2	17.6	6.2	3.8	3.6	0.6	6.3
RDX	DFNB24	ENSG00000137710	Radixin	P35241	11	109864295-110296712	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		"Actin capping, Actin-binding"	"Deafness, Disease variant, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adrenal gland: 155.0"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 484.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000263, HPA000763, CAB037312"	Enhanced		Supported	"Nucleoplasm,Plasma membrane"		NA	NA		38000000	"Cluster 2: Granulocytes - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 1: Pancreatic cells - Digestion"	"Plasma membrane"	Nucleoplasm	"CAB037312: AB_261933, HPA000263: AB_1856043, HPA000763: AB_1856042"	"unprognostic (2.23e-3)"	"unprognostic (2.56e-2)"	"unprognostic (3.85e-1)"	"unprognostic (2.74e-2)"	"unprognostic (6.93e-2)"	"unprognostic (9.82e-2)"	"unprognostic (2.01e-2)"	"unprognostic (1.44e-2)"	"unprognostic (3.91e-2)"	"unprognostic (6.91e-2)"	"unprognostic (1.32e-3)"	"unprognostic (6.47e-2)"	"unprognostic (4.14e-3)"	"unprognostic (5.43e-2)"	"unprognostic (4.40e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.08e-3)"	40.3	155.0	38.0	17.4	57.7	12.0	16.4	50.0	42.7	32.1	32.8	15.2	6.8	28.8	12.9	27.4	19.7	27.2	41.0	35.1	44.7	50.2	68.5	48.8	11.4	52.7	48.2	52.8	52.7	33.2	7.6	35.3	54.3	25.4	11.1	19.2	20.8	26.0	82.1	11.9	7.4	35.0	45.1	26.6	15.0	33.7	47.7	14.3	45.7	59.7	14.6	27.1	10.1	77.6	69.6	35.3	137.3	54.8	78.8	87.4	79.3	85.8	47.6	54.3	59.2	99.7	115.4	0.1	127.4	104.7	84.9	61.5	77.3	80.4	80.5	41.9	44.2	51.5	107.7	74.1	73.6	19.0	33.2	89.7	45.6	68.0	120.1	89.3	149.8	11.1	73.5	29.5	127.0	120.0	11.0	15.6	44.0	4.0	58.4	31.2	96.8	30.1	68.1	33.5	37.2	40.5	148.5	65.9	52.7	102.5	85.0	29.9	92.6	89.5	66.8	43.9	67.4	9.5	17.3	65.9	34.2	11.3	210.9	29.5	14.8	22.0	11.6	12.5	15.5	11.5	10.2	8.8	12.8	8.3	6.8	5.8	2.0	17.6	9.9	10.3	22.0	8.4	38.0	57.7	50.0	42.7	35.1	44.7	52.7	48.2	54.3	45.1	47.7	77.6	248.8	484.0	98.8	53.5	30.0	56.1	51.8	124.6	56.9	85.9	47.4	45.7	159.3	70.1	77.9	75.4	43.8	122.1	21.6	17.7	109.5	128.1	15.5	109.1	117.2	289.2	22.2	104.8	27.1	423.4	189.8	88.4	19.9	135.3	67.2	132.0	319.2	260.1	85.1	101.0	57.6	7.3	61.1	103.2	59.9	43.6	275.2	71.6	72.9	42.2	135.4	77.0	36.0	68.3	229.4	134.3	22.1	266.7	36.1	65.9	0.1	236.9	52.2	94.8	124.9	74.0	143.8	73.9	257.4	52.8	40.5	227.3	29.2	229.9	11.8	45.9
RFTN1	"FLJ23866, KIAA0084, MIG2, Raftlin"	ENSG00000131378	"Raftlin, lipid raft linker 1"	Q14699	3	16313574-16514026	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 117.4"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 87.6;monocytes: 143.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 151.7;Daudi: 122.9;HDLM-2: 177.5;SH-SY5Y: 132.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048725	Approved					NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 16: Immune cells - Immune response"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 3: Monocytes - Immune response regulation"			"HPA048725: AB_2680502"	"unprognostic (1.98e-1)"	"unprognostic (5.82e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.61e-1)"	"unprognostic (5.92e-2)"	"unprognostic (1.19e-2)"	"unprognostic (1.87e-1)"	"unprognostic (7.55e-3)"	"unprognostic (9.99e-3)"	"unprognostic (7.24e-2)"	"unprognostic (2.75e-2)"	"unprognostic (1.98e-1)"	"prognostic unfavorable (1.29e-7)"	"unprognostic (6.19e-2)"	"unprognostic (1.49e-2)"	"unprognostic (2.88e-2)"	"unprognostic (2.81e-1)"	57.2	11.2	15.1	44.7	18.3	13.3	33.2	13.6	22.7	28.2	15.8	15.2	9.3	36.6	4.9	14.5	26.0	15.4	44.7	18.3	20.2	18.4	24.8	46.9	117.0	21.7	14.9	30.4	4.7	9.0	7.4	51.0	16.1	16.4	14.1	11.4	11.3	10.3	25.5	17.1	22.8	31.3	13.9	45.5	11.8	7.0	15.2	73.2	53.4	26.6	117.4	26.2	14.5	17.5	0.1	2.9	5.3	0.0	151.7	75.7	7.7	38.8	65.9	19.3	15.6	21.5	1.0	122.9	18.6	71.2	4.3	0.6	0.1	51.4	25.5	177.5	9.0	19.8	4.9	0.3	78.6	14.7	10.8	111.3	3.4	60.7	19.0	67.5	40.5	19.8	0.5	0.4	47.0	6.6	31.3	5.0	3.5	0.0	1.4	29.6	60.8	15.0	8.0	0.1	0.1	132.6	1.3	1.3	7.2	7.4	0.2	12.2	59.9	47.3	23.0	47.8	16.8	0.4	0.5	82.5	22.0	38.6	19.2	56.0	19.6	13.2	35.3	46.4	18.1	16.3	27.2	37.6	33.6	32.0	18.4	27.8	1.2	80.1	81.7	25.8	60.4	38.3	15.1	18.3	13.6	22.7	18.3	20.2	21.7	14.9	16.1	13.9	15.2	17.5	37.9	22.4	40.0	8.1	51.2	6.5	0.3	2.3	0.0	3.2	0.7	1.5	14.3	5.7	6.9	0.0	0.0	6.2	61.1	0.1	0.0	7.2	38.0	2.6	51.8	34.4	1.2	10.3	87.6	0.9	1.1	32.4	3.1	2.0	24.7	2.1	36.0	7.2	10.5	0.0	16.5	0.0	0.0	17.6	63.6	12.2	18.6	27.0	10.6	19.7	143.8	37.2	64.9	3.0	2.4	0.9	0.1	8.6	43.2	0.6	0.0	0.4	3.3	3.2	0.0	28.2	35.2	2.8	2.4	0.8	5.1	2.5	39.5	12.6	0.3	0.4
RIPOR1	"FAM65A, FLJ13725"	ENSG00000039523	"RHO family interacting cell polarization regulator 1"	Q6ZS17	16	67518418-67546788	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 49.2;Endothelial cells: 23.6;Hofbauer cells: 30.0;Pancreatic endocrine cells: 37.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	7	"classical monocyte: 11.2;eosinophil: 9.3;intermediate monocyte: 15.6;memory B-cell: 15.8;myeloid DC: 10.2;naive B-cell: 9.4;neutrophil: 6.6;non-classical monocyte: 15.1;plasmacytoid DC: 14.4"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005923	Uncertain		Approved	"Golgi apparatus,Cytosol"		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 7: Non-specific - Mitochondria"	"Golgi apparatus, Cytosol"		"HPA005923: AB_1078809"	"unprognostic (7.41e-2)"	"unprognostic (2.07e-2)"	"unprognostic (1.56e-3)"	"unprognostic (3.71e-2)"	"unprognostic (1.11e-1)"	"prognostic unfavorable (6.53e-4)"	"unprognostic (1.10e-2)"	"prognostic unfavorable (5.00e-5)"	"unprognostic (1.45e-1)"	"unprognostic (1.98e-1)"	"unprognostic (3.38e-1)"	"unprognostic (1.24e-1)"	"prognostic favorable (5.82e-8)"	"unprognostic (8.51e-2)"	"unprognostic (3.52e-2)"	"unprognostic (1.19e-1)"	"unprognostic (7.46e-2)"	44.4	28.1	27.6	23.4	30.6	27.2	37.7	26.4	38.6	39.9	7.5	36.0	8.8	45.2	6.0	18.5	36.2	21.5	53.6	33.6	16.3	67.6	16.7	55.8	20.8	26.6	17.1	33.2	30.1	20.6	26.5	29.8	25.4	30.6	7.4	43.8	22.8	20.2	34.9	21.4	32.7	25.2	12.3	61.2	25.9	18.6	21.5	10.8	36.4	22.3	17.5	37.1	30.4	18.6	44.0	36.6	16.1	25.3	40.0	35.7	35.7	45.7	44.9	51.6	43.0	75.7	31.5	6.0	62.4	78.8	26.0	24.4	32.7	41.3	33.2	19.3	17.0	57.9	53.6	17.4	44.7	4.6	28.0	35.5	18.8	69.7	47.1	36.8	55.2	10.2	6.5	6.4	38.7	47.7	13.8	14.4	4.4	8.5	29.1	46.8	29.0	31.2	39.0	22.1	12.1	31.9	85.1	13.8	28.6	15.9	30.2	10.7	96.8	58.3	34.2	49.8	32.2	9.0	6.8	17.8	38.8	11.1	31.7	0.1	11.2	9.3	1.2	15.6	1.8	15.8	1.0	0.5	10.2	9.4	0.7	0.7	6.6	1.7	15.1	14.4	0.8	6.0	27.6	30.6	26.4	38.6	33.6	16.3	26.6	17.1	25.4	12.3	21.5	18.6	49.2	16.0	16.0	0.0	6.4	0.0	0.0	0.0	0.0	0.0	12.1	8.8	0.0	0.0	1.8	7.3	0.0	0.8	3.7	0.0	0.0	15.8	0.0	9.3	17.9	23.6	0.0	0.0	0.0	12.5	1.3	6.9	0.0	18.5	10.1	7.9	0.0	0.0	30.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.0	0.0	0.0	4.2	0.0	0.0	0.0	0.0	37.0	0.0	0.0	2.3	0.0	0.0	5.8	2.2	0.0	0.0	0.0	8.4	0.0	0.0	0.0	0.0	2.1	2.3	16.6	0.0	0.0
ROBO4	"ECSM4, FLJ20798, MRB"	ENSG00000154133	"Roundabout guidance receptor 4"	Q8WZ75	11	124883691-124898500	"Disease related genes, Human disease related genes, Plasma proteins, Predicted membrane proteins"	"Angiogenesis, Differentiation"	"Developmental protein, Receptor"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	7	"Adipocytes: 181.5;Endothelial cells: 119.7;Hepatic stellate cells: 148.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	10	"HUVEC TERT2: 247.6;TIME: 224.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA065212			Approved	"Plasma membrane"		NA	NA		380000000		"Cluster 82: Adipose tissue - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Plasma membrane"		"HPA065212: AB_2685434"	"unprognostic (2.86e-1)"	"unprognostic (9.35e-2)"	"unprognostic (2.67e-1)"	"unprognostic (1.07e-1)"	"unprognostic (3.82e-2)"	"unprognostic (6.97e-2)"	"prognostic favorable (4.85e-4)"	"unprognostic (7.94e-2)"	"unprognostic (2.27e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.73e-3)"	"unprognostic (2.17e-1)"	"unprognostic (1.17e-2)"	"prognostic unfavorable (8.73e-4)"	"unprognostic (1.55e-1)"	"unprognostic (4.63e-1)"	"unprognostic (5.15e-2)"	41.4	7.2	11.4	6.6	9.6	0.2	31.8	9.0	9.4	10.0	5.8	6.5	2.9	10.9	2.1	5.5	10.3	9.7	25.8	7.9	9.2	18.5	5.3	34.8	7.8	11.3	10.7	4.1	4.3	4.7	4.6	28.6	11.2	7.0	1.7	0.2	4.1	4.6	13.9	6.9	7.3	9.9	9.5	43.5	6.3	1.4	13.2	1.8	16.7	11.9	2.0	9.4	7.0	8.6	0.4	0.0	0.4	0.0	0.0	1.1	0.1	0.2	3.1	0.7	1.5	0.0	0.0	0.0	23.6	0.1	1.0	0.0	0.0	0.4	1.2	0.0	0.0	0.9	0.0	0.1	0.6	0.0	0.0	0.1	0.0	8.9	3.0	0.4	247.6	0.0	0.0	0.0	8.6	0.0	0.0	0.2	0.0	0.0	3.4	0.0	8.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	224.8	1.2	0.6	0.3	1.1	0.0	0.0	0.0	0.3	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.4	9.6	9.0	9.4	7.9	9.2	11.3	10.7	11.2	9.5	13.2	8.6	181.5	0.0	4.2	2.3	1.6	2.2	1.0	0.2	0.6	0.2	0.6	1.0	3.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.5	0.5	0.2	0.3	119.7	0.0	4.0	0.0	0.2	0.0	5.2	0.0	0.3	2.5	0.6	148.9	1.5	0.1	0.0	0.0	0.0	0.0	8.1	3.7	1.7	4.4	2.8	1.8	20.6	0.1	1.1	0.0	0.5	0.1	0.1	0.0	1.2	2.6	0.3	0.0	0.0	0.0	5.2	0.0	4.5	2.1	0.0	0.1	0.6	1.3	0.0	0.9	2.0	0.1	0.2
SH2D3C	NSP3	ENSG00000095370	"SH2 domain containing 3C"	Q8N5H7	9	127738317-127778710	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 52.6;dendritic cells: 29.7;Endothelial cells: 52.2;Hepatic stellate cells: 41.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HMC-1: 53.3;HUVEC TERT2: 60.0;REH: 60.7;RPMI-8226: 46.1;TIME: 50.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047586	Enhanced		Supported	Cytosol		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Cytosol		"HPA047586: AB_2680093"	"unprognostic (8.33e-2)"	"unprognostic (4.77e-3)"	"unprognostic (3.28e-2)"	"prognostic favorable (9.47e-4)"	"unprognostic (5.23e-2)"	"prognostic favorable (1.98e-4)"	"unprognostic (3.75e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.58e-3)"	"unprognostic (1.61e-1)"	"unprognostic (1.88e-3)"	"unprognostic (1.22e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.18e-1)"	"unprognostic (5.28e-2)"	27.3	7.6	11.2	15.9	10.5	11.2	24.9	11.7	13.2	12.2	2.8	7.6	4.5	15.8	1.2	5.8	12.6	9.2	44.7	10.7	9.6	19.9	4.7	52.2	25.8	8.6	7.5	5.0	4.8	3.9	7.1	15.8	8.4	8.5	1.8	0.8	6.8	3.5	14.6	7.4	15.1	7.3	8.1	47.2	7.3	5.1	8.9	27.8	22.9	11.4	10.5	10.9	9.4	8.0	0.1	0.2	0.9	0.2	0.8	0.2	0.1	0.0	0.0	0.0	0.1	0.0	0.0	19.5	1.1	0.0	1.1	0.7	0.0	0.0	0.0	15.6	0.3	7.3	0.1	0.0	0.3	5.6	53.3	0.3	0.2	0.3	0.1	0.0	60.0	11.6	0.2	20.6	0.0	0.1	5.1	16.8	0.8	0.0	0.0	60.7	0.9	46.1	0.0	0.0	14.5	4.4	0.3	0.1	0.0	1.4	0.1	9.6	50.1	0.0	1.2	0.1	0.1	20.3	22.2	20.3	0.4	4.8	0.0	34.0	29.9	37.8	32.3	94.7	26.4	26.2	18.8	30.4	32.8	29.5	16.6	17.5	82.2	34.6	124.8	59.8	21.6	34.2	11.2	10.5	11.7	13.2	10.7	9.6	8.6	7.5	8.4	8.1	8.9	8.0	52.6	3.2	5.8	0.7	15.9	1.3	0.3	1.9	0.6	3.2	1.1	1.7	10.5	2.8	0.9	0.0	0.0	0.3	29.7	0.0	0.0	0.5	13.8	2.2	2.8	52.2	4.2	3.6	10.8	0.0	0.2	3.1	2.0	0.8	11.4	0.0	41.7	0.7	6.0	3.3	10.7	0.3	0.0	6.0	3.7	16.3	1.2	10.7	1.8	23.4	13.4	3.6	21.6	3.0	0.7	0.1	0.0	0.7	7.6	0.1	0.0	0.1	0.8	2.4	6.6	1.2	12.5	1.8	1.5	0.9	0.4	0.7	15.5	2.0	0.1	0.2
SHE		ENSG00000169291	"Src homology 2 domain containing E"	Q5VZ18	1	154469772-154502412	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 56.9;Alveolar cells type 2: 23.4;Endothelial cells: 64.4;Hepatic stellate cells: 85.3;Kupffer cells: 26.7;Late spermatids: 23.0;Microglial cells: 26.2;Spermatocytes: 30.6"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 8.7"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	7	"HUVEC TERT2: 49.1;TIME: 13.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA037417	Approved		Approved	Nucleoplasm,Cytosol	"Secreted - unknown location"	NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Nucleoplasm	Cytosol	"HPA037417: AB_10672384"	"unprognostic (3.24e-1)"	"unprognostic (4.95e-2)"	"unprognostic (7.06e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.80e-1)"	"unprognostic (6.80e-3)"	"unprognostic (7.24e-2)"	"unprognostic (3.07e-3)"	"unprognostic (3.10e-2)"	"unprognostic (8.22e-2)"	"unprognostic (4.04e-2)"	"unprognostic (8.29e-2)"	"unprognostic (2.40e-2)"	"unprognostic (7.31e-2)"	"unprognostic (1.62e-1)"	"unprognostic (3.33e-3)"	"unprognostic (1.33e-2)"	23.4	9.8	9.4	3.3	8.8	1.2	20.9	7.7	10.6	13.2	7.4	7.4	3.4	12.1	4.3	5.0	12.5	6.9	22.7	8.3	8.3	10.5	5.8	20.6	3.9	8.4	9.1	7.6	3.0	4.9	3.7	16.5	8.8	8.1	4.2	0.6	5.4	4.2	7.1	6.4	8.9	8.0	8.1	21.4	5.5	22.2	10.2	2.6	22.1	11.3	2.3	9.7	9.9	8.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.1	4.6	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	49.1	0.0	0.1	0.1	0.0	0.0	0.0	0.7	0.5	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.0	0.1	0.0	0.5	0.0	1.0	13.6	0.0	0.3	1.4	0.0	0.1	0.2	0.1	0.0	1.0	0.0	0.5	0.3	0.2	1.5	1.5	1.1	0.9	0.6	0.6	0.1	0.9	0.8	0.9	2.4	1.7	1.1	4.0	0.0	0.5	9.4	8.8	7.7	10.6	8.3	8.3	8.4	9.1	8.8	8.1	10.2	8.0	56.9	0.0	23.4	3.9	0.3	3.3	0.4	0.3	1.2	0.1	0.4	1.3	4.4	1.5	1.3	1.8	0.0	0.0	0.2	0.0	0.0	0.1	13.0	0.4	0.3	64.4	0.0	2.7	0.3	0.0	0.0	6.7	0.0	0.5	3.8	2.1	85.3	3.4	1.4	0.0	0.3	0.0	0.0	26.7	6.6	23.0	1.5	2.0	0.0	26.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.4	3.7	0.7	0.0	0.1	0.0	0.4	0.0	3.3	2.2	30.6	13.0	0.3	1.6	0.1	0.7	0.3	0.0	0.3
SHROOM4	KIAA1202	ENSG00000158352	"Shroom family member 4"	Q9ULL8	X	50591642-50814302	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		"Actin-binding, Developmental protein"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 30.7"	"Group enriched"	"Detected in many"	5	"Oligodendrocyte precursor cells: 126.7;Oligodendrocytes: 463.4"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 7.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"EFO-21: 6.7;HUVEC TERT2: 26.7;RH-30: 5.0;RPTEC TERT1: 5.5;TIME: 10.0;WM-115: 5.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA010089, HPA010565"	Uncertain		Approved	"Nucleoplasm,Vesicles,Focal adhesion sites"		NA	NA				"Cluster 70: Brain - Nervous system development"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Focal adhesion sites"	"Nucleoplasm, Vesicles"	"HPA010089: , HPA010565: AB_1079961"	"unprognostic (2.55e-2)"	"unprognostic (1.43e-1)"	"unprognostic (5.56e-2)"	"prognostic unfavorable (8.37e-4)"	"unprognostic (1.34e-1)"	"unprognostic (1.60e-2)"	"unprognostic (4.30e-3)"	"unprognostic (4.55e-2)"	"unprognostic (2.13e-1)"	"unprognostic (2.93e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.14e-1)"	"prognostic unfavorable (4.66e-4)"	"unprognostic (7.30e-2)"	"unprognostic (2.83e-1)"	"unprognostic (1.74e-2)"	"unprognostic (2.75e-1)"	8.1	1.8	9.8	1.9	20.0	1.2	5.4	17.1	12.4	3.3	0.9	1.8	1.1	3.6	1.6	2.7	2.2	3.0	7.8	8.9	12.6	5.3	0.9	13.3	0.9	23.8	17.6	1.3	0.9	1.9	2.0	9.0	21.8	2.2	1.4	1.3	2.0	1.8	3.6	1.7	1.5	4.1	13.8	1.0	1.3	0.6	17.3	0.6	3.3	5.0	1.0	3.5	2.3	30.7	0.0	0.0	1.8	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	1.1	0.2	0.0	6.7	0.9	0.0	0.6	4.3	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.4	0.0	0.0	0.5	0.0	26.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	5.0	0.0	5.5	2.5	0.1	0.0	0.0	0.8	1.5	3.6	0.1	0.1	10.0	0.0	0.0	0.0	0.7	0.5	0.0	0.0	1.3	0.2	5.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.8	20.0	17.1	12.4	8.9	12.6	23.8	17.6	21.8	13.8	17.3	30.7	45.0	25.6	18.6	3.3	0.0	3.6	2.0	1.9	2.2	0.3	1.0	1.5	4.2	0.0	2.0	5.5	0.0	0.6	0.2	1.1	3.9	0.7	0.1	2.8	5.4	46.5	3.0	0.0	1.1	0.2	3.0	3.0	0.0	2.9	3.8	2.3	30.7	0.9	0.5	0.0	1.1	2.8	0.0	2.4	2.7	0.6	1.2	0.6	0.0	51.5	0.0	3.6	0.0	126.7	463.4	2.3	1.0	1.2	0.0	1.2	0.3	3.5	2.5	0.6	0.0	2.5	2.6	0.0	1.0	2.0	3.1	0.3	0.6	3.0	3.2	1.6
SMAD7	"MADH7, MADH8"	ENSG00000101665	"SMAD family member 7"	O15105	18	48919853-48952052	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 54.5;Distal enterocytes: 56.6;Hepatic stellate cells: 71.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"basophil: 4.1;eosinophil: 5.6"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 38.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB026212, HPA028897"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 24: Non-specific - Transcription regulation"	"Nucleoplasm, Cytosol"		"CAB026212: , HPA028897: AB_10600811"	"unprognostic (1.63e-1)"	"unprognostic (3.72e-2)"	"unprognostic (1.02e-1)"	"prognostic unfavorable (5.61e-4)"	"unprognostic (8.15e-2)"	"unprognostic (5.35e-1)"	"unprognostic (2.76e-1)"	"unprognostic (6.02e-2)"	"unprognostic (2.37e-1)"	"unprognostic (1.87e-2)"	"unprognostic (2.70e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.91e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.50e-2)"	"unprognostic (4.44e-1)"	17.9	5.9	7.1	8.6	7.3	17.8	14.5	12.0	7.3	17.4	9.6	12.7	10.3	11.2	2.9	4.8	8.2	10.2	46.1	5.4	5.1	11.6	8.6	21.9	5.8	10.9	8.7	7.5	5.3	12.3	6.6	18.9	8.5	11.3	11.9	3.2	6.3	8.6	10.7	8.3	15.0	9.3	10.0	5.9	12.5	1.3	7.9	3.7	16.6	6.7	5.2	13.3	12.2	8.4	3.7	2.8	2.8	8.3	14.3	5.0	21.1	18.6	7.1	6.5	3.1	1.0	5.3	0.3	32.2	13.1	6.0	19.2	6.1	5.8	3.6	38.4	9.4	0.3	10.5	6.9	2.1	6.9	18.6	5.1	4.8	7.8	7.8	32.2	1.1	0.6	6.6	25.9	9.1	1.2	0.0	1.9	17.3	27.7	1.1	2.1	2.5	9.0	9.1	4.2	4.8	10.3	8.0	3.5	6.6	21.2	3.3	5.6	17.3	18.5	9.9	5.3	16.5	13.4	7.1	2.0	8.1	4.9	3.1	4.1	0.1	5.6	0.8	0.5	0.6	0.1	0.8	0.7	0.1	0.0	0.2	0.5	0.0	1.7	0.1	0.0	1.2	0.2	7.1	7.3	12.0	7.3	5.4	5.1	10.9	8.7	8.5	10.0	7.9	8.4	30.4	54.5	9.4	3.9	7.0	12.9	3.5	7.2	14.2	6.1	14.7	10.3	9.7	1.5	11.2	11.0	6.2	9.9	43.7	56.6	9.8	14.4	0.2	43.2	30.5	25.0	12.7	0.0	6.5	13.9	3.3	15.5	8.2	45.9	18.9	4.0	71.4	3.1	8.9	0.0	5.0	19.1	2.0	23.3	8.9	1.1	1.5	14.7	0.0	19.7	8.2	1.4	11.3	5.5	16.3	31.5	17.3	3.4	13.8	3.0	28.7	7.1	3.3	2.5	6.6	11.3	14.1	0.1	0.6	14.2	11.8	12.9	25.2	1.3	12.4	2.6
SPARCL1	MAST9	ENSG00000152583	"SPARC like 1"	Q14515	4	87473335-87531061	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 4430.9;Endothelial cells: 2372.1;Peritubular cells: 2523.5;Sertoli cells: 4674.1;Skeletal myocytes: 2379.0;Smooth muscle cells: 2781.9"	"Cancer enhanced"	"Detected in all"		"glioma: 528.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"AF22: 24.9;SuSa: 31.4;U-266/70: 9.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB026225	Enhanced				"Secreted in other tissues"	NA	NA		630000000		"Cluster 57: Non-specific - Angiogenesis"	"Cluster 12: NES - Nervous system development"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"			"CAB026225: "	"unprognostic (1.02e-2)"	"unprognostic (2.81e-2)"	"prognostic unfavorable (4.06e-4)"	"unprognostic (1.19e-1)"	"unprognostic (1.79e-2)"	"unprognostic (4.93e-2)"	"unprognostic (1.63e-3)"	"unprognostic (1.73e-2)"	"unprognostic (3.88e-2)"	"unprognostic (6.04e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.17e-1)"	"unprognostic (2.45e-3)"	"unprognostic (1.76e-2)"	"unprognostic (5.72e-2)"	"unprognostic (2.88e-3)"	"prognostic unfavorable (3.33e-4)"	755.6	129.5	664.6	124.5	810.9	0.5	532.1	612.4	1058.4	732.7	580.4	624.3	125.1	1244.5	443.8	308.1	754.5	487.9	600.2	744.6	723.5	72.5	25.0	481.1	99.1	655.7	730.9	286.8	91.8	128.0	197.8	315.4	663.4	584.2	187.5	95.2	228.3	999.2	244.8	130.2	280.1	1191.2	774.7	157.9	347.7	97.5	694.8	103.2	369.9	594.7	100.0	488.0	466.4	681.2	0.7	0.0	24.9	0.3	0.2	0.1	2.6	0.1	0.1	0.0	0.0	0.0	0.1	0.4	1.8	0.0	0.0	1.4	2.4	0.0	0.0	1.7	0.0	0.3	1.1	0.4	1.1	0.3	1.2	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.4	3.3	0.0	0.5	0.2	3.5	0.6	0.0	0.0	0.3	0.4	1.2	0.0	0.1	0.8	1.6	0.1	0.2	0.1	31.4	0.4	0.5	0.0	0.2	0.3	1.5	0.2	9.1	1.4	0.6	3.4	0.5	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	664.6	810.9	612.4	1058.4	744.6	723.5	655.7	730.9	663.4	774.7	694.8	681.2	4430.9	12.8	56.4	1155.7	6.2	46.3	187.2	0.6	59.7	10.7	24.4	251.6	334.2	4.3	43.3	7.3	2.1	2.2	8.6	0.0	13.7	0.8	11.8	34.9	935.8	2372.1	0.0	32.0	382.3	0.4	3.2	1413.1	6.1	46.7	7.6	1.4	899.5	9.1	9.2	3.3	450.1	0.0	0.0	5.3	55.2	47.0	659.5	31.6	56.9	261.4	0.0	179.4	0.0	210.6	53.8	0.1	0.0	2523.5	25.2	50.4	0.0	24.6	7.4	34.4	4674.1	2379.0	2781.9	5.7	7.9	56.8	39.9	2.5	26.9	38.8	0.0	124.2
ST8SIA4	"PST, PST1, SIAT8D"	ENSG00000113532	"ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 4"	Q92187	5	100806933-100903282	"Metabolic proteins, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 14.0"	"Cell type enhanced"	"Detected in many"		"Inhibitory neurons: 73.3;Kupffer cells: 92.4;Langerhans cells: 149.3;Microglial cells: 101.2;monocytes: 97.5;Plasma cells: 73.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 91.7"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"AF22: 41.1;HDLM-2: 69.3;Karpas-707: 57.2;NB-4: 27.9;RPMI-8226: 44.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA051126, HPA053995"	Approved		Approved	"Golgi apparatus"	"Intracellular and membrane"	NA	NA		980000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 41: Macrophages - Immune response"	"Golgi apparatus"		"HPA051126: AB_2681352, HPA053995: AB_2682336"	"unprognostic (2.25e-1)"	"unprognostic (2.04e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.98e-2)"	"unprognostic (1.14e-1)"	"unprognostic (6.45e-3)"	"unprognostic (1.91e-1)"	"unprognostic (5.46e-2)"	"unprognostic (2.87e-1)"	"unprognostic (1.49e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.17e-1)"	"prognostic unfavorable (7.80e-7)"	"unprognostic (6.07e-2)"	"unprognostic (4.38e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.23e-2)"	5.8	1.9	2.2	14.0	2.4	7.6	2.2	1.6	2.4	1.9	2.5	3.3	3.2	1.6	0.5	1.1	1.8	5.0	2.3	1.8	4.5	0.7	2.6	5.7	12.3	4.8	3.6	0.5	0.8	1.0	0.6	11.1	5.2	1.3	4.2	0.6	1.2	0.8	0.8	0.8	4.5	2.8	2.7	11.8	3.0	0.4	4.3	9.5	2.0	1.7	10.3	5.5	1.1	4.5	0.0	6.1	41.1	0.0	2.6	3.9	1.0	0.0	0.0	0.0	0.3	0.0	0.0	3.3	0.1	0.0	1.0	0.1	1.0	0.1	0.1	69.3	0.0	2.5	0.4	0.0	0.0	13.0	5.0	3.2	0.0	0.1	0.1	5.3	7.7	10.1	0.0	57.2	2.4	0.6	18.6	27.9	0.3	0.0	0.3	10.3	0.7	44.8	0.2	0.0	0.9	0.0	0.0	0.0	0.1	0.2	0.0	11.6	2.7	0.4	0.2	0.0	0.6	18.6	20.3	3.9	1.0	15.8	5.1	58.0	18.5	22.9	13.1	21.7	9.9	11.1	8.7	11.1	12.2	9.9	5.4	10.1	91.7	10.6	24.0	3.7	17.4	12.2	2.2	2.4	1.6	2.4	1.8	4.5	4.8	3.6	5.2	2.7	4.3	4.5	35.8	6.4	14.1	1.6	49.7	8.3	0.4	2.1	2.2	0.6	0.9	0.9	2.3	1.5	10.1	0.0	0.0	9.4	44.0	0.0	1.9	0.2	0.2	0.9	1.6	28.4	0.0	8.2	6.8	0.0	42.4	5.0	1.1	0.3	24.1	0.1	7.1	0.1	22.6	0.0	73.3	0.2	4.1	92.4	149.3	0.7	0.0	57.5	14.2	101.2	97.5	3.2	34.0	4.5	1.6	0.0	0.0	0.4	73.8	0.2	0.0	0.3	16.6	0.9	13.1	1.2	3.7	0.5	0.8	0.4	5.5	19.2	37.7	0.7	0.0	0.5
STEAP4	"FLJ23153, SchLAH, STAMP2, TIARP, TNFAIP9"	ENSG00000127954	"STEAP4 metalloreductase"	Q687X5	7	88270892-88306894	"Enzymes, Predicted membrane proteins, Transporters"	"Electron transport, Ion transport, Iron transport, Transport"	Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adipose tissue: 113.7"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 402.5;Club cells: 152.8;Sertoli cells: 460.2;Smooth muscle cells: 255.3"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 45.9"	"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in some"	12	"neutrophil: 163.6"	"Lineage enriched"	"Detected in many"	12	"granulocytes: 163.6"	"Group enriched"	"Detected in some"	6	"HSkMC: 122.1;SiHa: 119.7;U-2197: 166.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA065201			Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 18: U-2197 - ECM organization"	"Cluster 48: Smooth muscle cells - ECM organization"	"Nucleoplasm, Plasma membrane"		"HPA065201: "	"unprognostic (3.76e-2)"	"unprognostic (2.16e-2)"	"unprognostic (8.82e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.62e-1)"	"unprognostic (9.96e-2)"	"prognostic favorable (2.97e-4)"	"unprognostic (7.40e-2)"	"unprognostic (3.12e-1)"	"unprognostic (4.66e-2)"	"unprognostic (4.21e-1)"	"unprognostic (2.98e-1)"	"unprognostic (7.51e-3)"	"prognostic unfavorable (5.77e-4)"	"unprognostic (1.72e-1)"	"unprognostic (2.00e-1)"	"unprognostic (4.53e-2)"	113.7	46.3	1.0	31.7	0.9	7.1	68.6	2.8	1.5	21.3	17.0	13.3	3.8	17.9	7.8	15.4	36.1	22.7	24.1	1.4	1.0	11.8	24.3	67.5	7.2	1.2	0.9	4.4	10.6	16.0	13.0	15.3	0.8	60.0	9.2	1.9	26.8	10.6	13.4	19.3	10.6	29.3	0.4	5.4	10.6	13.4	1.1	7.8	53.1	16.6	5.1	34.3	22.7	1.1	4.9	0.0	0.1	0.1	0.1	1.9	0.3	0.0	0.3	0.0	0.1	0.1	23.6	0.1	0.1	0.0	0.4	18.7	0.1	0.0	0.1	0.0	0.1	0.1	7.9	0.1	0.1	0.1	0.2	122.1	0.1	0.4	0.9	0.0	0.0	0.1	0.3	0.4	0.0	3.0	0.1	0.5	0.1	1.0	0.0	0.2	0.1	0.3	0.0	0.3	0.2	0.2	119.7	9.9	0.0	0.1	0.8	0.0	0.1	0.4	0.3	166.4	0.1	0.1	0.1	0.1	0.2	0.9	0.2	0.4	13.5	1.4	0.0	0.8	0.0	0.0	0.0	0.0	1.0	0.1	0.0	0.0	163.6	0.2	0.1	0.3	0.0	3.2	1.0	0.9	2.8	1.5	1.4	1.0	1.2	0.9	0.8	0.4	1.1	1.1	77.2	54.5	402.5	0.0	0.8	9.4	5.8	8.6	1.8	1.8	21.6	8.3	9.1	0.0	152.8	0.0	2.1	0.4	1.1	0.4	0.0	14.6	23.8	14.6	20.5	14.7	0.0	0.0	0.5	9.6	10.6	39.8	1.1	51.2	16.4	0.0	15.4	0.7	2.8	0.0	0.8	0.2	16.2	7.2	7.4	10.9	114.9	12.2	5.4	6.5	19.0	2.7	0.0	1.0	0.1	18.6	0.0	9.1	0.2	49.3	0.1	0.1	72.8	0.3	460.2	9.6	255.3	0.9	0.3	1.5	18.8	10.9	3.1	57.7	0.2	16.6
STK10	"LOK, PRO2729"	ENSG00000072786	"Serine/threonine kinase 10"	O94804	5	172042079-172188224	"Disease related genes, Enzymes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Cell cycle"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 76.5;lymphoid tissue: 45.2"	"Cell type enhanced"	"Detected in all"		"dendritic cells: 107.7;Kupffer cells: 91.4;NK-cells: 171.0;T-cells: 81.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"WM-115: 143.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015083, CAB020840"	Enhanced		Approved	"Nucleoplasm,Plasma membrane"		NA	NA		16000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 63: NK-cells & T-cells - Immune response"	"Nucleoplasm, Plasma membrane"		"CAB020840: , HPA015083: AB_2669151"	"unprognostic (1.17e-1)"	"unprognostic (5.43e-2)"	"prognostic favorable (2.76e-4)"	"unprognostic (2.88e-1)"	"unprognostic (6.96e-3)"	"unprognostic (1.02e-1)"	"unprognostic (5.25e-3)"	"unprognostic (3.07e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.65e-1)"	"unprognostic (3.43e-1)"	"prognostic unfavorable (1.63e-4)"	"unprognostic (1.09e-1)"	"unprognostic (1.01e-2)"	"unprognostic (3.10e-1)"	"unprognostic (1.84e-1)"	14.9	5.7	3.1	37.1	3.6	76.5	11.4	18.4	5.6	4.5	3.5	8.5	8.4	4.9	1.7	5.6	4.7	13.2	7.6	3.1	4.0	5.9	6.2	18.4	44.1	6.2	4.4	2.5	7.2	3.1	4.1	17.2	5.8	4.4	6.9	1.2	4.7	3.5	5.0	14.2	16.0	7.8	5.4	45.2	11.1	14.0	6.4	20.6	5.3	5.5	25.0	14.9	5.2	7.0	22.2	20.2	12.7	18.8	14.7	18.1	31.5	28.4	24.0	20.2	18.9	10.6	28.6	26.8	14.6	35.6	42.3	25.4	5.7	35.1	13.5	35.0	9.3	32.1	8.2	6.1	20.2	32.7	36.4	17.4	7.5	27.4	23.1	7.5	18.3	10.4	3.0	36.2	14.7	35.7	23.5	73.4	5.0	11.3	16.1	38.2	9.9	17.7	8.2	27.6	8.3	10.2	16.4	22.5	77.9	15.6	8.2	68.7	24.8	22.3	11.3	15.8	15.5	30.2	48.4	17.1	29.4	49.8	143.3	16.7	26.5	23.4	36.5	46.3	26.9	10.0	19.3	26.3	22.5	8.1	11.0	20.0	48.9	16.9	71.8	7.1	26.7	44.0	3.1	3.6	18.4	5.6	3.1	4.0	6.2	4.4	5.8	5.4	6.4	7.0	35.8	3.2	11.2	1.6	40.5	6.6	8.4	7.2	5.7	4.3	3.3	3.7	3.8	5.7	6.1	1.8	6.2	4.1	107.7	11.8	1.9	4.5	2.5	3.5	4.6	23.9	12.0	11.8	8.5	6.2	27.2	9.3	20.9	7.1	28.4	3.6	18.2	2.3	36.3	47.1	7.9	19.9	2.0	91.4	43.8	3.2	2.8	61.3	8.8	32.8	49.8	2.1	171.0	10.1	14.4	10.7	11.8	1.5	42.8	11.7	6.5	2.0	6.1	2.2	13.1	5.1	10.2	5.3	7.8	2.6	4.1	5.1	81.4	11.4	5.3	10.7
TAOK2	"KIAA0881, MAP3K17, PSK, PSK1, TAO1, TAO2"	ENSG00000149930	"TAO kinase 2"	Q9UL54	16	29973868-29992261	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Adipocytes: 52.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA010650	Approved		Approved	Nucleoplasm,Nucleoli,Cytosol		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 72: Non-specific - Transcription"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Nucleoplasm, Cytosol"	Nucleoli	"HPA010650: AB_1080204"	"unprognostic (7.30e-2)"	"unprognostic (1.78e-1)"	"prognostic unfavorable (2.51e-4)"	"prognostic favorable (3.87e-5)"	"unprognostic (8.46e-2)"	"unprognostic (2.14e-3)"	"unprognostic (6.08e-2)"	"unprognostic (1.12e-3)"	"unprognostic (1.01e-2)"	"unprognostic (1.60e-1)"	"prognostic favorable (4.78e-4)"	"unprognostic (3.85e-3)"	"prognostic favorable (3.66e-4)"	"unprognostic (7.42e-3)"	"unprognostic (3.17e-1)"	"unprognostic (7.47e-2)"	"unprognostic (1.37e-1)"	31.4	36.0	23.4	14.7	21.2	12.7	30.8	18.0	26.1	24.8	11.9	21.8	17.3	25.9	11.1	20.8	22.6	12.0	32.6	23.0	18.9	22.7	17.6	34.0	14.4	21.0	20.0	24.1	19.5	17.4	29.4	19.4	18.9	22.5	8.5	14.3	20.5	13.3	23.4	22.4	24.4	13.3	15.3	33.8	21.8	34.8	20.8	13.2	25.4	12.7	10.5	22.4	21.6	19.0	22.2	41.8	22.4	35.1	25.8	17.1	34.2	40.0	21.1	26.4	24.4	33.6	28.7	23.8	32.8	28.8	18.0	33.9	20.4	20.0	14.1	37.5	43.3	25.8	46.2	34.8	18.7	25.5	47.5	20.0	17.1	28.1	11.2	18.5	44.7	22.4	23.5	23.6	25.8	41.0	29.8	36.0	21.5	16.4	27.6	54.2	32.5	22.2	16.6	20.5	26.1	20.8	22.8	30.2	12.1	14.4	37.5	28.5	62.9	45.0	20.7	32.4	23.6	34.2	23.7	22.1	27.6	28.8	33.7	0.3	0.7	0.4	0.7	0.7	0.8	0.5	0.7	0.6	0.4	0.6	0.4	0.3	1.2	0.5	0.4	0.8	0.9	0.6	23.4	21.2	18.0	26.1	23.0	18.9	21.0	20.0	18.9	15.3	20.8	19.0	52.0	9.6	11.5	21.9	6.3	10.7	4.6	7.5	7.4	14.6	10.5	5.7	9.8	7.2	9.1	9.2	39.6	7.8	7.6	27.0	1.9	8.5	3.9	8.7	9.5	35.3	13.1	3.4	7.9	12.0	6.2	9.7	14.3	8.9	3.8	16.0	47.2	11.8	9.8	10.1	10.7	16.8	12.2	11.2	11.1	4.4	12.5	8.2	7.2	7.5	9.0	8.4	11.3	9.0	12.7	16.1	14.8	12.8	5.9	7.4	27.2	8.0	10.0	21.4	6.6	8.7	8.7	19.7	21.6	9.1	9.7	12.0	9.2	16.0	14.7	7.4
TCF4	"bHLHb19, E2-2, ITF2, SEF2-1B"	ENSG00000196628	"Transcription factor 4"	P15884	18	55222185-55664787	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis, Transcription, Transcription regulation"	"Activator, DNA-binding"	"Corneal dystrophy, Disease variant, Epilepsy, Mental retardation, Primary microcephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 65.1"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 820.0;Endothelial cells: 574.5;Inhibitory neurons: 1177.6;Oligodendrocyte precursor cells: 719.8;Oligodendrocytes: 573.6"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in many"		"cerebellum: 65.1"	"Group enriched"	"Detected in many"	14	"memory B-cell: 173.6;naive B-cell: 146.8;plasmacytoid DC: 559.8"	"Group enriched"	"Detected in many"	33	"B-cells: 173.6;dendritic cells: 559.8"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 140.4;SH-SY5Y: 157.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB020722, HPA025958"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 21: Non-specific - Transcription"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Nucleoplasm, Cytosol"		"CAB020722: , HPA025958: AB_1857849"	"unprognostic (2.11e-1)"	"unprognostic (9.10e-2)"	"unprognostic (8.69e-2)"	"unprognostic (7.89e-3)"	"unprognostic (1.42e-1)"	"unprognostic (1.36e-3)"	"unprognostic (3.03e-2)"	"unprognostic (8.64e-2)"	"unprognostic (1.79e-2)"	"unprognostic (3.29e-2)"	"unprognostic (2.77e-1)"	"unprognostic (8.44e-2)"	"prognostic unfavorable (7.24e-5)"	"unprognostic (1.99e-3)"	"unprognostic (2.68e-2)"	"unprognostic (2.76e-3)"	"prognostic unfavorable (9.95e-4)"	20.3	9.6	3.7	12.8	12.5	9.5	11.6	65.1	26.5	28.5	0.0	7.4	5.1	23.0	2.1	9.7	13.4	17.4	17.5	29.8	0.0	4.4	4.4	15.5	14.7	5.5	1.0	25.9	5.8	8.0	6.5	28.9	3.9	6.6	7.9	14.0	6.8	10.2	6.1	6.4	5.0	24.1	2.2	13.1	6.0	15.4	2.4	9.8	13.3	16.7	14.7	13.1	7.3	14.4	0.1	4.1	36.8	11.4	8.5	14.4	0.1	18.4	40.6	13.2	17.2	23.1	3.6	28.8	0.1	41.9	2.7	4.5	17.9	17.1	9.2	140.4	13.9	12.1	0.1	0.0	4.0	5.3	2.8	19.6	5.3	18.5	0.7	9.1	45.8	1.6	19.5	22.0	11.0	0.0	7.6	0.0	10.4	0.1	2.4	41.6	14.9	65.4	0.0	0.9	12.6	157.7	0.0	1.5	0.0	11.1	1.6	1.3	49.1	48.5	17.4	2.1	14.6	16.3	32.2	25.7	11.0	5.2	15.5	0.9	7.4	0.8	0.9	8.3	0.7	173.6	0.2	0.5	20.6	146.8	0.5	0.3	1.8	11.2	7.4	559.8	0.7	11.3	3.7	12.5	65.1	26.5	29.8	0.0	5.5	1.0	3.9	2.2	2.4	14.4	820.0	6.4	13.1	501.1	217.4	117.0	37.8	34.0	80.8	293.0	6.5	23.4	35.5	4.3	32.6	22.0	83.4	1.8	446.8	0.1	0.0	1.5	103.2	17.5	201.4	574.5	5.4	34.2	503.8	7.1	1.5	296.7	1.5	12.2	13.9	105.7	316.3	6.6	39.6	25.2	1177.6	0.3	26.4	112.4	129.2	116.3	205.3	80.4	64.0	474.1	32.7	372.8	13.4	719.8	573.6	2.1	0.1	182.1	131.7	20.8	0.0	2.3	25.9	54.7	236.7	304.5	221.0	8.7	14.5	47.5	84.4	2.6	15.1	164.8	0.2	17.8
TDRD10	DKFZp434M202	ENSG00000163239	"Tudor domain containing 10"	Q5VZ19	1	154502219-154548147	"Cancer-related genes, Predicted intracellular proteins"		RNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"testis: 55.6"	"Group enriched"	"Detected in some"	5	"Early spermatids: 61.8;Late spermatids: 89.0;Spermatocytes: 103.7"	"Cancer enhanced"	"Detected in many"		"testis cancer: 5.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HUVEC TERT2: 3.0;TIME: 1.4"					"Not detected"	"Not detected"			HPA054327			Approved	Vesicles		NA	NA				"Cluster 71: Testis - DNA repair"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 66: Spermatocytes - Spermatogenesis"	Vesicles		"HPA054327: AB_2682452"	"unprognostic (1.30e-1)"	"unprognostic (6.33e-2)"	"unprognostic (1.78e-1)"	"unprognostic (5.33e-3)"	"unprognostic (9.69e-3)"	"unprognostic (5.80e-3)"	"unprognostic (2.99e-1)"	"unprognostic (5.97e-3)"	"unprognostic (2.44e-2)"	"unprognostic (2.06e-1)"	"unprognostic (1.00e-3)"	"unprognostic (1.61e-1)"	"unprognostic (1.34e-3)"	"unprognostic (1.15e-2)"	"unprognostic (1.13e-1)"	"prognostic favorable (8.04e-5)"	"unprognostic (1.62e-1)"	11.1	4.5	3.7	0.5	3.7	0.1	6.8	3.1	3.7	5.1	3.3	2.8	0.7	4.2	2.3	2.4	6.5	1.6	7.6	3.3	3.2	3.5	4.5	8.1	0.8	3.2	3.5	10.1	0.9	0.9	2.6	1.7	3.3	3.9	1.3	0.1	1.8	1.2	1.9	2.3	3.5	1.8	3.2	8.9	1.9	55.6	3.7	0.5	11.0	1.4	0.4	3.9	3.6	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	3.7	3.1	3.7	3.3	3.2	3.2	3.5	3.3	3.2	3.7	3.1	10.0	3.2	6.7	4.9	0.1	0.6	0.0	0.0	0.0	0.0	0.1	0.5	1.3	1.5	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	61.8	0.0	0.1	8.2	0.0	0.0	0.3	0.0	0.0	2.1	0.0	0.0	1.3	0.7	6.1	0.4	0.4	0.0	0.5	0.0	0.0	4.0	2.1	89.0	2.5	1.0	0.0	6.5	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.7	0.4	103.7	16.5	0.1	0.3	0.0	0.0	0.1	0.0	0.0
TEK	"CD202b, TIE-2, TIE2, VMCM, VMCM1"	ENSG00000120156	"TEK receptor tyrosine kinase"	Q02763	9	27109141-27230174	"Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins"	Angiogenesis	"Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease variant, FDA approved drug targets, Glaucoma"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 46.3"	"Group enriched"	"Detected in many"	10	"Adipocytes: 70.8;Endothelial cells: 73.9;Hepatic stellate cells: 122.0;Microglial cells: 38.4;Oligodendrocyte precursor cells: 137.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"HUVEC TERT2: 90.9;NTERA-2: 45.2;TIME: 99.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010359, HPA073265"	Approved		Supported	"Plasma membrane,Centriolar satellite"	"Secreted to blood"	NA	NA	7750000	13000000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Plasma membrane"	"Centriolar satellite"	"CAB010359: AB_2203226, HPA073265: AB_2686592"	"unprognostic (2.24e-1)"	"unprognostic (1.74e-1)"	"unprognostic (5.55e-2)"	"unprognostic (1.83e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.26e-3)"	"prognostic favorable (2.31e-5)"	"unprognostic (7.48e-2)"	"unprognostic (1.72e-2)"	"unprognostic (1.41e-1)"	"unprognostic (5.58e-2)"	"unprognostic (2.72e-1)"	"prognostic favorable (7.81e-4)"	"unprognostic (7.50e-3)"	"unprognostic (6.87e-3)"	"unprognostic (1.83e-1)"	"unprognostic (5.24e-3)"	20.1	9.1	8.1	5.8	7.0	0.2	14.0	6.1	8.4	9.3	4.3	5.0	3.7	12.4	2.3	5.3	6.7	11.2	16.8	7.1	6.8	23.0	10.5	28.8	3.7	7.2	6.6	3.5	3.5	4.4	3.0	46.3	7.6	3.8	5.4	0.7	3.1	6.2	10.5	2.8	5.5	12.7	6.8	28.8	4.0	1.4	9.4	1.8	9.1	22.9	2.8	6.9	3.9	6.8	0.3	0.0	3.5	0.0	0.4	5.6	0.1	3.2	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.0	2.4	0.0	1.6	0.0	0.0	1.8	0.0	2.2	0.8	0.1	90.9	0.0	0.0	0.0	0.7	0.0	0.0	0.0	45.2	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	18.3	0.0	0.0	99.1	0.0	0.5	9.1	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	8.1	7.0	6.1	8.4	7.1	6.8	7.2	6.6	7.6	6.8	9.4	6.8	70.8	3.2	1.3	1.3	0.4	1.5	0.0	0.0	0.0	0.0	0.3	0.5	8.6	0.0	0.6	1.8	0.0	0.4	0.4	0.0	0.0	0.0	0.6	0.6	0.8	73.9	0.0	2.7	4.3	0.0	2.8	4.2	0.0	0.7	0.0	0.3	122.0	1.3	0.3	0.0	5.0	0.0	0.0	6.7	2.2	0.9	0.6	0.4	0.0	38.4	0.0	0.1	0.0	137.7	2.1	1.3	0.0	0.4	0.0	0.2	0.0	0.1	0.0	0.2	0.0	1.6	1.9	0.1	0.4	0.3	1.3	1.4	0.5	1.8	0.0	0.0
THBD	CD141	ENSG00000178726	Thrombomodulin	P07204	20	23045633-23049672	"Candidate cardiovascular disease genes, CD markers, Disease related genes, Human disease related genes, Predicted membrane proteins"	"Blood coagulation, Hemostasis"	Receptor	"Disease variant, Hemolytic uremic syndrome, Thrombophilia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 254.3;Endothelial cells: 200.6;Langerhans cells: 138.1;Leydig cells: 130.8;Macrophages: 130.9;Peritubular cells: 259.2;Squamous epithelial cells: 237.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 24.6"	"Group enriched"	"Detected in many"	7	"dendritic cells: 10.8;granulocytes: 24.6;monocytes: 9.0"	"Cell line enhanced"	"Detected in many"		"ASC diff: 24.3;CAPAN-2: 39.2;EFO-21: 33.5;HaCaT: 33.1;hTCEpi: 42.6;OE19: 29.8;THP-1: 24.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002425, HPA002982"	Supported		Approved	Nucleoplasm,Cytosol		NA	NA	5550000	1300000	"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 31: Skin - Epidermis development"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 41: Macrophages - Immune response"	"Nucleoplasm, Cytosol"		"CAB002425: AB_563497, HPA002982: AB_1078444"	"unprognostic (1.96e-1)"	"unprognostic (2.93e-3)"	"unprognostic (8.70e-2)"	"unprognostic (3.00e-2)"	"unprognostic (3.07e-2)"	"unprognostic (1.88e-1)"	"unprognostic (7.81e-3)"	"unprognostic (4.70e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.52e-2)"	"unprognostic (2.30e-1)"	"unprognostic (5.33e-2)"	"unprognostic (2.23e-2)"	"unprognostic (7.35e-3)"	"unprognostic (3.01e-2)"	"unprognostic (7.58e-3)"	"unprognostic (9.71e-2)"	65.4	11.4	2.0	19.6	1.8	15.5	25.5	1.6	3.2	16.7	3.4	16.5	5.5	12.6	3.1	36.8	27.5	26.5	31.0	2.4	3.0	19.7	9.7	56.7	14.5	4.1	2.7	6.9	13.2	9.9	20.4	28.5	2.8	8.0	5.9	0.2	10.8	4.6	40.7	71.4	20.0	15.6	3.0	43.6	30.8	7.6	8.5	5.1	35.5	17.5	8.0	20.8	21.0	2.4	11.5	9.9	0.3	0.0	24.3	1.4	0.2	0.2	0.0	0.0	0.0	0.0	39.2	0.0	33.5	3.4	1.7	33.1	0.0	1.8	0.0	0.0	0.1	0.1	1.0	0.0	4.7	0.0	0.2	1.1	42.6	0.7	2.8	23.0	11.0	0.0	4.2	0.0	0.9	0.8	0.0	4.2	0.1	29.8	1.6	0.0	0.0	4.9	0.2	16.2	0.7	0.0	9.4	1.2	17.4	2.9	0.0	24.8	21.7	0.1	0.6	3.2	0.0	0.0	0.0	0.0	2.0	5.8	0.8	0.0	4.1	0.0	0.0	9.0	0.0	0.0	0.0	0.0	10.1	0.0	0.0	0.0	24.6	2.0	8.7	10.8	0.0	2.0	2.0	1.8	1.6	3.2	2.4	3.0	4.1	2.7	2.8	3.0	8.5	2.4	254.3	22.4	21.4	0.0	2.0	34.3	10.4	9.5	23.3	0.1	3.9	5.3	16.8	1.5	21.3	0.0	0.0	3.2	16.9	0.0	0.0	1.8	0.9	1.9	1.8	200.6	0.0	2.7	0.3	0.2	37.1	46.1	2.6	7.2	7.6	0.2	65.3	0.8	14.9	0.0	0.7	0.4	4.1	32.4	138.1	4.9	130.8	130.9	16.0	1.0	8.1	0.0	0.0	0.0	0.0	9.0	0.0	259.2	2.3	4.5	0.0	0.3	2.5	0.0	6.6	51.4	39.0	0.2	1.0	237.3	98.6	42.4	3.2	2.8	0.1	58.2
THSD7A	KIAA0960	ENSG00000005108	"Thrombospondin type 1 domain containing 7A"	Q9UPZ6	7	11370365-11832198	"Disease related genes, Predicted membrane proteins, Predicted secreted proteins"	"Angiogenesis, Differentiation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 7.5"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 150.5;Bipolar cells: 183.8;Horizontal cells: 208.6;Inhibitory neurons: 494.3;Oligodendrocyte precursor cells: 262.4"	"Cancer enhanced"	"Detected in many"		"renal cancer: 3.5"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	54	"basophil: 5.3"	"Lineage enriched"	"Detected in single"	54	"granulocytes: 5.3"	"Cell line enhanced"	"Detected in some"		"A549: 10.3;HUVEC TERT2: 6.7;REH: 7.1;SH-SY5Y: 10.2;THP-1: 19.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000923	Supported				"Secreted to blood"	NA	NA		6100000	"Cluster 38: Basophils - Unknown function"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA000923: AB_1080271"	"unprognostic (3.01e-1)"	"unprognostic (7.90e-2)"	"unprognostic (3.09e-2)"	"unprognostic (1.96e-1)"	"unprognostic (5.88e-1)"	"unprognostic (3.33e-2)"	"unprognostic (1.44e-1)"	"unprognostic (9.66e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.42e-2)"	"unprognostic (2.07e-1)"	"unprognostic (8.75e-2)"	"prognostic favorable (2.24e-6)"	"unprognostic (2.13e-3)"	"unprognostic (1.66e-1)"	"unprognostic (2.28e-2)"	"unprognostic (3.33e-2)"	2.4	0.7	2.9	0.7	2.3	0.0	2.1	3.2	4.4	3.3	0.0	1.0	0.3	2.8	0.8	0.5	2.1	2.6	0.7	4.2	3.5	7.5	0.6	1.1	0.3	2.8	4.9	2.5	0.4	1.2	1.6	4.1	2.5	3.4	0.7	5.0	0.5	2.1	0.2	0.5	0.5	2.4	3.4	0.9	0.5	0.8	4.8	0.2	1.9	1.2	0.2	1.8	1.7	2.4	0.0	10.3	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.6	0.0	0.0	0.0	1.8	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	1.6	6.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	7.1	0.0	0.0	0.3	0.1	0.7	10.2	0.0	0.3	0.0	1.6	0.1	19.2	3.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.1	5.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	2.3	3.2	4.4	4.2	3.5	2.8	4.9	2.5	3.4	4.8	2.4	46.9	22.4	8.2	150.5	0.0	2.7	1.4	0.0	1.2	183.8	0.8	0.5	1.5	21.5	2.8	55.2	112.6	23.5	0.1	0.4	7.9	7.0	1.2	4.9	22.4	42.6	41.7	0.0	56.6	2.2	4.3	8.1	0.5	18.8	0.0	6.1	28.2	1.3	2.2	208.6	494.3	0.8	0.0	1.5	2.9	0.5	24.2	0.5	12.4	105.9	0.0	20.7	0.0	262.4	5.4	5.5	6.8	1.5	0.1	7.7	0.1	8.8	0.1	9.3	0.0	10.6	5.0	1.6	1.1	0.6	2.4	51.9	0.8	21.5	1.2	1.1
TINAGL1	"ARG1, LCN7, LIECG3, P3ECSL, TINAGRP"	ENSG00000142910	"Tubulointerstitial nephritis antigen like 1"	Q9GZM7	1	31576485-31587686	"Enzymes, Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 1235.1;Sertoli cells: 427.3;Syncytiotrophoblasts: 1946.1"	"Cancer enhanced"	"Detected in all"		"urothelial cancer: 87.8"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"basophil: 2.0"	"Lineage enriched"	"Detected in single"	4	"granulocytes: 2.0"	"Cell line enhanced"	"Detected in many"		"BEWO: 322.7;CAPAN-2: 178.9;EFO-21: 403.6;HaCaT: 181.4;HBEC3-KT: 211.9;HUVEC TERT2: 173.4;TIME: 376.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048695	Approved				"Secreted to extracellular matrix"	NA	NA		370000	"Cluster 17: Basophils - Unknown function"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 47: Cytotrophoblasts - Unknown function"			"HPA048695: AB_2680497"	"unprognostic (1.27e-1)"	"unprognostic (2.94e-2)"	"unprognostic (7.53e-2)"	"unprognostic (1.80e-3)"	"unprognostic (2.74e-1)"	"unprognostic (1.72e-3)"	"unprognostic (8.29e-3)"	"unprognostic (6.02e-3)"	"unprognostic (4.18e-1)"	"unprognostic (6.96e-2)"	"unprognostic (7.02e-3)"	"unprognostic (1.22e-1)"	"prognostic favorable (3.65e-6)"	"unprognostic (7.42e-2)"	"unprognostic (6.64e-2)"	"prognostic favorable (9.64e-4)"	"unprognostic (3.43e-2)"	173.7	40.8	19.0	18.5	17.7	0.9	150.5	17.9	19.9	86.8	16.4	83.2	26.7	101.8	10.7	31.0	82.4	23.9	230.7	15.2	17.9	177.7	22.7	85.7	8.5	19.6	18.3	38.8	31.0	13.2	25.3	183.6	19.8	71.2	16.5	1.0	63.8	40.6	46.6	37.0	51.6	36.5	16.4	119.6	66.4	6.2	21.2	3.8	115.1	30.6	5.3	88.4	70.2	17.1	96.6	0.2	0.0	0.5	0.8	0.2	322.7	14.9	1.9	0.7	0.4	44.5	178.9	0.2	403.6	13.4	7.0	181.4	0.2	211.9	0.1	0.7	0.1	0.1	7.3	11.5	4.5	0.1	0.5	0.2	37.9	0.0	7.6	0.1	173.4	0.1	2.4	0.4	0.0	0.0	0.7	0.6	0.9	52.6	6.1	0.4	0.1	0.4	57.0	72.6	0.4	0.5	38.0	125.6	4.2	18.8	7.5	0.3	376.6	0.3	91.6	0.7	2.8	0.4	0.5	1.6	0.2	0.2	3.3	2.0	0.1	0.1	0.2	0.0	0.1	0.1	0.1	0.1	0.0	0.3	0.2	0.2	0.8	0.4	0.1	0.1	0.1	0.0	19.0	17.7	17.9	19.9	15.2	17.9	19.6	18.3	19.8	16.4	21.2	17.1	345.4	9.6	5.8	0.7	2.7	11.0	121.5	244.1	8.0	0.0	32.0	73.0	46.7	37.1	28.6	132.4	0.0	1235.1	2.6	158.9	1.9	378.7	1.4	8.4	3.2	161.4	11.4	13.5	0.1	92.2	223.5	35.0	50.0	14.4	14.7	49.7	306.6	4.4	89.3	0.0	1.1	35.5	14.2	8.8	10.3	0.7	7.5	4.2	23.2	13.1	2.0	0.2	0.0	0.5	0.0	344.6	115.3	4.1	0.2	131.4	45.2	80.9	9.1	0.4	427.3	9.5	357.4	0.3	0.8	4.9	6.5	1946.1	3.8	2.7	59.7	219.4
TJP1	"DKFZp686M05161, MGC133289, ZO-1"	ENSG00000104067	"Tight junction protein 1"	Q07157	15	29699367-29968915	"Predicted intracellular proteins, Transporters"		Calmodulin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Oligodendrocytes: 893.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001636, HPA001637, CAB010822"	Enhanced		Enhanced	"Cell Junctions"		NA	NA				"Cluster 57: Non-specific - Angiogenesis"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 44: Endometrium - Transcription"	"Cell Junctions"		"CAB010822: , HPA001636: AB_1080762, HPA001637: AB_1080760"	"unprognostic (2.11e-2)"	"unprognostic (6.83e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.81e-2)"	"unprognostic (9.43e-2)"	"unprognostic (1.21e-1)"	"unprognostic (4.54e-2)"	"unprognostic (6.71e-3)"	"unprognostic (1.98e-1)"	"unprognostic (2.86e-1)"	"unprognostic (2.86e-3)"	"unprognostic (3.54e-1)"	"prognostic favorable (1.72e-4)"	"unprognostic (2.85e-3)"	"unprognostic (3.02e-1)"	"unprognostic (5.04e-2)"	"unprognostic (1.20e-1)"	37.4	16.5	22.1	4.4	35.3	1.1	30.8	21.4	24.4	33.2	17.9	30.5	7.1	42.3	16.5	60.4	27.8	12.6	37.1	22.0	22.2	24.3	18.6	34.0	5.7	26.6	28.6	22.3	30.0	13.4	16.8	31.6	25.2	20.4	9.5	10.0	29.6	10.9	22.0	27.8	19.8	17.4	20.6	13.5	25.8	29.7	30.3	3.7	24.8	5.0	10.2	23.8	35.3	42.6	62.4	36.8	29.1	18.4	17.0	31.7	28.9	18.6	21.1	18.0	20.2	59.2	22.9	0.3	24.8	24.6	21.3	47.4	20.1	23.8	19.0	0.5	14.9	0.3	22.3	24.7	57.9	0.1	0.8	16.5	15.8	21.4	39.2	23.0	38.2	0.1	24.3	12.5	14.2	32.2	0.2	0.7	21.9	23.4	14.6	0.1	35.0	0.2	28.1	33.4	12.9	16.8	39.2	12.8	16.8	42.9	13.3	0.6	54.7	14.3	23.9	12.5	25.6	4.4	4.6	0.4	17.8	0.3	9.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.1	35.3	21.4	24.4	22.0	22.2	26.6	28.6	25.2	20.6	30.3	42.6	212.1	169.9	49.2	299.7	1.6	35.8	115.2	36.4	39.3	42.4	53.7	28.6	107.2	51.5	48.6	58.8	10.4	32.3	0.8	87.7	25.4	116.0	19.1	132.2	97.0	166.0	46.0	2.7	293.8	83.7	11.3	56.6	86.6	290.7	5.7	87.7	100.3	49.1	3.8	126.2	187.3	45.4	32.6	6.1	12.1	13.7	33.8	5.2	64.0	266.1	1.6	32.8	0.0	345.3	893.8	178.3	82.0	63.9	5.9	151.4	37.8	26.0	39.2	52.4	78.9	64.1	118.7	63.0	83.9	139.2	60.1	33.7	4.1	120.8	33.1	194.6
TLL1		ENSG00000038295	"Tolloid like 1"	O43897	4	165873237-166104457	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	Differentiation	"Developmental protein, Hydrolase, Metalloprotease, Protease"	"Atrial septal defect, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 20.0;placenta: 6.4"	"Cell type enriched"	"Detected in many"	4	"Oligodendrocyte precursor cells: 115.1"	"Cancer enhanced"	"Detected in some"		"renal cancer: 1.7"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HeLa: 6.0;Karpas-707: 9.6;PC-3: 3.3"	"Low region specificity"	"Detected in many"			"Region enriched"	"Detected in all"	8	"cerebellum: 45.8"	HPA060767			Approved	Vesicles	"Secreted to extracellular matrix"	NA	NA		560000		"Cluster 6: Brain - Smell perception"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Vesicles		"HPA060767: AB_2684357"	"unprognostic (2.17e-1)"	"unprognostic (6.45e-4)"	"unprognostic (8.60e-2)"	"unprognostic (2.65e-5)"	"unprognostic (9.85e-2)"	"unprognostic (2.51e-4)"	"unprognostic (3.37e-2)"	"unprognostic (3.61e-2)"	"unprognostic (1.56e-1)"	"unprognostic (5.07e-4)"	"unprognostic (2.86e-2)"	"unprognostic (2.34e-1)"	"unprognostic (2.23e-2)"	"unprognostic (2.13e-3)"	"unprognostic (7.76e-2)"	"unprognostic (6.91e-3)"	"unprognostic (1.21e-5)"	3.1	0.5	0.7	1.0	5.9	0.0	2.7	20.0	8.9	1.8	0.0	1.2	0.6	1.1	0.3	0.7	1.3	2.4	0.7	9.9	5.4	1.6	0.1	1.2	1.0	3.5	6.9	0.3	2.3	0.8	0.9	6.4	4.4	0.9	0.9	1.8	0.8	0.8	0.4	1.4	1.8	1.4	0.0	0.0	0.7	0.4	3.0	0.3	1.4	0.4	0.8	1.6	1.5	1.1	0.0	0.8	0.0	0.0	0.0	0.0	0.0	1.3	0.3	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.6	0.0	0.1	0.0	6.0	0.0	0.0	0.0	0.0	0.3	1.1	0.0	1.3	0.0	0.9	0.0	0.0	9.6	0.0	0.0	0.0	0.1	0.9	0.0	3.3	0.0	0.0	0.0	0.2	0.0	0.7	0.0	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	5.9	20.0	8.9	9.9	5.4	3.5	6.9	4.4	0.0	3.0	1.1	10.2	0.0	0.6	0.0	0.0	1.8	0.3	1.3	0.6	14.1	0.2	0.1	7.1	1.5	1.8	0.0	0.0	4.4	0.0	0.0	0.0	1.5	0.1	0.0	2.0	18.9	0.0	0.0	24.9	2.0	1.4	2.4	0.0	0.1	0.0	0.0	2.5	0.0	0.3	8.4	8.0	0.1	0.0	0.0	1.0	0.0	3.1	0.1	1.8	10.3	0.0	0.1	0.0	115.1	0.5	0.1	0.0	4.5	0.0	1.1	4.0	1.1	0.8	0.7	0.0	0.2	0.3	0.1	0.2	0.1	1.7	1.9	0.8	0.0	0.6	0.2
TMEM233	"DSPB2, IFITMD2"	ENSG00000224982	"Transmembrane protein 233"	B4DJY2	12	119593774-119643075	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"skeletal muscle: 66.6;tongue: 21.2"	"Group enriched"	"Detected in some"	5	"granulocytes: 79.1;Skeletal myocytes: 77.8"	"Cancer enriched"	"Detected in many"	6	"thyroid cancer: 12.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"hTEC/SVTERT24-B: 22.2;hTERT-RPE1: 9.0;RH-30: 11.8;U-2197: 17.9;U-87 MG: 70.3"	"Not detected"	"Not detected"							"HPA047506, HPA075435"	Uncertain		Approved	Nucleoplasm		NA	NA				"Cluster 80: Striated muscle - Unknown function"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 60: Granulocytes - Receptor signaling"	Nucleoplasm		"HPA047506: AB_10963068, HPA075435: "	"unprognostic (1.46e-2)"	"unprognostic (1.16e-2)"	"unprognostic (1.39e-3)"	"unprognostic (1.03e-2)"	"unprognostic (1.99e-3)"	"unprognostic (1.71e-2)"	"unprognostic (5.86e-2)"	"unprognostic (1.55e-2)"	"unprognostic (2.06e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.63e-2)"	"unprognostic (4.41e-2)"	"unprognostic (6.06e-2)"	"unprognostic (3.10e-3)"	"unprognostic (2.94e-1)"	"unprognostic (4.38e-2)"	"unprognostic (3.66e-1)"	0.7	0.6	4.6	0.1	6.6	0.0	0.4	1.1	9.0	0.4	1.3	0.2	0.2	0.3	0.2	0.3	0.2	0.5	1.2	4.4	2.5	1.3	0.6	0.9	0.2	1.8	1.4	0.9	0.2	1.3	0.8	0.1	1.8	0.6	0.2	0.2	0.5	0.3	66.6	0.1	0.3	0.4	1.4	0.2	0.3	0.2	3.4	0.9	14.3	21.2	0.2	1.0	0.3	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.9	1.7	0.0	22.2	0.0	9.0	0.1	0.0	0.0	0.1	5.1	0.0	0.0	0.0	0.0	0.0	1.0	0.0	11.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	17.9	0.0	0.0	0.0	0.0	70.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	6.6	1.1	9.0	4.4	2.5	1.8	1.4	1.8	1.4	3.4	4.4	12.0	3.2	1.1	0.7	0.0	0.0	0.4	0.0	0.0	2.3	0.1	0.1	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.9	0.9	9.5	0.3	0.1	13.3	0.0	0.0	5.4	8.5	0.0	3.6	0.0	0.4	79.1	5.5	15.4	0.1	0.1	8.4	3.7	0.0	0.0	0.6	0.0	4.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	1.5	0.5	2.8	0.0	0.0	0.0	0.4	0.0	0.0	0.0	2.4	0.0	77.8	2.2	3.1	1.0	0.2	0.1	0.1	0.9	9.2	0.0	0.2
TMEM255B	"FAM70B, MGC20579"	ENSG00000184497	"Transmembrane protein 255B"	Q8WV15	13	113759226-113816995	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 65.0;Endothelial cells: 81.5;granulocytes: 39.3;Hepatic stellate cells: 105.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	6	"basophil: 31.2"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 31.2"	"Cell line enhanced"	"Detected in many"		"HMC-1: 28.6;HUVEC TERT2: 38.8;PC-3: 39.3;RPMI-8226: 25.1;TIME: 35.9;U-87 MG: 40.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			HPA043334	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Nucleoplasm		"HPA043334: AB_10795982"	"unprognostic (2.20e-1)"	"unprognostic (2.57e-3)"	"unprognostic (2.05e-2)"	"unprognostic (1.36e-1)"	"unprognostic (4.90e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.88e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.99e-1)"	"unprognostic (4.49e-3)"	"unprognostic (3.00e-2)"	"unprognostic (9.39e-2)"	"prognostic unfavorable (4.12e-5)"	"unprognostic (4.65e-2)"	"unprognostic (1.84e-1)"	"unprognostic (4.00e-1)"	"unprognostic (2.83e-1)"	14.2	6.1	1.3	3.7	1.3	0.7	10.6	1.1	2.2	10.1	2.1	4.0	1.6	8.4	0.3	3.9	8.1	3.6	6.6	1.6	3.7	10.1	3.4	13.2	2.4	2.1	1.3	4.3	3.1	1.6	3.5	1.0	1.7	7.0	1.4	0.4	4.2	2.2	2.9	4.2	4.8	5.0	1.4	8.2	4.3	3.3	1.9	0.8	11.2	3.9	1.8	7.5	7.1	1.5	10.3	0.0	0.6	0.0	2.8	0.0	0.1	4.8	10.7	5.5	3.5	0.4	0.2	0.2	0.1	7.7	12.5	1.5	1.1	0.7	2.3	0.1	0.9	0.3	0.4	0.0	1.4	2.9	28.6	1.8	2.3	11.7	4.6	15.7	38.8	0.6	0.1	0.2	12.0	0.2	1.5	0.9	1.0	1.6	39.3	1.8	0.8	25.1	5.4	0.5	2.2	5.1	0.2	1.5	0.1	1.0	0.6	8.2	35.9	1.6	10.3	0.6	1.7	0.0	0.0	1.9	40.6	2.7	0.3	31.2	5.4	0.7	0.0	5.5	0.0	0.9	0.0	0.0	1.5	2.8	0.0	0.0	2.7	0.0	4.0	0.0	0.0	1.4	1.3	1.3	1.1	2.2	1.6	3.7	2.1	1.3	1.7	1.4	1.9	1.5	65.0	6.4	4.8	2.3	1.9	5.9	1.2	0.9	1.2	0.9	1.1	1.7	9.1	0.0	0.2	1.8	0.0	0.1	0.3	0.0	1.9	8.2	0.8	0.3	0.8	81.5	1.2	3.2	2.7	1.7	0.1	4.7	0.0	0.2	39.3	2.3	105.0	0.7	12.9	0.0	0.1	0.2	0.0	17.4	14.6	1.1	7.8	16.3	8.8	7.5	3.4	0.5	0.0	0.0	0.6	1.3	0.1	3.0	1.4	1.7	0.0	0.1	0.5	0.8	6.6	0.9	3.6	5.1	19.1	0.2	4.7	0.0	1.8	2.1	0.3	1.0
TTLL10	"FLJ36119, TTLL5"	ENSG00000162571	"Tubulin tyrosine ligase like 10"	Q6ZVT0	1	1173880-1197936	"Metabolic proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"choroid plexus: 13.1;fallopian tube: 10.7;testis: 41.9"	"Group enriched"	"Detected in many"	6	"Early spermatids: 244.1;Late spermatids: 768.4"	"Cancer enhanced"	"Detected in some"		"cervical cancer: 1.5;endometrial cancer: 1.5"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	32	"SCLC-21H: 38.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA042712	Uncertain					NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 49: Ciliated cells - Cilium organization"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 25: Spermatids - Spermatogenesis"			"HPA042712: AB_10797019"	"unprognostic (1.74e-1)"	"unprognostic (7.95e-2)"	"unprognostic (2.66e-3)"	"prognostic favorable (1.61e-5)"	"unprognostic (5.33e-2)"	"unprognostic (2.68e-3)"	"unprognostic (4.93e-3)"	"unprognostic (2.14e-3)"	"unprognostic (4.50e-1)"	"unprognostic (3.69e-2)"	"unprognostic (1.28e-2)"	"unprognostic (6.63e-2)"	"unprognostic (6.00e-4)"	"unprognostic (8.35e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.12e-1)"	"unprognostic (4.39e-2)"	1.3	0.0	0.6	0.1	0.4	0.0	1.1	0.2	0.4	1.7	13.1	0.2	0.1	0.2	0.4	0.3	10.7	0.3	0.2	0.8	0.9	0.4	0.0	2.8	0.1	2.6	3.7	0.0	0.3	0.0	2.1	1.5	1.8	0.3	0.1	0.0	0.3	0.1	0.4	0.2	0.2	0.0	2.0	0.1	0.5	41.9	0.9	0.0	0.2	0.0	0.0	0.2	0.1	0.6	0.3	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	38.5	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.6	0.4	0.2	0.4	0.8	0.9	2.6	3.7	1.8	2.0	0.9	0.6	14.4	0.0	0.5	0.0	0.3	1.8	0.7	3.0	0.0	0.1	1.4	1.0	0.8	1.5	3.4	0.0	2.1	0.0	0.9	0.9	0.0	0.5	244.1	52.2	0.6	2.1	0.0	0.0	0.2	1.3	1.0	0.3	3.6	6.5	0.0	0.0	0.4	0.0	0.0	0.0	0.1	3.1	0.0	0.0	1.1	768.4	5.3	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.1	1.5	1.0	4.5	0.0	1.5	0.4	0.1	72.5	0.1	6.6	0.9	1.0	9.3	2.1	1.0	2.0	0.1	0.9	0.0	3.6	1.3
ULBP2	RAET1H	ENSG00000131015	"UL16 binding protein 2"	Q9BZM5	6	149942014-149949235	"Predicted membrane proteins, Predicted secreted proteins"	"Host-virus interaction, Immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 6.1"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 28.9;Basal respiratory cells: 17.9;dendritic cells: 12.1"	"Cancer enhanced"	"Detected in all"		"head and neck cancer: 12.9"	"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"gdT-cell: 2.7"	"Lineage enriched"	"Detected in single"	6	"T-cells: 2.7"	"Cell line enhanced"	"Detected in many"		"SiHa: 66.7;U-2197: 47.4"									"CAB018974, HPA066741"	Approved		Supported	"Vesicles,Plasma membrane"	"Secreted in other tissues"	NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 18: U-2197 - ECM organization"	"Cluster 7: Non-specific - Mitochondria"	"Vesicles, Plasma membrane"		"CAB018974: , HPA066741: "	"unprognostic (2.09e-5)"	"prognostic unfavorable (8.07e-4)"	"unprognostic (2.38e-3)"	"unprognostic (3.90e-1)"	"prognostic unfavorable (2.44e-4)"	"unprognostic (1.26e-2)"	"unprognostic (2.38e-3)"	"unprognostic (1.47e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.99e-1)"	"unprognostic (1.75e-2)"	"unprognostic (1.42e-4)"	"unprognostic (1.68e-1)"	"unprognostic (2.06e-1)"	"unprognostic (2.14e-1)"	"unprognostic (4.86e-1)"	1.5	0.7	1.3	0.6	1.6	1.8	0.7	1.6	2.6	0.9	0.7	0.2	0.2	0.1	0.1	6.1	0.2	0.5	2.0	3.0	1.0	2.1	0.5	3.4	0.3	1.8	1.2	0.0	0.4	0.6	0.5	1.6	1.8	0.2	0.1	0.2	0.7	0.1	0.3	0.5	0.2	0.7	0.8	0.2	0.3	1.5	1.1	0.7	1.2	0.7	0.8	1.4	1.6	1.7	19.9	1.8	0.5	6.1	1.1	5.6	3.3	20.1	11.8	20.6	16.8	7.4	11.0	0.0	29.9	23.0	29.6	13.9	7.6	18.4	11.8	9.1	3.9	1.1	2.8	0.0	7.1	0.0	1.5	2.7	13.9	18.3	8.0	16.7	11.9	16.6	2.5	0.0	15.4	13.9	1.8	0.0	0.0	3.6	10.2	3.0	4.5	0.0	29.0	5.7	0.6	0.0	66.7	1.4	1.9	3.2	1.8	8.5	18.8	13.5	17.1	47.4	23.5	0.0	0.1	0.9	19.2	10.7	9.9	0.0	0.0	0.0	2.7	0.0	0.3	0.0	0.8	1.5	0.0	0.0	0.3	1.8	0.0	0.4	0.0	0.0	1.7	0.5	1.3	1.6	1.6	2.6	3.0	1.0	1.8	1.2	1.8	0.8	1.1	1.7	28.9	0.0	1.3	0.0	1.2	3.7	6.5	17.9	7.4	0.0	1.3	4.4	0.3	0.0	9.4	1.8	0.0	0.0	12.1	0.5	0.0	7.5	7.0	0.3	0.5	9.1	0.0	0.0	3.0	8.8	0.5	3.0	1.1	0.2	0.0	0.1	7.1	0.2	2.2	0.0	0.7	0.3	2.0	0.8	2.1	8.0	0.0	3.1	1.8	0.0	0.0	0.4	4.1	0.5	0.3	4.5	0.0	0.0	1.4	1.4	0.0	0.1	1.4	0.0	0.0	1.0	4.2	3.1	7.0	11.8	2.8	0.0	11.0	0.6	0.4	5.2
ZEB1	"AREB6, BZP, FECD6, NIL-2-A, PPCD3, TCF8, ZEB, Zfhep, Zfhx1a"	ENSG00000148516	"Zinc finger E-box binding homeobox 1"	P37275	10	31318495-31529814	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis, Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"	"Corneal dystrophy, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 287.8;Excitatory neurons: 276.1;Inhibitory neurons: 261.9;Microglial cells: 479.7;Oligodendrocyte precursor cells: 968.6"	"Cancer enhanced"	"Detected in all"		"glioma: 15.4"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 113.1;TIME: 87.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027524, CAB058686, CAB079943"	Enhanced		Supported	Nucleoplasm,Nucleoli		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 68: Oligodendrocytes - Mixed function"	Nucleoplasm	Nucleoli	"CAB058686: AB_2665569, CAB079943: , HPA027524: AB_1844977"	"unprognostic (1.54e-1)"	"unprognostic (3.08e-1)"	"unprognostic (3.42e-2)"	"unprognostic (1.04e-1)"	"unprognostic (4.85e-2)"	"unprognostic (7.40e-2)"	"unprognostic (1.34e-2)"	"unprognostic (5.59e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.96e-2)"	"unprognostic (3.48e-1)"	"unprognostic (2.15e-1)"	"prognostic unfavorable (7.34e-6)"	"unprognostic (5.59e-3)"	"unprognostic (1.19e-1)"	"unprognostic (1.62e-2)"	"unprognostic (1.66e-2)"	26.6	8.6	16.4	12.9	16.2	8.6	16.8	14.0	20.1	33.2	9.9	49.2	6.0	38.7	13.4	11.7	18.6	20.0	34.8	15.2	22.8	7.5	10.4	16.0	9.6	21.1	19.2	9.3	3.8	3.4	7.9	17.5	21.2	14.5	12.3	14.8	8.0	26.9	54.4	7.0	11.8	39.9	16.8	8.1	18.1	10.1	18.2	29.9	11.2	60.5	9.7	24.4	16.4	18.5	0.1	11.1	35.1	43.9	58.4	113.1	0.0	32.7	44.9	6.6	9.3	0.2	0.1	11.3	15.6	39.6	9.3	0.0	14.9	0.0	11.8	19.1	7.9	0.0	7.0	6.3	44.4	9.8	0.3	53.4	0.1	19.6	17.6	21.4	54.9	9.5	7.5	14.4	42.7	0.1	33.7	6.2	2.3	0.0	6.6	11.6	66.0	5.1	12.9	0.0	0.9	15.6	11.1	0.0	0.0	7.2	0.0	6.7	87.7	40.8	9.4	10.0	16.7	9.1	6.3	12.8	10.9	0.0	4.2	4.9	0.0	5.4	2.4	0.0	3.2	4.1	3.2	1.7	1.3	3.1	6.8	3.5	8.5	6.6	0.0	3.1	5.0	1.6	16.4	16.2	14.0	20.1	15.2	22.8	21.1	19.2	21.2	16.8	18.2	18.5	104.4	0.0	7.7	212.9	34.6	11.2	3.0	2.0	0.6	42.7	1.4	2.8	106.3	1.5	3.6	1.8	45.9	0.3	22.0	0.0	0.0	2.1	110.1	7.2	287.8	110.6	0.0	12.2	276.1	2.7	0.5	66.1	2.0	6.5	1.3	17.0	49.6	13.4	1.2	10.1	261.9	0.0	0.0	3.8	25.6	141.8	30.7	6.3	26.6	479.7	10.7	7.2	7.2	968.6	7.3	2.5	0.0	102.0	33.2	3.7	0.0	1.6	1.5	43.4	78.9	99.2	74.2	17.4	15.7	1.1	8.7	0.7	36.2	12.0	0.0	3.8